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°parcoun µono duo pragµata : h epirthµh kai h gnwhµh .
To prwto paragei gnwsh ,thn telentaia agnoia.
There are, indeed, two things, knowledge and opinion;
of which the one makes its possessor really to know, the other to be ignorant.
Hippocrates o f Kos

Abstract
Tissue engineering (TE) is a multidisciplinary science aiming at designing and developing
biological substitutes to improve, repair and/or replace tissues in human organisms. Based
on the classical tissue engineering triad presented on the first chapter (Scaffold, Source and
Signal), the scaffold acts as 3D template, the cells represent the source while the bioreactor
provides the adequate physical/chemical signal. In this thesis work all three aspects were
taken into account considering as a target the osteochondral regeneration
The osteochondral defects, regarding cartilage injuries extending deep into the subchon-
dral bone, remains a challenging task in reconstructive surgery. They are difficult to treat
because the two tissues present very different intrinsic healing capacities and completely
different anatomic structures. Among the pletora of strategies in tissue engineering the use
of a scaffold is one of the building blocks. It is a polymeric structure, biocompatible and
biodegradable, able to replicate the extracellular matrix (ECM), whose major function is
to provide a temporary support for tissue structures. The scaffold must mimic as closely
as possible the structure of living tissue from a chemical and physical point of view. This
implies specific characteristics such as high interconnected porosity, appropriate pore size
and distribution (related to the tissue to be regenerated), sufficient initial mechanical strength,
biodegradability and biocompatibility, ease of sterilisation and processability.
One of the most versatile methods for the fabrication of tissue engineering scaffolds is
the so-called Thermally Induced Phase Separation (TIPS), presented in the second chapter,
through which it is possible to obtain a porous structure with a high degree of interconnection.
It has been widely reported in literature that via targeted temperature vs. time protocols it
is easy to cover a wide range of pore dimensions (from ca. 10 µm to more than 200 µm)
ensuring simultaneously remarkable levels of porosity, which makes those structures suitable
for cell seeding, migration and colonisation.
TIPS technique is based on changes in Gibbs free energy to induce the demixing of a ho-
mogeneous polymer solution into a two-phase system. When phase separation occurs, the
homogenous polymer solution separates into a polymer-rich and polymer-lean phase. For
polymer-solvent systems, a miscibility gap can be identified in a T vs. composition diagram
and, as a function of the separation pathway, various mechanisms take place: nucleation and
growth inside the metastable region, between the binodal and the spinodal curve; spinodal
decomposition, inside the unstable region (i.e. below the spinodal line). Depending on the
residence time inside the metastable region and/or the cooling rate, different morphologies
can be obtained.
The most relevant operating parameters include: polymer type, solvent to non solvent ratio,
polymer concentration and temperature vs. time history. These parameters are strongly
important both in the early separation stages, when the onset of the first clusters takes place,
and in the later stages, when the structure of the scaffold skeleton consolidates. It is evident
from the aforementioned scenario that a crucial point in scaffold formation via TIPS is the
thermal pathway, which allows one to obtain different morphologies by simply modifying
the temperature vs. time protocol.
Among the all possible biocompatible polymers, the poly(a-hydroxy acids), approved by
Food and Drug Administration (FDA) of USA for clinical applications, have been extensively
studied as scaffolding materials for tissue regeneration. In the particular the poly-(L-lactic
acid) (PLLA) has attracted most interest thanks to its suitable mechanical properties, low
toxicity and predictable biodegradation kinetics. Furthermore the PLLA can be easily pro-
cessed, and its mechanical and degradation properties can be tuned as a function of the target
application.
As previous mentioned, the scaffold must present a high level of porosity and interconnectiv-
ity, but although the presence of pores is sufficient for cell growth inside the 3D structure,
it is possible to significantly improve the quality of the regeneration by focusing on the
appropriate pore size distribution. Each organ or tissue is characterized not only by a specific
cell type but also by a specific spatial organization, for example: bone, from the compact to
the sponge bone, blood vessel, three layers (tunica intima, media and adventitia), etc. This
structure determines the overall characteristics and resulting behavior of the organ.
For this reasons, obtaining a porosity gradient becomes a crucial point in order to mimic in
the best possible way the tissue to regenerate. In order to attain a gradient pore size in the 3D
structure, an experimental apparatus able to impose the desired thermal history on two sides
of a scaffold in an independent way was designed, set-up and tested. The peculiarity of the
experimental apparatus, presented in the chapter 3, is the possibility to control simultaneously
temperature(s) and cooling rate. The sample is located between two Peltier cells, controlled
by a computer interface, able to apply and control a T vs. time protocol.
Polymers alone do not possess the adequate proprieties of bioactivity, osteoconductivity
or tissue integration, and therefore to overcome these limits, composite polymer/ceramic
scaffolds are necessary. The rational is to combine the processability of the polymer with
vi
good chemical/mechanical properties of the ceramic filler. In the chapter 4 composite scaffold
PLLA/hydroxyapatite(HA) and PLLA/bioglass(BG) were presented. The scaffolds were
characterized in terms of porosity (pycnometry), molecular structure (XRD), morphology
(SEM), filler content (TGA) and chemical structure (FT-IR).
To consider a specific scaffold suitable for tissue engineering purpose, the evaluation of cell
proliferation and growth is necessary. Chapter 5 presents the cell culture of different cell
strains in diverse substrates.
To evaluate the separate influence of scaffold morphology on chondrocyte growth and differ-
entiation, PLLA scaffold with two different average pore dimensions were tested. Similarly,
mesenchimal stem cell were cultured in gradient pore scaffold (from ~70 µm to ~200 µm)
to assess their suitability. On the other hand chondrocytes and osteoblasts were cultured in
PLLA/BG and PLLA/HA scaffolds, respectively, to check the influence of the filler in the
3D structure in relation to cell adhesion, proliferation and gene expression compared to the
neat polymeric scaffold.
In this thesis work the three aspects of the typical tissue engineering pathway were considered.
In particular, in chapter 6 a bioreactor able to replicate in vitro microphysiological conditions
of the osteochondral junction was characterized and tested with the gradient pore size scaffold.
The bioreactor consists of a dual chamber system to maintain separate chondrogenic/osteogenic
specific differentiation media. A removable insert hosted the scaffold seeded with human
bone marrow-derived mesenchymal stem cells (hBMSCs). The insert containing the gradient
pore scaffold was positioned with the smaller pore side in the chondrogenic medium chamber
(upper chamber) and the larger pore size in the osteogenic medium chamber (lower chamber).
At the end of the cell culture period, cell viability, gene expression and histological staining
were carried out.
vii

Sommario
L’ingegneria tessutale (TE) è una scienza multidisciplinare che mira a progettare e sviluppare
sostituti biologici per migliorare, riparare e/o sostituire i tessuti negli organismi umani. Sulla
base della tipica triade dell’ingegneria tessutale è incentrato il primo capitolo Scaffold, Source
and Signal; lo scaffold funge da struttura tridimensionale, le cellule rappresentano la source
mentre il bioreattore fornisce gli adeguati segnali chimico/fisici. In questo lavoro di tesi sono
stati presi in considerazione tutti e tre questi aspetti avendo come obiettivo la rigenerazione
osteocondrale.
La guarigione dei difetti osteocondrali, riguardanti le lesioni della cartilagine che si esten-
dono fino in profondità nell’osso subcondrale, rimangono tutt’oggi un difficile compito della
chirurgia ricostruttiva. Tali difetti sono difficili da trattare perché i due tessuti hanno differenti
capacità intrinseche di guarigione e diverse strutture anatomiche. Tra la pletora di strategie
nella rigenerazione dei tessuti lo scaffold è sicuramente uno degli elementi costitutivi. Si
tratta di una struttura polimerica, biocompatibile e biodegradabile, in grado di replicare la
matrice extracellulare (ECM), la cui funzione principale è quella di fornire un supporto
temporaneo per il tessuto vivente. Lo scaffold deve imitare nel miglior modo possibile il
tessuto da rigenerare, il che implica adeguata resistenza meccanica, biodegradabilità, bio-
compatibilità, facilità di sterilizzazione e lavorabilità.
Uno dei metodi più versatili per la produzione di scaffold è probabilmente la Separazione
di Fase Indotta Termicamente (TIPS), presentato nel secondo capitolo, mediante la quale è
possibile ottenere una struttura porosa con un elevato grado di interconnessione. In letter-
atura è stato ampiamente dimostrato che mediante opportuni protocolli tempo/temperatura
è possibile coprire un ampio range di dimensioni dei pori (da circa 10 µm a oltre 200 µm)
assicurando contemporaneamente notevoli livelli di porosità, rendendo tali strutture idonee
alla coltura cellulare.
La TIPS si basa sulla riduzione di energia libera di Gibbs per indurre la smiscelazione di una
soluzione polimerica omogenea in un sistema bifasico. Nel momento in cui si verifica la
separazione di fase, la soluzione polimerica omogenea si separa in una fase ricca in polimero
e una povera in polimero. In funzione della storia termica avvengono meccanismi di sep-
arazione differenti: nucleazione e crescita all’interno della regione metastabile (tra curva
binodale e curva spinodale) o decomposizione spinodale all’interno della regione instabile
(al di sotto della linea spinodale). In funzione del tempo di permanenza all’interno delle varie
regioni e/o della velocità di raffreddamento è possibile ottenere diverse morfologie finali
dello scaffold.
I parametri operativi più importanti sono: tipologia di polimero, rapporto solvente/non
solvente, concentrazione di polimero e storia termica. In particolare mantenendo constanti
tutti gli altri parametri, variando semplicemente il protocollo tempo/temperatura è possibile
ottenere morfologie dello scaffold molto diverse tra loro. Tra tutti i possibili polimeri biocom-
patibili, la famiglia dei poli(a-idrossiacidi), approvati dalla Food and Drug Administration
(FDA) degli Stati Uniti per applicazioni cliniche, è stata ampiamente studiata come materiale
per la reallizzazione di scaffold. In particolare all’interno di tale famiglia l’acido poli-L-
lattico (PLLA) ha attirato notevole interesse grazie alle sue buone proprietà meccaniche,
facilità di lavorazione e velocità di degradazione controllabile.
Come evidenziato precedentemente, lo scaffold deve possedere un’elevata porosità e inter-
connettività, ma sebbene la sola presenza dei pori sia sufficiente per la ricrescita delle cellule
è tuttavia possibile incrementare significativamente la qualità della rigenerazione ponendo
l’attenzione sulla distribuzione di dimensione dei pori. Ogni organo o tessuto non è solo
contraddistinto dalle diverse tipologie di cellule che lo compongono, ma anche e soprattutto
dal modo in cui queste cellule e la matrice che le circonda sono organizzate nello spazio,
cosa che determina le caratteristiche globali e il funzionamento dell’organo. Esempi in tal
senso sono: le ossa, dal tessuto osseo compatto al tessuto osseo spugnoso; i vasi sanguigni,
tunica intima, media e avventizia, ecc.
Al fine di ottenere uno scaffold che presenti un gradiente di dimensione dei pori è stato
realizzato e testata una strumentazione sperimentale in grado di imporre una data storia
termica ai due lati del campione in modo indipendente. La peculiarità di tale strumentazione,
presentata nel capitolo 3, è la possibilità di controllare contemporaneamente la temperatura e
la velocità di raffreddamento.
I polimeri da soli non possiedono le proprietà adeguate di bioattività, osteoconduttività e
capacità di integrazione nei tessuti, un modo per superare tali limitazioni è la produzione
di scaffold compositi polimero/ceramico. L’idea è quella di combinare la processabilità del
polimero con le buone proprietà chimico/fisiche del riempitivo ceramico. Scaffold compositi
PLLA/idrossiapatite (HA) e PLLA/bioglass(BG) sono presentati nel capitolo 4 . Gli scaffold
sono stati caratterizzati in termini di porosità (picnometro), struttura molecolare (XRD),
morfologia (SEM), contenuto di riempitivo (TGA), e struttura chimica (FT-IR).
Affinché un determinato scaffold possa essere considerato idoneo per l’ingegneria tessutale è
x
necessario valutarne la sua capacità di favorire la coltura cellulare. Il capitolo 5 presenta i
risultati delle colture di diversi tipi cellulari in varie tipologie di scaffold.
Per valutare la sola influenza della morfologia dello scaffold sulla crescita e la differenzi-
azione dei condrociti, sono stati realizzati scaffold in puro PLLA con due diverse dimensioni
dei pori. Allo stesso modo sono stati seminate cellule staminali mesenchimali per verifi-
care l’idoneità degli scaffold con gradiente di dimensioni dei pori (da ~70 µm ~200 µm)
alla crescita cellulare. D’altro canto sono stati seminati condrociti e osteoblasti in scaffold
compositi PLLA/BG e PLLA/HA, rispettivamente, per verificare l’influenza del riempitivo
nella struttura 3D in relazione all’adesione, la proliferazione e l’espressione genica cellulare
rispetto al puro polimero.
In questo lavoro di tesi sono stati analizzati tutti e tre gli aspetti del tipico protocollo
dell’ingegneria dei tessuti. In particolare nel capitolo 6 è stato caratterizzato e testato un
bioreattore in grado di replicare in vitro le condizioni microfisiologiche in vivo della giun-
zione osteocondrale. Il bioreattore è costituito da una sistema a doppia camera per mantenere
separati i mezzi di differenziazione condrogenico e osteogenico. Lo scaffold con gradiente
di dimensioni di pori è stato posto all’interno di un inserto estraibile e seminato con cel-
lule staminali mesenchimali umane estratte dal midollo osseo (hBMSCs). Lo scaffold è
stato posto i pori di dimensioni inferiori nella camera con il mezzo condrogenico (camera
superiore), mentre l’estremità con i pori maggiori è stata posta nella camera con il mezzo
osteogenico (camera inferiore). Al termine del periodo di coltura sono stati effettuati test di
vitalità cellulare, espressione genica e colorazioni istologiche.
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Chapter 1
Introduction
1.1 Tissue engineering (TE)
According to the definition provided by R. Langer and C. Vacanti in 1993 "Tissue engineering
is an interdisciplinary field that applies the principles of engineering and the life sciences
toward the development of biological substitutes that restore, maintain, or improve tissue
function". Tissue engineering has evolved from the integration of knowledge of diverse
fields; cell and developmental biology, basic medical and veterinary sciences, transplantation
science, biomaterials, biophysics, biomechanics and biomedical engineering (O’Brien, 2011).
On 1992 Eugen Bell defined tissue engineering as a list of a specific aims:
• Providing cellular prostheses or replacement parts for the human body
• Providing formed non-cellular replacement parts capable of inducing regeneration
• Providing tissue or organ-like model systems populated with cells for basic research
and for many applied uses such as the study of diseased states using aberrant cells
• Providing vehicles for delivering engineered cells to the organism
• Surfacing non-biological devices to create hybrid devices and systems
Three different strategies can be individuated to pursue such goals:
1. Individual or small clusters of viable cells reintroduced into the body. This strategy is
applicable in particular tissue in which the cells can directly interact with the living
tissue such as hepatocytes, myocytes, etc. It eliminates the need for a surgery.
2. Injection of an appropriate tissue-inducing agent able to stimulate the injured tissue for
self-recovery; example of tissue-inducing agents are cytokines and growth factors.
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3. Cells accomodated within matrices. This strategy can be used in two ways: Closed
system - cells or growth factors are contained in closed membranes that allow flow of
nutrients and waste; Open system - cells are seeded or attached in scaffold and finally
implanted in vivo.
To reach these targets a synergic cooperation between several knowledge fields is neces-
sary. TE covers a broader range of applications and it is closely connected with other fields,
i.e. transplantation of cells that perform a specific biochemical function (e.g., an artificial
pancreas, or an artificial liver). The term regenerative medicine is often adopted as synonym
of TE, althouth the first one focuses more on stem cells to produce tissue.
Among the different strategies the most adopted is probably the use of porous biodegradable
3-dimensional (3D) scaffold able to simulate the extracellular matrix (ECM) of the tissue to
regenerate. Considering that each tissue is characterized by different functions and features,
the scaffold should replicate as closely as possible the body structure to regenerate from a
physical and chemical point of view. The scaffold characteristics strongly depend on the
material and the production technique. The crucial point is the ability to shape the scaffold in
the suitable cell environment for the specific tissue.
The typical tissue engineering triad is composed by a triple S: Signal, Source and Scaffold
(fig. 1.1).
The signals can be chemical (growth factor) or physical (bioreactor), the source is the cell
culture, while the scaffold acts as 3D template. Depending on the final purpose, membranes,
tubes, gels or matrices can be developed.
Membranes are adopted when a barrier between two environments are necessary. Membrane
technology is of major importance in medical applications, in particular in a number of life
saving treatment methods. In literature is possible to find several applications involving
membrane engineering (Stamatialis et al., 2008): transdermal drug delivery (Pérez et al.,
2013), dialysis (Barzin et al., 2004), blood oxygenation (Messai et al., 2015), artificial liver
(Bikhchandani et al., 2011), artificial pancreas (Munkhjargal et al., 2015), etc.
Tubular biomaterial are primarily adopted for vascular tissue engineering (Nemeno-Guanzon
et al., 2012). Several tissue engineering strategies have emerged to address biological flaws
at the blood-material interface of the synthetic scaffolds. The biomaterial design have been
directed towards the generation of materials that does not only mimic the native vascular
tissue’s mechanical properties but also promote cell growth, inhibit thrombogenicity, and
facilitate extracellular matrix production (Ravi and Chaikof, 2010). The principal ECM
proteins of blood vessel are: collagen, elastin, fibronectin, vitronectin, and laminins (Parˇzek
et al., 2011). Materials for vascular replacements should be biomimetic and resistant not
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Fig. 1.1 Typical tissue engineering triad: Signal (growth factor-chemical or bioreactor-physical),
Source (cells) and Scaffold (3D network)
only to thrombosis, but also to inflammation and neointimal proliferation. Several materials
and technique has been adopted for vascular replacement, such as: polyglycolic acid (PGA)
(Xu et al., 2008), chitosan via TIPS technique (Zhang et al., 2006), poly(glycerol sebacate)
(PGS) (Gao et al., 2006), materials derived from amniotic membrane (Lee et al., 2012), etc.
Hydrogel biomaterials can encapsulate and represent a specialised environment for isolated
cells (Wolf et al., 2012). Collagen gels, as an example, can be used for the preservation and
immunoprotection of xenograft and homograft cells, such as hepatocytes or chodrocytes, used
for transplantation. Gels are particularly suitable in applications such as bone and cartilage
tissue regeneration where polymerization in situ can a be an useful route (Bhattacharjee et al.,
2015; Haleem-Smith et al., 2012; Ni et al., 2014). Semipermeable gels can be a support for
cells in systems where cell-cell communication and interaction with surrounding tissue has
to be minimised as well as the movement of peptide factors and nutrients through the implant
(Nichol et al., 2010).
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1.2 Bone
Bone tissue is a particular type of connective tissue specialised in support function. The
tissue is constituted by an extracellular matrix, mineralised, and by four cell components:
osteoblasts, bone lining cells, osteocytes, and osteoclasts.
Bone is composed by inorganic and organic matrix. The organic matrix is basically composed
by collagenous proteins (90%), in particular type I collagen, and non collagenous proteins
including osteocalcin, osteopontin, bone morphogenetic proteins (BMPs) and growth factors
(Aszódi and Bateman, 2000).
The inorganic material of bone consists on calcium phosphate in the form of hydroxyap-
atite crystals, Ca10(PO4)6Ca(OH)2 (about 85%), calcium carbonate (~10%) and traces of
the salts and elements (magnesium phosphateMg3(PO4)2, calcium fluorideCaF2, sodium,
potassium, etc.)
Bone matrix provides not only mechanical support on the body but also an essential role on
homeostasis (constant concentration) of calcium.
Depending on the shape of the bones it is possible to classify them on: long bones, short
bones, flat bones is possible to distinguish (fig. 1.2).
Leg and arm bones (femur, radius, phalanges and others) are examples of long bones. Long
bone consists in a central part (diaphysis) and two terminal parts (epiphyses). Long bones
are composed of a hard outer surface of compact bone and a spongy inner. At the epiphyses
is located the red bone marrow, while the yellow bone marrow is located in a cavity within
the diaphysis.
Short bones are wider than long and have a primary function of providing support and
stability with little movement. Examples of short bones are the carpals and tarsals.
Flat bones have different shapes and dimensions. They are strong, flat plates of bone with the
main function of providing protection to the bodies vital organs and being a base for muscular
attachment. Flat bones consists in two layers of compact bone tissue. Classic examples of a
flat bones are: scapula (shoulder blade), sternum (breast bone) and cranium (skull).
Two additional types of bone are: sesamoid bones, usually short or irregular bones imbedded
in a tendon, and irregular bones, with a non-uniform shape.
Two types of bone tissues can be individuated: compact bones and spongy bone. The
first one has higher density than the second one, due to higher packed structure. Externally,
the bone is covered by a fibrous connective twisted bundles tissue, the periosteum, while the
diarthrodial joints are covered with articular cartilage. In the case of the shaft of long bones,
the spinal canal is covered by the endosteum, thin vascular membrane of connective tissue
that lines the surface of the bony tissue.
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Fig. 1.2 Different types of bones in the human body: long bones, short bones, flat bones and irregular
bones
The organic components of the bone are: collagen, proteoglycans, some non-collagenous
proteins, cytokines and growth factors. The most abundant element is the type I collagen,
which is organized into fibers, supporting the sedimentation of salts during the mineralization
process.
Four types of cells contribuite to homeostasis: osteoblasts, osteoclasts, osteocytes and
osteogenic cells. Osteoblasts are bone forming cells, supporting to the bone formation.
Osteoblasts make and pack the matrix molecules, collagen protein fibres, and ions, Ca2+
and PO4 , for release into the extracellular environment. Once released, the molecules in
the matrix react with each other to form a rigid yet flexible bone tissue called osteoid that
eventually hardens to form bone.
Osteoclasts cells are responsible for the dissolution and absorption of bone. Osteoclasts
are formed by the fusion of many cells derived from circulating monocytes in the blood.
In contacts with bone, osteoclasts produce enzymes, among which the acid phosphatase.
Osteoclasts dissolve both the collagen and the inorganic calcium and phosphorus of the bone
in two steps. In the first step, the mineralized bone is broken into fragments, in the second
step the osteoclasts consume the fragments and digests them within cytoplasmic vacuoles.
The osteocyte is an osteoblast embedded within the bone matrix, occupying a small chamber
called lacuna, which is contained in the calcified matrix of bone. Osteocytes are the most
abundant cell type in mature bone tissue, surviving as long as the bone lifespan (up to
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decades). The osteocyte is capable of bone deposition and resorption. It is also involved
in bone remodeling by transmitting signals to other osteocytes in response to even slight
deformations of bone caused by muscular activity.
The osteogenic cells are the only ones able to divide via mitosis mechanism. They are
undifferentiated cells with high mitotic activity, able to differentiate in osteoblast cell and
involved in the bone formation process.
The equilibrium among these cells maintains a health bone tissue.
Fig. 1.3 Internal structure of a bone: compact bone, outside, to provide the adequate mechanical
properties; sponge bone, inside, with large pores to host the bone marrow
In figure 1.3 the internal structure of a long bone is reported. The compact bone forms a
shell around cancellous bone. Mature compact bone is lamellar, or layered. The structure is
organized around vascular cavities to ensure the properly supply of nutrients to the osteocytes
arranged in concentric lamellae; these channels can be parallel to the bone axis, Haversian
canals, or transversally to the axis, Volkmann channels.
The bone is arranged in concentric layers around those canals, forming structural units called
osteons, with a thickness from 4.5 to 11 µm. Immature compact bone does not contain
osteons and exhibits a woven structure. It forms around a framework of collagen fibres and
is eventually replaced by mature bone in a remodeling process of bone resorption and new
bone formation that creates the osteons.
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The spongy bone is a inner part of bone enclosing numerous large spaces that give a hon-
eycombed or spongy appearance. The bone matrix, or framework, is organized into a
three-dimensional latticework of bony processes, called trabeculae, arranged along lines of
stress. The spaces inside the trabeculae is filled with marrow and blood vessels.
Bone diseases are disorders and conditions that cause abnormal development and/or
impairment in normal bone development. The main bone diseases are:
• Osteoporosis, characterized by an abnormal loss of bone mass and disintegration of
bone structure;
• Imperfect osteogenesis, genetic disorder characterized by brittlness bones;
• Osteomalacia, abnormal bone formation caused by a defect of vitamin D, the name is
Rickets if the disease affects young people;
• Paget’s disease, error in balancing between osteoblasts and osteoclasts populations that
causes imperfect rebuilding and remoulding of bone tissue.
1.3 Cartilage
Cartilage is an important structural component of the body. It is a firm tissue but softer
and much more flexible than bone. The cartilage is a metabolically active tissue, but the
chondrocytes (corresponding to about 1% of the volume of hyaline cartilage) have a rela-
tively slow turnover. Irrespective of cartilage species (joint, tracheal, laryngeal, nasoseptal,
auricular cartilage etc.) it possesses low repair capacity due to the lack of vascular system
that could support repair and remodeling. Furthermore, chondrocytes have not direct access
to progenitor cells, as for many other tissue, then the limited capacity of self-renewal implies
that even minor injuries may lead to progressive damage and degeneration.
Chrondrocytes are chondroblasts (cells that produce the collagen extracellular matrix) that
are caught in the matrix. They lie in spaces called lacuna with up to eight chondrocytes
located in each.
The base substance of cartilage is chondroitin sulfate and the microarchitecture is subtantially
less organized than in bone. It is possible to distinguish three major types of cartilage that
differ in biochemical composition and structure of extracellular matrix (ECM) (which implies
a variety of mechanical properties).
• Elastic cartilage
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• Hyaline cartilage
• Fibrocartilage
The elastic or yellow cartilage is characterized by chondrons with few cells and small
concentration of proteoglycans (PGs), but much elastin. Elastin is the protein giving flex-
ibility to the tissue, it is interwoven in the collagen mesh. This tissue is less vulnerable to
degenerative process. It is found in the epiglottis (part of the larynx) and the pinnae (the
external ear flaps of many mammals including humans). Elastin fibers turn dark purple/black
with Verhoeff stain.
Hyaline cartilage is the most widespread cartilage type and, in adults, it forms the articular
surfaces of long bones, the rib tips, the rings of the trachea, and parts of the skull. The name
is due to the glassy appearance and it is predominately collagen with few collagen fibers.
Hyaline cartilage is the first step of ossification before the formation of bone. The hyaline
cartilage is externally covered by a fibrous membrane, called perichondrium except at the end
of long bone. It consists of a rounded or bluntly angular cells, linked in groups of two or more
forming a homogeneous matrix. Hyaline cartilage presents high resistance to compression
and high tensile force for the relevant presence of collagen type II combined with high con-
centration of PGs. Articular cartilage is a particular type of hyaline cartilage, presents on the
articular surfaces of bones. Figure 1.4 reports the schematic structure of the articular cartilage.
Fibrocartilage has different types of collagen fibers (Type I and Type II), and it tends to
grade into dense tendon and ligament tissue. The fibrocartilage consists of a mixture of white
fibrous and cartilaginous tissue. Flexibility and toughness are the results of this combination,
the elasticity is basically due to cartilaginous tissue. Like the elastic type, the fibrocartilage
contains small amount of PGs, but on the contrary small concentration of elastin. An example
of fibrocartilaginous is the meniscus, but also the pubic symphysis and annulus fibrousus.
Among the possibles disease of the cartilage the costochondritis is probably the most common.
It is an inflammation of the cartilage that connects a rib to the breastbone (sternum), causing
severe pain. Other typical cartilage diseases are: herniation, achondroplasia, polychondritis,
etc.
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Fig. 1.4 Extracellular matrix of articular cartilage. The interaction between collagen and
proteoglycans provides the compressive and tensile strength of the tissue, from Sophia Fox et al.
(2009)
1.4 Osteochondral junction
The osteochondral junction is composed of the articular cartilage and the subchondral bone.
This region has a multilayered structure, connecting the articular cartilage through the
calcified cartilage with the subchondral bone.
This body structure is present in many joints in the human body, where cartilage connects to
the subchondral bone, as the diarthrodial joints, knee or hip, or the fibrocartilaginous joints
such as the intervertebral discs.
The osteochondral junction has a complex structure because several different tissue exist in a
very small space. The upper part is the uncalcified cartilage, characterised by three layer: on
the top, the superficial zone with collagen fibrils aligning parallel to the articular surface; a
deep zone where chondrocytes and fibrils are organised perpendicular to the articular surface
and a transition middle zone with less organization compared to the other two layers.
The deepest zone is the subchondral bone, consisting in a almost impermeable cortical bone.
The thickness of the subchondral bone is around 2mm but it varies as a function of location,
age and joint degeneration.
Between the uncalcified cartilage and the subchondral bone a wavy tidemark of basophilic
matrix is present, the calcified cartilage. This latter provides mechanical stability and
resistance against shear stress. It is composed by a large amount of HA (~65%), metabolically
9
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active, including the ability to remodel with loading and aging. The thickness is maximum,
~200 µm, at 20 years old, and gradually decreases with age until 100 µm. (Lopa and Madry,
2014; Yousefi et al., 2014)
Figure 1.5 reports the osteochondral junction structure from articular cartilage to subchondral
bone.
Fig. 1.5 Osteochondral junction divided into five different zones. From the top to the bottom. 1 -
Superficial zone has chondrocytes and collagen fibres parallel to the joint surface; 2 - Middle zone in
which collagen fibres interlacing each other without a specific spatial organisation; 3 - Deep zone
has fibres perpendicular to the joint surface; 4 - Tidemark of basophilic matrix; 5 - Subchondral bone,
a thin cortical lamella, lying immediately beneath the calcified cartilage
The most common disease of the osteochondral junction is the osteoarthritis. It is a
chronic, degenerative disease of the articular joint that involves cartilage, bone, tendon, and
peri-articular muscle. Healthy cartilage allows bones to move over one another and it absorbs
energy from the shock of physical movement. In osteoarthritis, the cartilage breaks down,
causing pain, swelling and problems when moving the joint. At further steps bits of bone or
cartilage may chip off and float around in the joint. Osteoarthritis affects above all patients
older than 40 of all races and sexes. Until now there are not specific medical treatments
for the osteoarthritis, the only possibility being to reduce pain and improve function of the
affected joints (Lozito et al., 2013).
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1.5 Scaffold for tissue engineering purpose
Scaffold is one of the other major component of the tissue engineering approach; the choice
of scaffold includes its constitutive material, its design and often the surface or bulk treatment.
The scaffold is a three-dimensional support suitable for the growth of a tissue or an organ. The
aim of the scaffold is the temporary replace of extracellular matrix to support the proliferation
and growth of cell. Several studies showed that, without a guide, the cells tend to organise in
a two-dimensional (2D) layer forming a flat structure with poor mechanical properties (Tian
et al., 2008). In particular, by using scaffolds, transplanted cells can be delivered to a specific
place in a tissue driving the growth of cells inside a desired site. Thus scaffolds represent the
space available for the tissue to develop and a physical support for cells growth.
To achieve these objectives, the scaffold must possess some basic requirements:
• Biocompatibility. A materials causing minimal biological responses is considered
biocompatible. In tissue engineering a biocompatible materials is defined as able to
generate the most appropriate cellular or tissue response in the specific tissue to regen-
erate. Chemistry, structure, morphology or specific surface treatment are important
parameters that can determine the scaffold’s biocompatibility.
Adhesion and proliferation of cells on materials primarily depends on the surface
characteristics such as wettability, bulk chemistry, surface roughness, hydrophilic-
ity/hydrophobicity ratio, etc.
• Biodegradability. One of the peculiarity of the scaffold is the degradation in a natural
environments. This includes changes in chemical structure, loss of mechanical and
structural proprieties and, at the end, the complete conversion in other small molecules
such as water, carbon dioxide and various minerals. The biodegradation of the materials
is due to chemical, biological and physical forces depending on temperature, pH,
humidity, etc.
• Architecture. The morphology of the scaffold depends on the specific application
(large or small pore size, interconnection, shape). A porous structure is usually needed
for two critical functions. First, pore channels provide ports of entry for migrating cells
or for capillary suction of blood. Secondly, a large area is available for specific and
numerous cell interactions. In particular microporosity is fundamental for capillary
ingrowth and cell-matrix interactions while macroporosity for nutrients supply and
waste removal of cells grown on the scaffold.
• Mechanical properties. Scaffolds provide mechanical and shape stability to the tissue
defect. The intrinsic mechanical properties those of biomaterials used for scaffolding
11
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or their post-processing properties should match the host tissue. Recent studies demon-
strated the connection between the mechanical characteristics and the cell seeding
efficiency (mechanobiology, Jansen et al. (2015)).
• Sterilizability. Typical sterilisation process for biomaterials are: autoclave, UV, gamma
or ethylene oxide treatment. These treatments are often poorly adapted to polymeric
scaffolds due to their low melting points and degradation mechanisms. Furthermore,
some methods can provoke undesirable polymer chain scission or crosslinking with an
alteration of the final properties. Thus, the effect of the sterilisation procedure must be
accounted for in the scaffold design process.
Several different types of biomaterials has been used for tissue engineering purposes,
but the most important are natural and synthetic polymers. Ceramic materials are also used,
particularly in combination with polymers, forming composite materials with improved
mechanical and biological properties. In the next two paragraphs a small overview about
synthetic and natural polymers is reported.
1.5.1 Natural polymers
The natural polymers are typically biocompatible and biodegradable via enzymatic process.
The main advantage in using natural polymers is that they contain functional biomolecules
helping the proliferation, attachment and differentiation of cells. However, there are some
disadvantages, depending on the application. First of all the rate of degradation cannot be
easily controlled, that implies a difficult to determine its duration when implanted. Further-
more, natural polymers often possess quite low breaking load, although this aspect improves
considerably if the polymer is cross-linked. In figure 1.6 a panel of the principal adopted
natural polymers is reported.
• Alginate. Alginate is a naturally derived polysaccharide abundant in cell walls of
brown algae. It is a polyanion composed of two repeating monomer units: b -D-
mannuronate (M) and a-L-guluronate (G). Chain length and relative proportions
determine its physical and mechanical properties. The chemical structure of alginate
allows a complete solubility in water.
The conventional role of alginate in pharmaceutics includes its use is as thickening, gel
forming, and as stabilizing agents, alginate can also play a significant role in controlled-
release drug products. Alginate was used in bone tissue applications delivery of
osteoinductive factors or bone-forming cells, but also in combination with HA to
enhance the adhesion of osteosarcoma cells (Andersen et al., 2015; Gould et al., 2013;
Haleem-Smith et al., 2012; Huang et al., 2015; Lee et al., 2007; Wen et al., 2014).
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Fig. 1.6 Chemical structure of principal natural polymer adopted in tissue engineering, adapted from
Seal (2001)
• Collagen. Collagen is the most abundant naturally occurring protein in connective
tissue and thus constitutes a major component of the extracellular matrix, providing
mechanical support. It is a fibrous protein with a long, stiff, triple-stranded helical
structure. Due to high sequence homology between species, collagen exhibits low
cytotoxicity and immunogenicity and high biocompatibility, making it one of the
most promising biomaterials for tissue engineering. Type I (in skin and bone), type
II (cartilage) and type III (blood vessels) are the three main collagen types. Collagen-
based scaffolds have been used in a variety of tissue engineering applications: cartilage,
ligament, heart valve, haemostatic agents in form of powder, sponge, plugs, etc. (Chen
et al., 2010a; D’Anchise et al., 2005; Davidenko et al., 2012; Han et al., 2010; Juncosa-
melvin et al., 2006; Knapp, 1997; Mullen et al., 2015; Nehrer et al., 1997; Zhang et al.,
2014b)
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• Chitosan. Chitosan is a linear, semi-crystalline polysaccharide composed b (1-4) linked
D-glucosamine with randomly dispersed N-acetyl-D-glycosamine groups. Chitosan
can be derived by partial deacetylation of the chitin via enzymatic hydrolysis of
chitosanase and lysozyme. Molecular weight and deacetylation degree (DD) influence
the behaviour of the polymer. Chitosan DD varies between 60 and 100% while the
molecular weight from 300 to 1000 kDA, depending on source and preparation.
Chitosan is poorly soluble in water. It is a very good candidate for biomaterial,
possessing several remarkable properties like: haemostatic activity, antimicrobial
activity and tunable crystallinity (maximum for DD 0% and 100% and decrease for
intermediate DD) (Chicatun et al., 2013; Croisier and Jérome, 2013; Han et al., 2010;
Hsieh et al., 2007; Wu et al., 2008).
• Hyaluronic acid. Hyaluronic acid or hyaluronan is an unbranched non-sulfated gly-
cosaminoglycan (GAG) composed of repeating disaccharides (b -1,4-D-glucuronic
acid (known as uronic acid) and b -1,3-N-acetyl-D-glucosamide). This material is an
anionic polysaccharide, with extremely high water-binding capacity and very high
molecular weight (105  107 Da); this implies that also dilute solutions show high
viscosity values.
Hyaluronic acid is one of the major elements in the ECM of vertebrate tissues. It is
present in a large part of body fluids and tissue, i.e. skin, cartilage, synovial fluid,
etc. The acid is produced and secreted by cells including fibroblasts, keratinocytes,
or chondrocytes and degraded via a step-wise process in enzymatic or non-enzymatic
reactions.
Tissue engineering applications of hyaluronic acid regard dermal filler, osteoarthritis
treatment, scaffold material to support chondrocyte growth, etc. (Jakobsen et al., 2010;
Kim et al., 2008; Pietrucha, 2005; Sawatjui et al., 2014; Zhao et al., 2014; Zhu et al.,
2014)
1.5.2 Synthetic polymers
Synthetic polymers offer considerable advantages compared to the natural ones. The main
benefit is that their properties (e.g., porosity, degradation time, and mechanical character-
istics) can be tailored for specific applications. Synthetic polymers are often cheaper than
natural polymer; they can be produced in large uniform quantities under controlled conditions
assuring reproducible behaviour. Furthermore, most of the synthetic polymers exhibits a
hydrolytic degradation almost independent of the host tissue. The most common synthetic
polymers are the polyesters that include polyanhydrides, polycarbonates, and polyphos-
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phazenes (fig. 1.7). A significant disadvantage in the use of synthetic polymers is the
degradation into undesirable products such as acids that at high concentrations can cause
inflammation (Barton and McHugh, 2000; Dhandayuthapani et al., 2011; Gunatillake and
Adhikari, 2003; Guo and Ma, 2014; Ma et al., 2010; Ma and Choi, 2001; Muñoz-Bonilla and
Fernández-Garcia, 2012; Singh and Singh, 2007).
Fig. 1.7 Chemical structure of principal synthetic polymer adopted in tissue engineering, adapted
from Seal (2001)
• Poly (a-hydroxyacids). Aliphatic polyesters are, probably, the most used synthetic
polymers in tissue engineering. The Poly (a-hydroxyacids) includes: Polylactide
(PLA), polyglycolide (PGA), and their copolymer poly(lactide-co-glycolide) (PLGA).
Besides their biodegradability and biocompatibility, these polymers are approved by
the U.S. Food and Drug Administration (FDA) for human clinical applications such
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as surgical sutures and some implantable devices (Curran et al., 2013; Gentile et al.,
2014; Park et al., 2005; Stölzel et al., 2014).
Degradation rates and degradation products of these linear aliphatic polyesters depend
on composition, molecular weight, exposed surface area, crystallinity, stresses, site of
implantation and, in the case of copolymers, the ratio of the hydroxy acid monomers.
Usually these polymers are synthesised by ring-opening polymerisation and shaped in
film, tubes, matrices, etc. (Burns et al., 2010; Maquet et al., 2003; Parent et al., 2013)
• Poly(e-caprolactone). Poly(e-caprolactone) (PCL) is a semi-crystalline polymer with
a very low glass-transition temperature of around -60°C and low melting point, about
60°C. Thus, it is always in the rubbery state, with high material permeability under
physiological conditions and a quite high thermal stability (the decomposition temper-
ature is 350°C). PCL degrades by hydrolytic mechanism at slower rate than PGA or
PLA. Usually PCL is adopted as blend with other polymers to increase the degradation
time and for drug-delivery systems (Dell’Erba et al., 2001; Du et al., 2014; Dziadek
et al., 2015; Hsu et al., 2013; Kouya et al., 2013; Ma et al., 2010; Nottrodt et al., 2014;
Oh et al., 2007; Salerno et al., 2011b; Vaquette and Cooper-White, 2013; Vert et al.,
1992).
• Poly(ortho-esters). Poly(ortho-esters) are hydrophobic, surface eroding polymers that
have three geminal ether bonds. During the biodegradation, the material becomes
thinner and thinner without a breaking of the material: for this reason, it has been
exploited for drug delivery applications. Degradation of poly (ortho-esters) occurs
via hydrolysis with a self-catalyst process due to the acidic products. The capacity to
be used as typical tissue engineering scaffolds are limited by their weak mechanical
properties and the tendency to induce an inflammatory response in the body (Andriano
et al., 1999).
• Polyphosphazenes. Polyphosphazenes are inorganic/organic hybrid polymers of high
molecular weight. The polymer backbone consists of alternating phosphorus and nitro-
gen atoms and organic substituents are linked to the phosphorus atoms as side groups.
The properties of the resulting material are highly dependent on the side-substituents
and their ratios, then various synthetic methods have been used to achieve different
properties (Babensee et al., 1998; Nichol et al., 2014; Peach et al., 2012). Further-
more, the organic groups do not have to be identical; this offers the possibility to add
mixed substituents to control the functionality and the properties of the polymer, such
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as amphiphilic properties, combination of recognition and release sites, bioerodible
properties, etc. (Babensee et al., 1998; Morozowich et al., 2011; Rothemund et al.,
2015; Teasdale and Brüggemann, 2013)
1.6 Scaffold fabrication technique
The choice of the biomaterial is also related to the production technique. Many fabrication
methods have been developed in order to attain the optimum porosity, pore interconnectivity
and mechanical properties to best match those of the tissue to regenerate. Among all the
possible techniques the widely adopted are: solvent-casting and particulate leaching, phase
separation techniques, gas-foaming, CAD based technique and electrospinning.
Solvent-casting and particulate leaching
The solvent casting technique consists of dissolving a polymer in a solvent and then adding
particles of a porogen: paraffin spheres, salt particles, wax, etc. The mixture is poured in a
mold and left to dry in air or under vacuum until the complete evaporation of the solvent.
At the end of the process the porogen is leached out and the polymer creates a network of
interconnected polymer. The dimension of the pores is a function of the porogen dimension.
In the case of composites, the filler is added with the porogen and it remains after the porogen
is leached out (Yanpeng et al., 2007).
It is possible to tune the crystallinity of the polymer via thermal treatment by controlling the
cooling rate. Polylactic and polyglycolic acid are the most adopted polymer for this technique.
The main advantage is the simplicity of the method without the necessity of sophisticated
apparatus. The disadvantages is directly related to use of porogen, inhomogeneity and lack in
interconnection of pores, as well as the presence of residual porogen and solvent (Huang et al.,
2014; Kothapalli et al., 2005). In fig. 1.8 the protocol of solvent-casting particulate-leaching
technique is reported.
Gas-foaming
Gas foaming technique uses high pressure CO2 gas as porogen agent. The porosity and
porous structure of the scaffolds depend upon the amount of gas dissolved and the rate and
type of gas nucleation. Under high pressure (50 bar) the dissolved carbon dioxide becomes
unstable and it separates from the polymer. To minimise the free energy of the system the
CO2 molecules become spherical (cluster) and the results is the formation of pores (Goswami
et al., 2013; Salerno et al., 2011b; Spadaccio et al., 2009).
17
Introduction
Fig. 1.8 Schematic protocol of solvent-casting particulate-leaching technique. a) Mixing of the sieved
particles in a polymeric solution, b-c) Evaporation of the solvent leaving the polymeric structure with
salt particles, d) Removal of the salt, e) Drying in a vacuum oven, from Liu and Webster (2007)
Despite this process cause a significant expansion of polymer volume often the structure
is still to compact for the cells, then a combination between gas-foaming and particulate
leaching is adopted. Figure 1.9 reports an example of combination of gas foaming and
particulate leaching in which effervescent salt particles are used. The mix polymer and
porogen are exposed to high pressure until the complete saturation with carbon dioxide,
followed by foaming process porogen is removed. The advantage is that gas foaming does
not require the utilization of organic solvent and high temperatures that can denature the
biologically active molecules incorporated into the scaffold (Salerno et al., 2008, 2011a;
Sunny et al., 2011).
Phase separation technique
Phase separation technique is based in the induction of a demixing of a solution in two
phases, one with low polymer concentration (polymer lean phase) and the other one with
high polymer concentration (polymer rich phase). Phase separation of polymer solutions
(solvent/polymer or nonsolvent/solvent/polymer) can be induced in four different ways.
• Thermally Induced Phase Separation (TIPS). This method is based on the change
of free energy of the system by varying the temperature. After the demixing of the
solution, the solvent is removed by extraction, evaporation or freeze drying.
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Fig. 1.9 Fabrication of porous scaffolds by gas foaming/particulate leaching. The process is divided
in four steps: 1) The effervescent salt particles are dispersed in the polymer, 2) The solution is poured
in a teflon mold for solvent evaporation, 3) The solution is immersed in water for gas foaming/salt
leaching, 4) The solution is freeze dried, adapted from Chung and Park (2007)
• Air-casting of a polymer solution. In this case the polymer is dissolved in a mixture
of a volatile solvent and a non-volatile non solvent. The phase separation takes place
when the solubility of the polymer decreases caused by evaporation of the solvent.
• Precipitation from the vapour phase. The demixing is induced by penetration of non
solvent vapour in the solution.
• Diffused Induced Phase Separation (DIPS). A polymer solution is cast as a film on
a support (tube, membrane), then it is immersed in a non solvent bath. The phase
separation occur as a consequence of the change between the solvent and the non
solvent (fig. 1.10).
The technique can be easily combined with other fabrication technology to obtain 3D struc-
tures with controlled pore morphology, while to take advantage of this scaffold production
technology it is necessary to know the phase diagram of the solution, which is very different
to determine experimentally and to predict theoretically. (Akbarzadeh and Yousefi, 2014;
Chen et al., 2010b; Gong et al., 2006; Hsu et al., 2013; Hu et al., 2009, 2008; Keshaw et al.,
2010; Ma et al., 2010; Zhang et al., 2002; Zhang and Ma, 1999).
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Fig. 1.10 Example of DIPS process. A fibre cover of a binary polymeric solution PLLA/Dioxane is
immersed in a non-solvent bath, water, where the phase separation takes place, from Carfì Pavia et al.
(2010)
Electrospinning
Via electrospinning technique is possible to produce scaffolds composed of fibers from the
nanoscale to microscale. A polymer solution is pumped at a constant rate through a needle
with a small-diameter in a space exposed to a very high electric field. The field is created
by two electrodes with opposite polarity. One electrode is placed in the polymer solution
and the other is placed in the collector. The polymer solution generally consists in a polymer
dissolved in a volatile organic solvent. When the polymer solution comes out of the needle a
droplet forms on the tip of the needle and deforms into a conical shape as the applied voltage
increases and causes electrostatic repulsion on the polymer droplet.
This process implies solvent evaporation and polymer deposition (in form of fibers) on
collector’s surface. The process is very versatile in terms of use of polymers, non-invasive and
does not require the use of coagulation chemistry or high temperature for fiber generation. The
morphology of electrospun structures is greatly affected by four main adjustable parameters:
a) flow rate of the polymer solution through the syringe, b) voltage applied to the needle,
c) concentration of the polymer solution and d) the distance between the needle and the
collecting plate. It can produce fibers with specific orientation, high aspect ratio, high surface
area, and ensure control over pore geometry (fig. 1.11).
The final product is a mat composed of a continuous nanofibers that can be used in many
different applications, including drug delivery (Vakilian et al., 2015) and tissue engineering.
Moreover, the nanofiber scaffolds typically result in pore sizes on the sub-micron to few
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micron scale scaffold thickness and usually the electrospun scaffolds tend to be thin, typically
less than one millimeter with a difficulty to precisely control where the fibers are deposited
(Huang et al., 2003; Kasuga et al., 2012; Kim et al., 2006; Leach et al., 2011; Li et al., 2006,
2002a,b; Liao et al., 2012; Rowe et al., 2015; Song et al., 2015; Vaquette and Cooper-White,
2013; Wang et al., 2009).
Fig. 1.11 Setup and principle of elettrospinning
CAD based technique
Computer Aided Design (CAD)-based manufacturing technologies are being developed for
the fabrication of tissues to overcome problems due to use of "cell unfriendly" chemicals,
UV or gamma rays, lasers, and high temperatures of the traditional methods. The advantages
of this fabrication are: the direct control of the structure from microscope to macroscale
yielding biomimetic feature, the ability to easy tune design and material composition. Solid
free-form fabrication (SFF) (Lee et al., 2010) or rapid prototyping (RP) are typical examples
of CAD technique. The computer transforms the model to slices or layers and the 3D
objects are constructed layer by layer. This process can take place by using RP techniques
such as fused deposition modeling (FDM), selective laser sintering (SLS), 3D printing (3D-
P) (Chumnanklang et al., 2007) or stereolithography. Furthermore, CAD technique can
easily integrated with the imaging technique to recreate the anatomical defect for particular
applications or for an individual patient. One of the main disadvantage the process, due to
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curing and shrinkage after post-processing is the fact that it presents a low resolution and,
especially for complicated objects, deformation phenomena can occur (Giannitelli et al.,
2014). To adopt these technique, the polymer must be photopolymerisable and only a few of
biocompatible polymer can be adopted, such as: Polyethylene glycol (PEG) acrylate, PEG
methacrylate, polyvinyl alcohol (PVA), hyaluronic acid and dextran methacrylate (Sachlos
and Czernuszka, 2003; Serra et al., 2014; Wu et al., 2014; Yang et al., 2014; Zhang et al.,
2014a). In figure 1.12 a typical pathway to fabricate a scaffold via CAD techniques is
reported.
Fig. 1.12 The image represents a scaffold fabricated via RP starting from a computational modelling.
Starting from the CT scan of the defect, this latter is adopted to generate a computer-based 3D model.
Thus the scaffold is generated via RP technique layer by layer, adapted from Seol et al. (2012)
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Chapter 2
Scaffold fabrication
In this chapter materials and method adopted in this thesis work will be described. The
scaffold technique adopted for the fabrication of the scaffold is based on the thermally
induced phase separation (TIPS). The produced scaffolds are PLLA-based with diverse filler:
bioglass and hydroxyapatite.
2.1 Thermally Induced Phase Separation (TIPS)
Thermally Induced Phase Separation (TIPS) is one of the most widely adopted techniques
for scaffold production, useful to obtain a well-interconnected porous structure.
This technique is based on the change in temperature to induce the de-mixing of a homoge-
neous polymer solution, creating a multi-phase system. When the de-mixing of the solution
occurs, the homogeneous solution separates into a polymer-rich and a polymer-less phase.
The de-mixing can be solid-liquid, for binary polymer-solvent mixture, or liquid-liquid, for
ternary polymer/solvent/non-solvent mixture. As a function of the separations conditions,
it is possible to obtain different morphologies and various characteristics, such as: open or
close pores, fibrous structure, membrane, etc. (He et al., 2009; Kim et al., 2009; Phaechamud
and Chitrattha, 2016; Yang et al., 2004).
One of the biggest advantages of this technique is the possibility to obtain a well-interconnected
polymer network with a simple, fast and adaptable process.
Many polymers have been used in this technique, among all: polylactic acid (Ruggiero et al.,
2015), polyurethane (Jing et al., 2014), polycaprolactone (Salerno and Domingo, 2015), etc.
In fig. 2.1 the phase diagram of a typical ternary solution is reported. The thermodynamic
equilibrium is represented by the binodal and the spinodal curve.
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Fig. 2.1 Ternary phase diagram. a) Phase diagram temperature vs polymer concentration, b)
Isothermal phase diagram at the cloud point temperature, from Tanaka and Lloyd (2004)
At high temperatures (above the binodal curve) the polymer solution is located in the
one-phase region and the solution is homogeneous. Keeping constant the concentration
and decreasing the temperature, the solution reaches the binodal curve and de-mixing in a
polymer rich and a polymer less phase occurs. The region between binodal and spinodal
curve is the metastable region, where a mechanism of nucleation and growth takes place.
The spinodal curve takes places above the unstable region, the separation mechanism of the
phase in this region is called spinodal decomposition.
The maximum of the temperature vs composition diagram, where binodal and spinodal
curve are in contact, is called critical point. The nucleating phase depends upon the initial
concentration, before or after the critical point. By changing the nucleating phase the final
morphology will be completely different, the proportion between the two phases being
determined by the lever rule. If the initial concentration is on the left of the critical point,
the nucleation of the polymer-rich phase occurs, forming a dense phase. On the other hand,
if the concentration is on the right of the critical point, the nucleation of the polymer-lean
phase occurs. In this latter case, once removed the solvent, the polymer-rich phase will
form a polymer network, suitable for tissue engineering purpose (fig. 2.2). Figure 2.2
reports a schematic representation of the obtainable morphologies as a function of the initial
concentration of polymer. In black the polymer-rich phase, in white the polymer-lean phase.
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Fig. 2.2 Schematic representation of the obtainable morphologies in a temperature-composition
phase diagram of polymer solution, from Nam and Park (1999)
The spinodal curve, as mentioned, divides the miscibility gap in two areas, the metastable
and the unstable region. Along the spinodal curve the second derivative energy is null.
Distribution, shape and size of the pores are the result of a delicate balance between different
parameters, such as molecular weight of the polymers, concentration, cooling rate, etc...
(Akbarzadeh and Yousefi, 2014) These criteria have a significant influence not only on the
onset of the phase separation, in which the domains of the nucleating phase start to grow, but
also in the next steps. Indeed, the coalescence of the separate phase, continues minimising
the free energy due to the presence of the interfacial surfaces. This process, called coarsening,
causes the increase of the pore dimension (Li et al., 2006b).
The principal operating parameters are:
1. Polymer type and concentration
2. Polymer molecular weight
3. Solvent/non-solvent ratio
4. Cooling path
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Polymer type and concentration
As aforementioned different polymers were adopted in the TIPS technique to produce scaf-
folds with diverse properties, but there ids also the possibility to change the characteristics of
the scaffolds simply by varying the polymer concentration.
Hua et al. (2002) report the different morphologies in a PLLA/Dioxane/water system, 87/13
solvent/non-solvent weight ratio, as a function of concentration and aging. In figure 2.3 the
scaffold morphologies at different times (10, 30 minutes) and different concentration (4.5%
and 6%) are shown.
It is evident that as the polymer concentration increases, keeping constant the cooling path,
pore dimension and porosity decrease accordingly.
Fig. 2.3 Effect of the polymer concentration on the morphology of the scaffold, a) 4.5% PLLA, 10 min,
b) 6% PLLA, 10 min, c) 4.5% PLLA, 30 min, d) 6% PLLA, 30 min; adapted from Hua et al. (2002)
Polymer molecular weight
The effect of the PLA molecular weight was investigated by Chen et al. (2010). In particular,
the molecular weight for PDLLA and PLLA in fig. 2.4 are reported. Dioxane/water ratio
was 87/13 and 7.5% polymer concentration; two different molecular weight for PDLLA
and PLLA were used: Mn = 12000 and Mn = 71000 for PDLLA and Mn = 42000 and
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Mn= 170000 for PLLA.
The foams at higher molecular weight result more homogeneous compared to the other ones.
The polymer solution with PDLLA at Mv = 12000 was even unable to form a complete
scaffold structure, but a powder structure was observed. This fact can be due to the first steps
of the phase separation, during the coarsening of the separated phases. In this step, indeed,
the viscosity plays a crucial role, an increase of the molecular weight implies an increase of
the viscosity of the solution that helps the complete formation of the two phases.
Fig. 2.4 Effect of the molecular weight on the morphology of the scaffold: a) PDLLA: Mn= 12000
[2000X], b) Mn= 71000 [500X]; c) PLLA: Mn= 42000 [200X], d) 170000 [350X], from Chen et al.
(2010)
Solvent/non-solvent ratio
The solvent to non-solvent ratio is probably one of the most important parameters in the
TIPS technique as non-solvent allows the liquid-liquid phase separation. In figure 2.5 the
SEM micrographs of foam with different solvent/non-solvent ratio are reported.
The polymer adopted was PLLA with a concentration of 7.5% and the solution was directly
quenched in liquid nitrogen (-196°C). The first image (fig. 2.5a) presents a typical ladder-like
structure. This morphology is due to the presence of the solvent. In this case it is not
a liquid-liquid phase separation but a solid-liquid phase separation. There is not a cloud
point but only a freezing-point curve could be define. The ultimate scaffold structure was
dominated by the progress of the crystallization of the dioxane solvent.
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The structure completely change when adding the non-solvent. The liquid-liquid phase sepa-
ration allows the tuning of the pore dimension according e.g. to the thermal history. The other
two scaffolds (90/10 and 85/15) exhibited an isotropic lacy structure with interconnected
pores. The 85/15 foam shows larger, around 50 µm and less interconnected pores compared
to 90/10. The cloud point of the solution with higher concentration of dioxane is lower than
the other one. This means that the 85/15 spends more time inside the metastable region
compared to the 90/10 which determines at larger coarsening effect.
Fig. 2.5 Effect of the solvent/non-solvent ratio on the morphology of the scaffold: a) 100% Dioxane,
b) 90/10 Dioxane/Water, c) 85/15 Dioxane/Water; from Chen et al. (2010)
Cooling path
One of the principal advantage of the TIPS technique is the possibility to tune the structure
by changing the pathway. Starting from the same solution, the final morphology of the
scaffold can change (in terms of pore dimension, distribution, interconnectivity, etc) by
tuning the cooling path. The starting solution in the work of Carfì Pavia et al. (2008) is
PLLA/Dioxane/Water; 4% PLLA, 87/13 Dioxane/Water. In figure 2.6a the morphology of
the scaffold depending on the demixing time inside the metastable region is reported. At the
temperature of 35°C, when increasing the demixing time the pores appear larger and with a
major presence of micropores between the larger pores.
The graph in figure 2.6b reports the trend of the pore dimension as a function of the tempera-
ture and time. It is clear that at 25°C the pore size is basically independent of the demixing
time. For the examined solution at 25°C the predominant process is spinodal decomposition,
not related by the time. For the other two temperatures 30°C and 35°C, when increasing the
demixing time from 15 to 45 minutes the pore dimensions are more then quintupled.
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(a)
(b)
Fig. 2.6 Effect of the cooling path on the morphology of the scaffold. a) SEM micrographs at 35°C
and different demixing time: a1) 15 minutes, a2) 45 minutes, a3) 60 minutes; adapted from Carfì
Pavia et al. (2008)
2.1.1 Thermodynamic and kinetic aspect
Two components in a mixture, e.g. polymer/solvent, will be miscible if the Gibbs free energy
of mixing is less then zero, DGm < 0, otherwise if DGm > 0 the system will be immiscible.
A completely miscible system exists when the second derivative of the Gibbs free energy
with respect to the composition is less then zero for every composition:
∂ 2DGx
∂x 2
< 0 (2.1.1)
where ∂ 2DGx = DGmX , DGx is the molar Gibbs free energy, X the total volume or number of
moles and x the volumetric or molar fraction.
There is not difference between a total and a partial miscibility system in therms of Gibbs
free energy of mixing, in both cases , DGm < 0, is lower than zero the difference is only in
the second derivative.
In figure 2.7 the molar Gibbs free energy as a function of the composition is reported.
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Fig. 2.7 Gibbs free energy of mixing vs volumetric fraction for binary system. a) Complete miscible
system, b) Partially miscible system
Two phases in a system will be in thermodynamic equilibrium if:
Dµai = Dµ
b
i (2.1.2)
where Dµ is the chemical potential of the i species in a or b phase; defined as
Dµi =
∂DG
∂ni
    
T,P,n j
(2.1.3)
ni is the number of moles of the i component and j 6= i.
If re-writing the definition of chemical potential 2.1.3 as a function of DGx , the relation
becomes:
∂DG
∂ni
|T,P,n j = Xi

DGx +
∂DGx
∂xi
 
c 1
Â
i=1
xiDGx +
∂DGx
∂xi
 
(2.1.4)
Xi = ∂X∂ni and c is the number of species in the mixing. From 2.1.4 is possible to obtain
the chemical potential for the two species
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Dµ1 = X1

DGx +(1 x1)
∂DGx
∂x1
 
= X1

DGx +x2
∂DGx
∂x2
 
(2.1.5)
Dµ2 = X2

DGx +(1 x2)
∂DGx
∂x2
 
= X2

DGx +x1
∂DGx
∂x1
 
(2.1.6)
Combining the 2.1.5, 2.1.6 equations and indicating x = x1 = 1  x2, the equilibrium
condition can be written as
∂DG
∂x
    
xa
=
∂DG
∂x
    
xb
(2.1.7)
then on the DGx  x diagram a tangent represents the equilibrium among the two phases.
Taking into account figure 2.1 it is possible to identify the various regions from a
thermodynamic point of view.
Above the binodal curve, so-called one phase region, the solution is completely homogeneous.
The points where the equation 2.1.7 is satisfied are called binodal points and the curve
connecting these point is called called binodal curve.
Below the binodal curve the second derivative of the Gibbs free energy with respect to the
composition is positive
∂ 2DGx
∂x 2
> 0 (2.1.8)
in this metastable region, one phase is possible but it is not stable.
The inflection points, represented by
∂ 2DGx
∂x 2
= 0 (2.1.9)
are the spinodal points and the curve connecting them is the spinodal curve. Below the
spinodal curve the system is unstable, in this case
∂ 2DGx
∂x 2
< 0 (2.1.10)
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the system spontaneously demixes in two continuos phases.
The point of contact between the spinodal and binodal curve is called critical point and the
thermodynamic condition is
∂ 2DGx
∂x 2
=
∂ 3DGx
∂x 3
= 0 (2.1.11)
above this point the solution is homogenous at all compositions.
Introducing a third component the phase diagram can considerably change compared to the
binary case. The third component can increase or decrease the miscibility gap. In particular
thermodynamic conditions it is possible that a mixture of two low molecular weight liquids
can dissolve large amounts of a given polymer, whereas each of these liquids alone exhibits a
miscibility gap with the polymer. This phenomenon is called co-solvency. (Hsu et al., 2013)
Depending in which region of the diagram the phase separation occurs, the mechanism is
different. Inside the metastable region the demixing process takes place via nucleation and
growth. Inside the spinodal curve, the phase separation process takes place spontaneously,
because any fluctuation in concentration means a reduction in the Gibbs energy. In accord to
the different demixing processes, the morphology of the two phase systems looks consider-
ably different.
In figure 2.8 an example of the different mechanism occurred in the thermally induced phase
separation. In both cases the ternary solution adopted is PLLA/Dioxane/water, 4% in poly-
mer, 87/13 Dioxane/Water weight ratio is presented. In figure 2.8a the cooling path adopted
for the two morphology is reported. The first steps are common. The solution was initially
kept at 60°C to ensure the homogenisation, then the temperature was slowly decreased at
1°C/min until 35°C and maintained for 30 minutes. In the first case (blue line) the solution
was immediately quenched at -20°C, in the second case (red line) the temperature was slowly
decreased reaching -20°C at 1°C/min. Fig. 2.8b shows a closed-pore morphology typical of
nucleation and growth mechanism, fig. 2.8c shows a micro-structure with very small pores
and highly interconnected, basically related to spinodal decomposition.
In the case of nucleation and growth mechanism the droplets of the minor phase formed at
the beginning of the process grow slowly. The droplets are dispersed in a matrix of the other
phase and gradually increase their dimension.
For spinodal decomposition, the morphology is co-continuous. The driving force for this pro-
cess is the minimisation of the interface in order to reduce the Gibbs free energy of the system.
The most common way to determinate the phase diagram of a ternary system is via
experimental approach.
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(a)
(b) (c)
Fig. 2.8 Evidence of mechanism in ternary PLLA/Dioxane/Water solution, a)Thermal history, b)
Nucleation and growth mechanism, c) Spinodal decomposition; adapted from Mannella et al. (2014)
Starting from a homogeneous solution, this is brought to a specific temperature inside the
miscibility gap. Thus the solution is maintained for 12-24h, to allow the phase separation and
segregation. At the end the two formed phases are weighted and it is possible to determine
the composition (Tanaka et al., 2006).
A useful way to determine the miscibility gap is based on the detection of the cloud point.
This latter is determined by cooling or heating a given homogeneous solution until it becomes
turbid. The temperature when this phenomena occurs is called cloud point temperature Tcp
caused by the phase separation of a second phase. The reason for this milky appearance lies
in the normally pronouncedly different refractive indices of the components. The dependence
of Tcp on the composition of the mixture is called cloud point curve.
The lost of transparence can be identified via light attenuation or laser diffraction. The
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sample is placed between the laser, on the top, and a photodiode, on the bottom, and kept
at a controlled temperature. In the one phase region the solution will be transparent, when
the temperature reaches the two-phase boundary for the specific composition, the amount of
laser-light through the samples will decrease. The temperature at which occurs the variation
of intensity is the cloud point.
Theoretically the cloud point corresponds to the binodal curve but this is not always true.
The value of temperature, at certain compositions, changes as a function of the cooling
modality and rate. Furthermore, at the beginning of the demixing the domains have very
small dimension what makes them, basically impossible to determine.
Usually, the cloud point diagrams are diagrams temperature-polymer concentration. In figure
2.9 an example of the diagram is reported.
Fig. 2.9 Cloud point curves at 4% of PLLA and different Dioxane/Water weight ratio, from Mannella
et al. (2014)
When comparing the cloud point diagram to a binary phase diagram there are three main
differences:
1. There in not a maximum on the curve
2. It is not possible to determine the composition of the separate phases
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3. It is not possible to individuate the spinodal curve
The kinetics of the process influences the different steps of the mechanism and then the final
morphology of the foam.
In the traditional nucleation theory for the formation of spherical cluster the free energy
change (DF) is given by
DF = 4p
3
R3DG+4pR2s (2.1.12)
where R is the radius of the cluster, s is the interfacial energy between the polymer-rich
cluster and the other phase and DG is the change in the Gibbs free energy related to the level
of supersaturation.
In the eq. 2.1.12 the first therm is proportional to the cluster volumes, while the second term
is proportional to the surface area.
Figure 2.10 represents the effect of the two contribution as a function of R.
Fig. 2.10 Energy barrier as a function of domain radius
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By deriving the 2.1.12 equation as a function of R it is possible to calculate the R⇤ value,
maximum of the curve, and the corresponding DF⇤.
R⇤ =  2s
DG
(2.1.13)
DF⇤ = 16ps
3
3DG2
(2.1.14)
If R> R⇤ the clusters grow spontaneously, otherwise, if R< R⇤ the clusters redissolve in the
continuous phase. Inside the spinodal region R⇤ ! 0, the clusters grow independently from
the initial dimension.
Assuming a steady state condition and considering that the growth rate is slower than the
cluster generation, the nucleation rate can be written as:
r = NsZ j exp
✓
 DF
⇤
kbT
◆
= r0 exp
✓
 DF
⇤
kbT
◆
(2.1.15)
Ns represents the number of nucleation sites, j is connected to the mobility of the molecules,
Z is the probability that a nucleus at DF⇤ will form the new phase. kbT is the thermal energy
of the system with T the absolute temperature and kb the Boltzmann constant. Ns jZ can be
summarised in an unique pre-exponential factor r0.
2.2 Ternary system: PLLA-Dioxane-Water
The ternary system adopted in this thesis was PLLA-Dioxane-Water (polymer-solvent-
nonsolvent). The dioxane to water ratio was 87/13 wt/wt in all cases, the polymer concentra-
tion was varied as a function of application. It is possible to find in literature different works
adopting this ternary system for different applications: adipose tissue engineering (Frydrych
et al., 2015), membranes (Kouya et al., 2013), bone tissue engineering (Eftekhari et al., 2014),
vascular tissue engineering (Carfì Pavia et al., 2012), cartilage tissue engineering (Bian et al.,
2013), etc.
2.2.1 PLLA
The polylactid acid (PLA) is s a biodegradable thermoplastic aliphatic polyester. It is one
of the most promising environmental friendly material, showing high-strength and high-
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modulus. It is mainly used in the biomedical fields in forms of fibers, films, microparticles or
microspheres.
The lactid acid is the simplest 2-hydroxycarboxylic acid. This latter has a chiral carbon atom
and exists in two stereoisomers, namely L and D enantiomers (S and R respectively). The
racemic acid DL-lactic shows different optical characteristic from the singular enantiomers.
In fig. 2.11 the stereoisomers are reported.
Fig. 2.11 First row: chemical structures of L-, D- and DL-lactic acids. Second row: chemical
structures of lactides
As a function of the lactic unit, different lactide can be obtained. The typical way to
produce the lacted is by depolymerization of the corresponding oligo(lactic acid) (OLLA) ob-
tained by polycondensation of the lactic acid. This reaction is catalysed by metal compounds
of Sn, Zn, Al, etc. The crude lactide is purified by melt crystallisation or recrystallisation
from solution (fig. 2.12).
Fig. 2.12 Chemical production from lactic acid to lactide via oligolactide
Figure 2.13 the two main synthetic routes to produce PLA polymers are:
1. Direct polycondensation of lactic acid
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2. Ring-opening polymerization (ROP) of lactide
Fig. 2.13 Polymerisation process for different PLAs, from Masutani and Kimura (2014)
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The first one was established by Mitsui Chemicals Co. (Japan), wherein lactic acid and
catalyst are azeotropically dehydrated in a refluxing, high boiling point, aprotic solvent such
as diphenyl ether, under reduced pressure to obtain PLA with very high weight-average
molecular weight.
The second one is most used for industrial production. The polymerisation of the pure L-
or D-lactides gives isotactic hoopolymers of, respectively, PLLA and PDLA. If the starting
compound is pure, L or D stereoisomer, the final product is semicrystalline showing a melting
temperature around 180°C. A decrease of the purity of L- and D- lactose means a reduction
of crystallinity and Tm. If the reagents are rac- and meso-lactides the obtained polymer will
be PDLLA. This latter is an amorphous polymer with an atactic sequence of D and L units.
In any case crystalline polymer can be obtained also controlled stereo-regularity of the D- L-
units (Masutani and Kimura, 2014). Table 2.1 shows the solubility of different poly-lactide
in different solvents. Rissanen et al. (2008) tested co-polymer PLLA-PDLA at various ratio,
96/4 (two inherent viscosity 2.2 and 4.8 dL/g), 70/30 and 50/50. The solubility is dependent
on the ratio of the two polymers, except for dicholomethane. This latter is able to dissolve
every polymers ratio. Increasing the D segment, the amorphous regions increase accordingly.
then to dissolve the polymer results gradually easier. P(D,L)LA can be dissolved in every
tested solvents. The two polymers with different inherent viscosity show a slight different
solubility. Low molecular weight (2.2 dL/g) promotes the ability of molecules of the solvents
to penetrate into the polymer structure, thus increasing the solubility.
2.2.2 Dioxane
The solvent adopted to prepare the ternary solution is the dioxane at all proportions. The
dioxane is a stable, clear liquid at ambient temperatures and miscible with water. Dioxane is
produced by the acid-catalysed dehydration of diethylene glycol, derived the hydrolysis of
ethylene oxide.
It is used primarily as a solvent for chemical processing. It has also been used as a laboratory
reagent; in plastic, rubber, insecticides, and herbicides; as a chemical intermediate; as part of
a polymerization catalyst; and as an extraction medium of animal and vegetable oils. Dioxane
may also be found as a contaminant in ethoxylated surfactants, which are used in consumer
cosmetics, detergents, and shampoos. The boiling point is 101°C and the melting point 12°C.
Three different isomers of the dioxane exist (fig. 2.14), but the most common is 1,4-Dioxane.
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Table 2.1 Solubility test of co-polymer PLLA-PDLA at different ratio. The interaction between
polymer and solvent were classified with the following legend: 1) a clear solution; 2) gel-like, thread-
shaped structures; 3) a gelatinous solid; 4) very swollen; 5) slightly swollen; 6) insoluble, from
Rissanen et al. (2008)
Fig. 2.14 Dioxane isomers
Binary-ternary solution
Dioxane and water are miscible in all composition forming a not-ideal mixture. The vapour-
liquid equilibrium presents an azeotrope (Nayak et al., 2004) and the freezing point is lower
of the pure compound (Goates and Sullivan, 1958), with a minimum of -15°C at 0.14 dioxane
molar fraction (fig. 2.15).
Van de Witte et al. (1996) analyzed the thermodynamics characteristics of PLLA and
PDLLA (semicrystalline and amorphous, respectively) as a function of the ternary system.
In figure 2.16 the variation of the intrinsic viscosity is reported. In the case of chloro-
form/methanol the decrease of the intrinsic viscosity of the solution is almost linear for both
52
2.2 Ternary system: PLLA-Dioxane-Water
Fig. 2.15 Freezing point at different dioxane/water molar ratio, from Goates and Sullivan (1958)
PLLA and PDLLA. On the other hand adopting dioxane/water as system, the reduction of
intrinsic viscosity is almost cubic. Passing from 4 dl/g and 3 dL/g, for PLLA and PDLLA
respectively, to 1.5 dL/g for both polymers in less 1.5% of volumetric ratio of water.
Fig. 2.16 Intrinsic viscosity vs volume fraction of non-solvent for PLLA and PDLLA, from Van de
Witte et al. (1996)
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Figure 2.17 shows the cloud point varying the dioxane/water ratio at fixed temperature,
25°C. It is clear that to induce the demixing of the solution at 25°Cit is necessary an amount
of water at least of 12% for PLLA and 14% for PDLLA. The limit of solubility of PLLA in
pure dioxane is 15% at 25°Cand increase to 26% at 50°C.
Fig. 2.17 Isothermal ternary phase diagram of PLLA-PDLLA/Dioxane/water. L: PLLA, DL: PDLLA,
m: solubility curve at 25°C and 50°C, cp: cloud point curve at 25°C, from Van de Witte et al. (1996)
2.3 Composite scaffold
Ceramics are solid compounds formed by application of heat or heat and pressure. They
are inorganic non-metallic solid made up of either metal or non-metal compounds, hard,
corrosion-resistant and brittle. Ceramics comprised of calcium phosphates, silica, alumina,
zirconia and titanium dioxide are used for various medical applications due to their positive
interactions with human tissues (Carter and Norton, 2007).
Different examples in literature show the possibility to use the ceramic in various biomedical
field: dentistry (Duraccio et al., 2015), othophedics (Taksali et al., 2004), platic surgery
(Spetzger et al., 2013), etc.
The ceramics present interesting features such as osteoconductivity, good mechanical pro-
prieties in compression, biocompatibility, but on the other hand they present very slow
degradation rate and brittle behaviour.
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Table 2.2 Ca-P compounds with their formula and Ca/P ratio, from Habraken et al. (2007)
To increase the biodegradability of the ceramics, porosity at different scale can be introduced,
from macroporosity to microporosity but, in any case, they are hard to tune according to the
specific necessity.
For this reason, increasing attention has been posed in ceramic/polymer composite. A large
variety of polymers has been used in combination with the biopolymers, e.g. chitosan,
collagen, poly(lactic acid), poly(glycolic acid) and so on. These latter are approved from
FDA for medical purpose but they are not intrinsically bioactive and will not bond directly to
living tissue. Furthermore they are lack in mechanical strength required to meet the demands
of orthopaedic surgery. The composite scaffolds can combine the tailored degradability
of the polymer with the osteoconductivity and the ability to bond with the living tissue of
the ceramic materials. The polymer can also counterbalance the brittleness of the ceramic
material, given it main handling proprieties of the pure calcium phosphate cement.
Due to their similarity to human bone, calcium phosphate ceramics are probably the most used
filler for diverse clinical applications since the last 30 years. Different types of CaP-ceramics
are available, though they can be classified as either hydroxyapatite (HA), beta-tricalcium
phosphate (b -TCP), biphasic calcium phosphate (BCP), amorphous calcium phosphate
(ACP), carbonated apatite (CA) or calcium deficient HA (CDHA).
Table 2.2 shows the principal calcium phosphates with their composition. In the following
two paragraphs a small overview of the composite scaffold with hydroxyapatite and bioglass
are reported.
2.3.1 Hydroxyapatite
Scaffold for bone tissue, besides the typical characteristics, must supply the necessary me-
chanical strength and osteogenic environment. The hydroxyapatite (HA), chemical formula
Ca10(PO4)6(OH)2, is the main mineral presents in the osseous tissue. Over then 70% of
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the overall mass of the bone is hydroxyapatite (the other 30% is collagen type I). Natural
bone is a complex inorganic-organic nanocomposite materials, in which hydroxyapatite
nanocrystallites and collagen fibrils are organised in a hierarchical architecture.
The HA is a basic calcium phosphate of the apatite family. In its structure large Ca polyhedra
share faces and thus form chains parallel to the crystallographic c-axis [0001]. These chains
are linked into a hexagonal array via sharing edges and corners with PO4 tetrahedra. The
OH  ions are located in wide hexagonal channels parallel [0001]. The unit cell of hydroxya-
patite with orthohexagonal metric is reported in fig. 2.18a, while the phase diagram in fig.
2.18b.
The open channel structure of HA is able to incorporate other ions by substituting Ca2+ as
(a) (b)
Fig. 2.18 a) Crystallographic structure of the hydroxyapatite, b) Phase diagram of the quasi-binary
system CaO P2O5 H2O, from Heimann (2013)
well as OH  and PO3 4 anions without large distortion of the structure or other cations sch
as Na+,Mg2+, Sr2+, K+, moreover it is possible to find trace of metabolically important ele-
ments such as Pb2+, Ba2+, Zn2+ and Fe2+ (Heimann, 2013). This compositional variability
of HAp causes its high biocompatibility and osteoconductivity. The Hydroxyapatite can be
synthesised in different ways, e.i. wet chemical process (Ethirajan et al., 2008), hydrothermal
method (Liu et al., 1997), use of sol-gel procedures (Weng and Baptista, 1998), solid-state
reaction (Ramachandra Rao and Kannan, 2002), emulsion or micro-emulsion routes (Lim
et al., 1999). As regards the physical-chemical properties of this material, it is characterised
by high melting temperature, good toughness and high resistance to compression, extremely
important factor for scaffolds that need high mechanical properties; unfortunately, however,
it has a certain fragility and difficult processability (Kothapalli et al., 2005; Swetha et al.,
2010).
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HA has been applied widely in medical field as a bone repair material because of its excellent
biocompatibility and bioactive properties (Sun et al., 2011). Furthermore HA is known for
its osteoconductive, non-toxic, non-inflammatory, non-immunogenic properties. Thus, HA is
one of the ideal materials for bone substitution and composite scaffolds.
In order to achieve the requirements for bone regeneration, biomimetic matrices are usually
adopted which may provide a suitable microenvironment to promote osteoblast proliferation
and osteogenesis.
Different technique has been adopted to produce composite HA scaffold, such as: solvent
casting (Albano et al., 2013; Tanaka et al., 2008), in situ mineralization of HA in polymers
(Verma et al., 2006), electrospinning (Li et al., 2006a; Sui et al., 2007), fabrication methods
of 3-D microstructures (Tanodekaew et al., 2013), electrodeposition (Yang et al., 2008) and
TIPS (Akbarzadeh and Yousefi, 2014; Krishnan and Lakshmi, 2013).
2.3.2 Bioglass
Over the past year the use of the bioglass for tissue engineering purpose was widely studied
and applied. Several studies show that the bioglass can stimulate a rapid expression of the
genes that regulate the osteogenesis and the production of the growth factors.
The bioglass was discovered around the 60s and 70s by Professor L. Hench. The research
was funded by the US army to solve the problem of the rejection by the human body of the
insert in metal or plastic, the only material available for surgeons in that period. The idea
was to find a new family of materials able to bind to living tissue, avoiding the necrosis of
the tissue.
Thus the idea to fabricate a material able to produce a layer of hydroxyapatite.The first
produced bioglass was the 45S5, with a nominal composition in weight of 45%SiO2 
24.5%Na2O 24.5%CaO 6%P2O5 .
This composition was chosen for the high amount ofCaO with some P2O5 in a Na2O SiO2
matrix. Furthermore this composition is near the eutectic point, then easy to melt (Krishnan
and Lakshmi, 2013).
Small samples of bioglass 45S5 were used in rat femoral implant model. After six weeks, the
bioglass showed a strong bond with the bone, forming a layer of hydroxyapatite. This layer
of hydroxyapatite crystals, perfectly compatible with the human bone, was firmly connected
to the native tissue through collagen fibrils.
Wilson et al. (1981) showed the possibility of the bond between bioglass and soft connective
tissue with an immobile interface.
In figure 2.19 the ternary phase diagram SiO2 Na2O CaO is reported at a fixed composi-
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tion, 6% of P2O5.
Fig. 2.19 Ternary phase diagram SiO2 Na2O CaO and bone bonding, from Hench (2006)
• Region A: The compositional range for bonding of bone to bioactive glasses and
glass-ceramics;
• Region B: The concentration of SiO2 is too high (over 60%), the material is bioinert;
• Region C: The reaction is too fast and there is not the formation of bonding;
• Region D: The concentration of SiO2 is too low, there is not the formation of the glass;
• Region E: Glasses with the highest degree of bioactivity (the 45S5 is this region);
• Region S: The glasses with rapid reaction can form soft tissue bond. If the glass
composition exceeds 52% by weight of SiO2 the glass will bond to bone but not to
soft tissues.
The 45S5 composition is not the only kind of bioactive glass, in table 2.3 other types of
bioglass with related chemical composition are reported.
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45S5 1393 6P53B 58S 70S30C 1393B1 1393B3 P50C35N15
Na2O 24.5 6.0 10.3 0 0 5.8 5.5 9.3
K2O 0 12.0 2.8 0 0 11.7 11.1 0
MgO 0 5.0 0 0 4.9 4.6 0
CaO 24.5 20.0 18.0 32.6 28.6 19.5 18.5 19.7
SiO2 45.0 53.0 52.7 58.2 71.4 34.4 0 0
P2O5 6.0 4.0 6.0 9.2 0 3.8 3.7 71.0
B2O3 0 0 0 0 0 19.9 56.6 0
Table 2.3 Small overview about the different type of bioglass and their composition
As example 1393 and 6P53B start from the same composition of the 45S5 but adding K2O
and MgO, 58S presents a higher amount ofCaO, 1393B1 and 1393B3 modified by boron.
Two important parameters concerning the bioglass are: the bioactivity index (IB) and the
class of bioceramics.
The first one is defined as:
IB = 100/t0.5 (2.3.1)
where t0.5 is the time necessary to bind that more the half of the material is linked to the
tissue. Materials with IB > 8, like bioglass, can bond to hard and soft tissue, material with
0< IB < 8 can bond only to hard tissue.
The bonding between bioglass and tissue has been attributed to the formation of a carbonate-
substitute hydroxyapatite-like (HCA) forming on the surface of the bioglass in contact with
the body fluid. For the similarity of HCA with the hydroxyapatite this layer is able to firmly
bond with the living tissue and bone (Huang et al., 2006; Kaur et al., 2014; Rahaman et al.,
2011).
Hench (1998) proposed a mechanism for the formation of HCA starting from bioglass, as a
sequence of reactions of ion exchange:
• 1st Step: Exchange of ions between the H+ from the solution and the glass network
modifiers (Na+ andCa2+) leads to formation of silanol Si O groups as a consequence
of hydrolysis of the silica groups. During this process the pH of the solution increases
due to the increasing of the OH  ions. The reaction mechanism is the following:
Si O Na++H+! Si OH++Na+ (2.3.2)
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• 2nd Step: The increase in pH (or OH  concentration) leads to attack of the SiO2 glass
network. The dissolution of silica occurs resulting in the formation of silicic acid leads
that is Si(OH)4 on the surface of glass as follows:
Si O Si+H2O! 2Si OH (2.3.3)
The silanol group act as nucleation site for the apatite formation. The dissolution
process is controlled by interface reaction with a linear dependence on the time. The
kinetic equation can be written as:
dC
dt
= ks(Ce C) (2.3.4)
where Ce is the equilibrium concentration of silicon, C is the concentration of silica in
solution, S is the surface of the particles, k is the rate constant and t is time.
• 3rd Step: Condensation and polymerization process allows the formation of a silica gel
layer of 1-2 µm on the surface of the glass. Thus the precipitation and migration of
calcium ions from the supersaturated solution to the particles occurs.
• 4th Step: Migration and incorporation of Ca2+ and PO3 4 anions from the solution
to the SiO2-rich layer leads the formation of an amorphous calcium phosphate layer
(ACP). The concentration ofCa2+ and Si(OH)4 are crucial parameters for HA forma-
tion.
• 5th Step: The incorporation of OH  and CO2 3 ions from the solution to the layer
continues, converting the ACP layer to an HA layer. The formation of HA is pseudo-
morphic as it starts at the surface of the glass and gradually spreads in all available
surface
The different types of bioceramics can be divided in two classes:
• Class A: bioactive materials osteogenetic and osteoconductive;
• Class B: bioactive materials only osteoconductive.
The bioglass belongs to the class A.
The bioglass scaffold can be divided in two main families: bioglass scaffold and bioglass as
60
2.3 Composite scaffold
filler in a polymer matrix.
In the first case the production of the scaffold can occur via sol-gel technique, foam replica
technique or gel casting. The sol-gel consists in the formation of an oxide network via
polycondensation reactions of a molecular precursor in a liquid. The idea is to dissolve the
compound in a liquid in order to obtain a solid in a desiderated shape (Dziadek et al., 2015).
In the foam replica technique a polymer network (e.g. polyurethane) is immersed in a slurry
of bioglass. At the end of the process, the system polymer-bioglass is placed in a furnace
to reach around 1400°C. In this way at 300-400°C the polymer is degraded and at 1350°C,
there is the sintering of the bioglass, to obtain the final morphology (Chen et al., 2006).
About the gel-casting, the starting point is the mixing of glass powder with deionized water,
monomer (e.g. acrylamide) and the cross-linker to produce a slurry. The mixture, then,
is vigorously agitated to produce a foam with the aid of surfactants. Initiator and catalyst
are added to the mixture and poured in a mold where the pore structure is stabilised by the
completion of gelation. Finally the structure is dried and sintered to eliminate all the organic
matter, leaving the porous network. (Ghomi et al., 2011; Wu et al., 2010, 2011)
Concerning the bioglass as filler, different polymer processing technique has been developed
to produce composite scaffold. As example solvent casting with and without particle leaching
(Huang et al., 2014; Lu et al., 2014), TIPS (Barroca et al., 2010; Noh et al., 2016), etc.
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Chapter 3
Gradient pore scaffolds
A high level of porosity of the scaffold is a crucial parameter to allow the tissue regeneration
in vivo. Although the only presence of pores is sufficient for cell growth inside the 3D
structure, however, it is possible to significantly improve the quality of the regeneration by
focusing on pore size distribution. Each organ or tissue is characterised not only by a specific
cell type but also by well defined spatial organization, such as: bone, from the compact to
the sponge bone, blood vessel, three layers (tunica intima, media and adventitia), etc. This
structure determines the overall characteristics and behaviour of the organ. For this reason
obtaining a porosity gradient becomes a crucial point in order to mimic in the best possible
way the tissue to regenerate. Three different kinds of gradients as a function of the gradient
direction is possible to distinguish:
1. Radial pore size
2. Axial pore size
3. Longitudinal pore size
In the case of a cylindrical shaped scaffold, a change of pore dimensions along the radius
is called radial pore size gradient. A typical body tissue example of radial pore variation is the
bone tissue, starting from the maximum pore size in the inner part that gradually decreases to
minimum in correspondence of the outer radius.
Taking as a reference a cylindrical scaffold, we have axial gradient if the scaffold shows a
pore size modification along the axis of the cylinder, with large pore size at the bottom of the
cylinder and gradually decreasing along the direction of the cylinder axis.
The longitudinal porosity gradient refers to the scaffolds of different geometries in which the
pore size varies along one of the characteristic dimensions of the structure. For example in
a cubic scaffold, a longitudinal porosity gradient means that the pore size variation insists
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along one of its sides. In literature it is possible to find different method to obtain scaffold
with radial (Harley et al., 2006; Kalita et al., 2003; Ma et al., 2010; Tang et al., 2013), axial
(Davidenko et al., 2012; Oh et al., 2007; Salerno et al., 2008; Wu et al., 2008; Zhu et al.,
2014), or longitudinal (Matsuyama et al., 1998, 1999; Sherwood et al., 2002; Sobral et al.,
2011; Zhang et al., 2013) pore size gradient. In the next paragraphs two examples for each
gradient are reported.
3.0.1 Radial pore size
One of the adopted techniques to obtain a radial pore size was the spinning process. A
collagen-glycosaminoglycan (CG) suspension in acetic acid was spun in a cylindrical mold
able to rotate around its longitudinal axis at variable angular velocities and for different
times (fig. 3.1). After the specified spinning time, the mold was placed into a bath of liquid
nitrogen where the suspension was rapidly frozen in liquid nitrogen and then the frozen
solvent was removed via sublimation. By varying the time or the speed of rotation a change in
the structure of the obtained scaffolds was observed. In this work 5000 rpm was individuated
as the minimum speed to produces the radial porosity gradient. Increasing velocity and
spinning time an increasing amount of solid in the external region and ultimately a hollow
tube with an homogeneous inner diameter was obtained (Harley et al., 2006).
Fig. 3.1 Spinning apparatus from Harley et al. (2006)
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Producing scaffolds with radial porosity gradient it is also possible via TIPS technique.
To obtain this result a mould that allows to establish a radial temperature gradient between
the center and edge was realised (Ma et al., 2010). The mold, figure 3.2 is composed by an
outer steel cylindrical wall, while inner cylindrical wall, base and lid of teflon. The solution
polymer/solvent (PLLA/benzene) is poured between the two cylindrical walls of the mold.
The difference of thermal conductivity between the two materials (the steel layer cools faster
than the walls of teflon) will create a radially distributed temperature gradient in the sample.
The as-obtained sample shows lowest pore size in the outer part, in contact with the steel
wall, which increases progressively to reach the maximum in the inner part in contact with
the teflon wall. It is also noted that the pores are arranged along the temperature gradient
(forming a radial structure in a herringbone pattern, fig. 3.2). A range of pore size is possible
to obtain by varying the polymer/solvent ratio or the temperature at which the cooling process
takes place. For example a decrease of porosity and pore size dimension was observed by
increasing the polymer concentration from 2.5% to 10% or reducing the freezing temperature
of from - 20°C to -196°C.
Fig. 3.2 Schematic illustrations of the molds, from Ma et al. (2010)
3.0.2 Axial pore size
Wu et al. (2008) adopted the particulate-leaching technique to fabricated scaffold with a well
defined gradient pore size. The used salt in the study was the NaCl. The latter was ground to
obtain different size particles. A copolymer chitosan/PCL (called CPC) was adopted. The
powders of CPC and salt are then mixed with a predetermined weight ratio and arranged in a
circular form with a movable base. A thin layer (around 1 mm) of mixed powders was first
spread and pressed tightly, then a motor-controlled syringe reciprocally moved above the
powder bed and deposited very small solvent (dimethyl sulfoxide, DMSO) droplets. In this
way the powders were bound into many parallel filaments in one layer. After one layer was
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completed, the bottom of the mould was lowered (around 1 mm), turned a given angle and a
new layer of powders with an increasing weight ratio and particle size of salt was spread and
pressed, followed by additional deposition of solvent droplets. The fabrication was repeated
until the required structure were built, figure 3.3 The result is a scaffold with a varying pore
size along its axis from 100µm to 400µm to the bottom on top. Although particulate-leaching
technique is commonly used to fabricate porous scaffolds, this technique has, however, some
disadvantages. In this case, for example, even with high percentages of porosity the salt
particles remain trapped between the layers of the scaffold, this involves the impossibility to
achieve a continuous variation of microstructure (Wu et al., 2008).
Fig. 3.3 Micrographs of scaffold sections at different layers, from Wu et al. (2008)
A combination of gas foaming and salt microparticles was adopted by Salerno et al.
(2008). The employed polymers were PCL and NaCl as pore-forming agent. PCL and salt
was initially mixed together and then compressed to 90°C and 30 bars to obtain a sample of
3 mm thick. After the mixing so obtained was saturated withCO2 at 70°C and 65 bar for 3
hours (fig. 3.4). By changing the value of temperature, the rate of pressure drop and the ratio
polymer/salt is possible to control porosity, interconnection and average pore size.
3.0.3 Longitudinal pore size
Longitudinal gradient pore size scaffold was fabricated via freeze-drying technique. Collagen
was dissolved in a mixture of ethanol and acetic acid. Then the latter was immersed in
liquid nitrogen to create the suspension of ice crystals. The ice particulates were prepared
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Fig. 3.4 micrographs of PCL foams; a) 100X, b) 500X, from Salerno et al. (2008)
by spraying deionized water into liquid nitrogen using a sprayer. In this way ice crystals of
spherical form with diameters of 150-250, 250-355, 355-425, 425-500 µm were obtained.
The four scaffolds are then stacked in a silicon structure, with particulates size growing from
the bottom to the top (fig. 3.5). The whole set was frozen at the temperature of -80°C for 6
hours and then lyophilized to remove the ice. At the end of the process the scaffold shows a
good pores interconnection, a porosity of 98.8% in all regions and a pore size gradient along
the scaffold (Zhang et al., 2013).
Fig. 3.5 The preparation scheme for gradient collagen scaffolds, from Zhang et al. (2013)
The 3D plotting technique allows to sketch the scaffold design. The material studied in
this work was a blend of corn starch with PCL previously optimised for use in 3D scaffolds
produced by 3D plotting and injection molding for tissue engineering applications. SPCL
granules were milled in an ultra-centrifugal mill with liquid nitrogen. Alternating layers were
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oriented at 90o to each other fig. 3.6. The scaffolds were fabricated as 5 x 5 x 5mm cubes.
Via this technique different kind of scaffolds were fabricated by varying the spacing between
the layer (Sobral et al., 2011).
Fig. 3.6 CAD 2D sections, pore size along the scaffolds and 3D models pore size gradient scaffolds,
from Sobral et al. (2011)
3.1 Experimental apparatus
In order to obtain a gradient of pore dimension along scaffold thickness, an experimental
apparatus able to impose a different T vs time pathway on two sides of a sample was
designed and set up. Previous studies about TIPS process have highlighted that, when a
nucleation-and-growth mechanism occurs, the pore dimension is mainly dependent on the
thermal history (Mannella et al., 2014). Thus, by varying the residence time in the metastable
region, it is possible to control the pore sizes. The peculiarity of this instrumentation is
the possibility to control simultaneously temperature and cooling rate. The experimental
apparatus consists in: two heat sinks, two Peltier cells in which the sample is located and four
thermocouples to control the temperature of heat sinks and Peltier cells. The sample holder
is a bag (35x35 mm surface, 10 mm thickness), a multilayer package, polycarbonate in the
inner surface and polyethylene in the outer surface. All components have been connected
to input/output devices and remotely controlled via personal computer (PC). The software
was been realised in LabVIEW, a system-design platform and development environment, by
National Instruments. Below a schematic diagram of the experimental instrumentation is
shown, figure 3.7.
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Fig. 3.7 Experimental apparatus
3.1.1 Circuit diagram
The experimental apparatus is connected to a PC via a NI-6210 (National Instruments)
for the analog input/output and an Arduino-Uno for the digital input/output. In figure 3.8
the connection of analog input (AI) channels was reported. Four thermocouples (TC) were
connected to a signal amplifier to reduce the background noise and then to four AI channels in
nonreferenced single-ended (NRSE) mode. A thermistor, needful as reference, is connected
to a +5V voltage source and the corresponding ground, DG; 100 W resistance and a zener
diode were adopted to reduce the signal noise and for the sake of protection, respectively.
Four digital channels were employer to control the Peltier cells via Arduino UNO board.
Two channels (P1-P2) were used for H bridge to control the direction of the current across
the Peltier cells. These letters are controlled via pulse width modulation (PWM) controller
(CTR1-CTR0) to tune the duty cycle. All channels were connected to a DG. Scheme 3.9
reports the digital input channels.
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Fig. 3.8 Circuit scheme of the analog input channels
Fig. 3.9 Circuit scheme of the analog input channels
3.1.2 Peltier cell
Peltier cells (or Thermoelectric Module, TEM) are thermoelectric devices based on a princi-
ple known as Peltier-Seebeck effect, which describes the reversible conversion of thermal
energy into electrical energy or viceversa (Drebushchak, 2008). When a voltage is supplied
through the material a temperature difference between the faces of the Peltier is produced; a
temperature difference between the two faces causes a voltage across the terminals (Hermes
and Barbosa, 2012).
The Peltier-Seebeck effect is due to the charge carriers drift, electrons or holes depending
on semiconductor, caused by a variation of electric potential inside the module. Electrons
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are the charge carriers for n-type semiconductor, holes for p-type semiconductor (fig. 3.11)
(Zhang et al., 2010).
Fig. 3.10 Schematic structure of Peltier Cell
Heating a peltier cell face produces an increase of kinetic energy of the charge carriers,
then these latter flow towards the lower temperature face, according to energy gradient
(Chakraborty and Kim Choon, 2006). The migration will continue until the amount of
charge will be sufficient to produce an electrical potential to oppose the Seebeck-Peltier
effect. (Huang and Duang, 2000). The Seebeck voltage is the result of the application of a
temperature difference, it is defined as
S=
V
DT
(3.1.1)
where S is the Seebeck coefficient, V is the voltage and DT the temperature difference.
However the Seebeck coefficient is on the order of microvolts per kelvin degree, even for
the best thermoelectric materials. For this reason, to increase the generated voltage, a large
number of elements (even more than 100) are connected in series from an electrical point of
view but in parallel from an thermal point of view. Figure 3.10 shows the internal structure
of a Peltier cell.
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Fig. 3.11 Band of Peltier effect
The Seebeck coefficient is around 10-60 µV/K, for metals or alloys employed in the thermo-
couples, while this value is much higher for semiconductors (Casano and Piva, 2011). The
Peltier effect is opposite of the Seebeck effect, applying a potential difference it is possible
to provide or subtract heat between the two sides of the Peltier. Electrical current (I) and the
heat flux (Q) are linked by the Peltier coefficient (P)
Q=PI (3.1.2)
Peltier and Seebeck coefficient are in a direct relationship by the absolute temperature
(Pérez-Aparicio et al., 2012), in fact
P= SDT (3.1.3)
Peltier faces are in ceramic material with a high thermal conductivity but a low electrical
conductivity. In this way they allow an easy heat transport avoiding energy losses. To
achieve the maximum efficiency, the thermoelectric material must minimize the heat loss and
maximize the current. The thermoelectric figure of merit, Z, measures the effective electrical
transport capacity compared with the thermal transport capacity. Z is defined as:
Z =
S2s
k
(3.1.4)
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where s is the electrical conductivity, S the Seebeck coefficient and k the thermal conductivity,
indicates the thermodynamic efficiency. High Z values indicate great efficiency of the Peltier
Cell. It can be observed that a low thermal conductivity is necessary for high efficiency.
The electrical conductivity defines the internal resistance of a TEM and consequently the
heat generated by Joule effect, while the thermal conductivity represent the ability to conduct
heat. For metallic systems k and s are linked by the Wiedemann-Franz’s law
k
s
= LT (3.1.5)
where L is Lorenz’s number 2.45x10 8WW/K2 and T the absolute temperature.
The Peltier cell efficiency is given by
h = Qel
Qh
(3.1.6)
Qel is the released electrical power whileQh is the input electrical power. The heat transferred
through the module is given by the Fourier’s first law
Z =
kA
t
DT (3.1.7)
with A and t, respectively, TEM surface and thickness.
Qel = V
2
R is the electrical power generated and R is the global electrical resistivity which
includes external and internal resistance. The resistance can be measured directly, while
the thermal conductivity should be measured indirectly by determining the heat transferred
through the cell (Mitrani et al., 2003).
An ideal thermoelectric device should have infinite electrical conductivity and zero thermal
conductivity. In absence of losses the total heat flux can be written as:
Q= ISDT (3.1.8)
because Q=PI andP= SDT . Thus, in an ideal case (Carnot’s efficiency) the thermoelectric
efficiency (h) can be rewritten as h = SDTP or h =
DT
Th
. This equation can be considered
as a verification of second law of thermodynamics if Peltier and Seebeck coefficient were
calculate independently each other.
The performance of a real thermoelectric device depends, however, on the figure of merit and
the temperature at the two cell sides. Using crystalline mixtures, substitutional point defects
and radiation damage, reduce the semiconductor thermal conductivity. Currently the most
efficient materials for the construction of Peltier cells are Bismuth telluride (Bi2Te3) and lead
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telluride (PbTe) p-type and n-type doped, respectively. The efficiency of a real thermoelectric
generator can be lower than the Carnot’s efficiency.
Considering the aforementioned contributions the heat flux globally removed from the cold
side and transferred to the hot side of the TEM and viceversa are respectively:
Qc =PcI  12 I
2R KDT (3.1.9)
Qh =PhI  12 I
2R KDT (3.1.10)
The first terms, PcI and PhI, are peltier cooling and heating term. The second term, 12 I
2R,
represents the Joule heating effect associated the passage of an electric current through a
resistance. The Joule heat is distributed throughout the element, so 1/2 the heat goes towards
the cold side, and 1/2 the heat goes towards the hot side. The last term, KDT , represents
the Fourier effect, transferring heat from regions of higher temperature to regions of lower
temperature. So, the peltier cooling term is reduced by the losses associated with electrical
resistance and thermal conductance. An example of electric current versus temperature
difference is shown in figure 3.12.
From the energy conservation, the electrical power output of a thermoelectric module is
expressed as:
P= Qh Qc = SI(Th Tc)+ I2R (3.1.11)
The coefficient of performance (COP) is one of the main parameters to estimate a Peltier
cell efficiency. COP is the ratio of heating or cooling provided to work required.
COP=
Qc
P
=
PhI  12 I2R KDT
SIDT + I2R
(3.1.12)
The coefficient depends both on current and temperature difference. Usually the Seebeck
coefficient is negligible, this one will be relevant only for very low current (Huang et al.,
2000). If I2R<< SIDT and DT = 0 the Carnot’s efficiency will be reached.
By considering the maximum performance of a module it is possible to obtain the internal
parameters of a TEM . DTmax is the largest temperature differential that can be obtained
between the hot and cold plates for a specific Th. Imax is the input current which will
produce the maximum possible DT across the TEM. Vmax is the voltage that will deliver
the maximum possible DT at the supplied Imax. Qmax is the maximum heat absorbed when
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Fig. 3.12 The temperature difference versus the electric current
DT = 0. Adopting the figure of merit Z is possible writing the relations as:
DTmax = Th+
1 p1+2ThZ
Z
(3.1.13)
Imax =
(
p
1+2ThZ 1)k
S
(3.1.14)
Qmax =
(
p
1+2ThZ(
p
1+2ThZ 1)2)k
2Z
(3.1.15)
Then k (thermal conductivity), R (electrical conductivity) and S (Seebeck coefficient) are
calculated from 3.1.4
k =
ImaxVmax(Th DTmax)
DTmax2Th
(3.1.16)
s = ImaxTh
Vmax(Th DTmax) (3.1.17)
S=
Vmax
Th
(3.1.18)
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The aforementioned values can be regarded as constant, though increasing Th, Seebeck
coefficient and electrical resistance increase while thermal conductivity decreases. Assuming
constant the hot side temperature, the temperature difference can be written as:
DT = Th Tc =
SITh  12 I2R
SI+ k
(3.1.19)
The difference of temperature can be expressed also as a function of the duty cycle (y). This
latter is generally defined as percentage of one period during which a component, device, or
system is active. In the adopted experimental apparatus the Peltier cells are controlled by
means of the duty cycle. In this case the duty cycle is described as ratio between the supplied
current (I) and the maximum deliverable current Im = 5A. The duty cycle have a range from
0 and 1, y = 0) I = 0, y = 1) I = Im.
The temperature difference can be written as a function of duty cycle as
DT = ySTh 
1
2y
2ImR
yS+ kIm
(3.1.20)
In figures 3.13 and 3.14 is shown the temperature difference versus duty cycle in cooling and
heating.
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Fig. 3.13 Heating process: temperature versus duty cycle
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Fig. 3.14 Cooling process: temperature versus duty cycle
3.1.3 Dynamics and control
The Peltier Cells can be considered as first order transfer function
Gp(s) =
Kp
tps+1
(3.1.21)
where Kp and tp are process gain and constant time, respectively. Generally a transfer
Function is the ratio of the output to the input of a system in the Laplace domain considering
its initial conditions and equilibrium point to be zero. In this case the output is the difference
temperature between the hot and cold side, while the input is the duty cycle. Thus the relation
between output and input can be rewritten as
Gp =
DT
y
(3.1.22)
Identifying with an overline the steady state value, the gain and the constant time of the
system are obtainable by
Kp =
DT
y
(3.1.23)
DT (t) = DT0 e
  ttp (3.1.24)
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Kp and tp are values tentatively acquired, depending by the complete system (heat sink,
Peltier Cell, sample holder, etc.). In fig. 3.15a, 3.16a and 3.15b, 3.16b are shown, respec-
tively, the system response for a step input of duty cycle 0.1 and 0.3. The graphs show, at
constant duty cycle, the temperature difference obtained in heating process is significantly
higher that in cooling process. As example, at y = 0.3) DT = 70°C , while in cooling
process y = 0.3) DT = 22°C. This behavior is caused by Joule effect, which creates a heat
generation to the current passage, regardless of the direction. This one involves a summative
term in heating, but a subtractive term in cooling.
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(a) Step input duty cycle 0.1
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(b) Step input duty cycle 0.3
Fig. 3.15 System dynamic behaviour for a duty cycle step input in heating process
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(a) Step input duty cycle 0.1
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(b) Step input duty cycle 0.3
Fig. 3.16 System dynamic behaviour for a duty cycle step input in cooling process
To realize the control system the characteristic values of Peltier cells in heating and
cooling were calculated by means of a step input. Simulink software, a graphical environment
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for multidomain simulation, fully integrated in Matlab, was adopted to simulate the system
response of the system. In fig. 3.17 is shown the closed-loop block diagram.
Fig. 3.17 Closed-loop block diagram in negative feedback
A negative feedback control loop was used, figure 3.17. Negative feedback is the most
common form of used feedback control in process, micro-computer and amplifier systems.
Negative feedback opposes or subtracts from the input signals providing it many advantages
in the design and stabilization of control systems. For example, if the systems output changes
for any reason, then negative feedback affects the input in such a way as to counteract the
change. Feedback reduces the overall gain of a system with the degree of reduction being
related to the systems open-loop gain. Negative feedback has effects of reducing distortion,
noise, sensitivity to external changes as well as improving system bandwidth and input and
output impedances. Primarily the configuration control has been simulated on Simulink,
inserted in the real system and adapted to obtain the best results. The used control algorithm
was the following:
y(i) = y+Pe(i)+ IDt
i
Â
j=1
e( j)+D
N e(i) e(i 1)Dt
e(i) e(i 1)
Dt +N
(3.1.25)
Where P, I, D and N are respectively: proportional, integral, derivative action and filter. For a
first estimation of the parameters Ziegler-Nichols method was adopted (Seborg et al., 2010).
The Ziegler-Nichols rule is a heuristic PID tuning rule that attempts to produce good values
for the three PID gain parameters. Initially turning PID controller into a P controller by
setting I = 0 and D= inf. Starting from P= 0 the proportional gain is manually increased
up to reach a sustained oscillations in the signals in the control system. Then via specific
table it is possibile obtaining the other parameters.
After the first estimation with the Ziegler-Nichols rule, the autotuning command presents in
the latest versions of Simulink was adopted. Finally these parameters were applied in the
real system and slightly modify to better matching with system applications. Figure 3.18
represents the experimental and the simulated response of the system for a step input from
15°C to 60°C.
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Fig. 3.18 Experimental and the simulated response of the system for a step input
3.1.4 Modeling and simulation
To better characterise the examined system a heat transfer analysis was carried out. The
study concerns the distribution and evolution of the temperature in the slab. The temperature
distribution in the sample is a function f (x), symmetrical with respect of the median plane
(x= 0) (Bairi et al., 2004). For this 1D transient problem, the second Fourier’s equation must
be solved:
a52 T = a ∂
2T
∂x2
=
∂T
∂ t
(3.1.26)
where a = krcp is the thermal diffusivity (W/m
2), k thermal conductivity (W/mK), r density
(kg/m3), and cp the specific heat capacity (J/kgK). Using the outside temperature T• as a
reference temperature and inserting the temperature difference defined as:
J(x, t) = T (x, t) T• (3.1.27)
it is possible to re-write the Fourier equation as
a ∂
2J
∂x2
=
∂J
∂ t
(3.1.28)
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The second Fourier equation is a partial differential equation, second order in space and first
order in time, then three boundary conditions are necessary (Isachenko et al., 1980).8>>>><>>>>:
t = 0) T (x,0) = T0) J = J0 (3.1.29)
x= 0) ∂J
∂x
|x=0 (3.1.30)
x= d ) k∂J
∂x
|x=L = hJ |x=L (3.1.31)
This equation can be solved by means of a separation of the variables. The first one variable
time dependent and the second one space dependent, writing
J(x, t) = f(t)y(x) (3.1.32)
Solving for a non-zero solution, the calculation of the successive differentials that appear in
3.1.27 yields
y(x)f 0(t) = y(x)df(t)
dt
= a d
2y(x)
dx2
f(t) = f(t)y 00(x) (3.1.33)
Then the separation of the variables is possible
1
a
f 0(t)
f 0(t)
=
y 00(x)
y(x)
= cost = l 2 (3.1.34)
Breaking up the two equations the functions become:
df
dt
+l 2af = 0 (3.1.35)
d2y
dx2
+l 2f = 0 (3.1.36)
whose solutions are respectively
f =C1e al
2t (3.1.37)
y =C2sin(lx)+C3cos(lx) (3.1.38)
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from 3.1.32
J(x, t) =C1e al
2tC2sin(lx)+C3cos(lx) (3.1.39)
C1,C2,C3 and l are obtained from boundary conditions. The final solution is
J = J0
•
Â
n=1
2sin(µn)
µn+ senµncosµn
cos(µn
x
L
)e µ
2
n
at
L2 (3.1.40)
The parameter µn|n2N is a function of the Biot number, Bi = hLk , with h convective heat
transfer coefficient, L characteristic length of the system and k thermal conductivity.
cotµn =
µn
Bi
(3.1.41)
The Biot number is used the characterise the heat transfer resistance "inside" a solid
body. The Biot number can be considered as the ratio of internal diffusion resistance, L/k, to
external convection resistance, 1/h. Bi! • means that there is no temperature difference
between wall and outside temperature, a distributed parameter system. Bi! 0 the heat flow
is much faster inside the body than outside, a lumped parameter system can be adopted.
In the case of distributed parameter problem the Fourier number Fo = atL2 occurs. This
latter represents a dimensionless time predicting of the temperature response of materials
undergoing transient conductive heating or cooling In figure 3.19 the internal thermal profile
in a slab are represented. By increasing the Fourier number the internal profiles change
function of distributed or lumped parameter system (Bird et al., 2006).
To evaluate the temperature variation within the sample a simulation software COMSOL
Multiphysics was used. It is a software that performs a Finite Element Analysis (FEA).
The FEA is a numerical technique designed to calculate approximate solutions to problems
described by partial differential equations, reducing the latter to an algebraic equations
system.
The system was considered as three-dimensional and one-dimensional problem. Three-
dimensional system to evaluate the overall temperature distribution inside the sample, one-
dimensional system to simplify the computational burden by taking advantage from the
symmetry of the system.
The modules of COMSOL adopted to carry out the simulation were "heat transfer in fluids"
and "phase change". The dimensions of the model match with the dimension of the real
system: 1 cm width, 3 cm depth, 3.5 cm height. Figure 3.20 shows the adopted geometry.
The thermal history was applied on side 1 and 2. The others side was simulated as external
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(a) Bi! • (b) Bi! 0
Fig. 3.19 Internal temperature profile in a slab, by varying the Fourier number
Propriety Liquid Solid
Heat Capacity at constant pressure [J/kgK] 2004 2052
Density [Kg/m3] 1002 918
Thermal conductivity [W/mk] 0.218 2.31
Latent heat fusion [J/kg] 170000
Melting point [K] 274.7
Table 3.1 Thermal proprieties of the model
natural convection to better replicate the physic of the system. Sides 3 and 4 as vertical well,
side 5 "horizontal well downside" and side 6 "horizontal well upside". The outside fluid is
air at temperature of 20°C. The system simulated was a solution dioxane/water with 87/13
weight ratio, the same mixture adopted for the scaffold production. In table 3.1 the thermal
proprieties adopted in the model was summarized. Two thermal history was reported as
example of the system behaviour. The first thermal history is a step input from 60°C to 35°C
(fig. 3.21), to simulate the internal temperature profiles inside the fluid region. The second
one is a step input from 35°C to -20°C (fig. 3.22), to show the temperature profiles when a
phase change occurs.
In both cases the temperature profiles on the external surface and in a "virtual" surface on the
center of the samples were reported.
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Fig. 3.20 Geometry in Comsol Multiphysics
Figure (3.21a), t = 0s all system at 60°C.
Figure (3.21b), t = 10s the temperature span is from 35°C on the side of the slab to 46.2°C
on the center part. It is possible to see that almost 500 µm are above 40°C.
Figure (3.21c), t = 20s all system is under 40°C, included the sample center and the parts in
contact with the external air.
Figures (3.21d), (3.21e), (3.21f), respectively t = 30s, t = 40s, t = 60s. From t = 30s
the temperature range between the set point (temperature on edges 1-2) and the highest
temperature in the slab is under the 5%. Consequently the process can be defined concluded
at 30= s.
The phenomenon is completely different when a change phase occurs. It is necessary more
time to reach the desiderated temperature and not all slab attains at -20°Cdue to heat exchange
with air outside.
Figure (3.22a), t = 0s all system at 35°C.
Figure (3.22b), t = 180s, the edges 1-2 reach very quickly the set point, while the freezing
process concerns the major part of the system. After 3 minutes only 2 millimetres are under
2°C.
Figure (3.22c), t = 360s, the freezing process proceeds towards the center of the slab. The
maximum temperature difference around 2°C, while over half part of piece is solidified.
Figures (3.22d), (3.22e), (3.22f), respectively t = 540s, t = 720s, t = 1200s. From t = 540s
all sample is frozen. The system rapidly reach the stationary state until t = 1200s when
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(a) t = 0s (b) t = 10s
(c) t = 20s (d) t = 30s
(e) t = 40s (f) t = 60s
Fig. 3.21 Internal temperature profiles inside the fluid region
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(a) t = 0s (b) t = 180s
(c) t = 360s (d) t = 540s
(e) t = 720s (f) t = 1200s
Fig. 3.22 Internal temperature profiles for a phase change
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the process is completely finished. The main part is at 253K, except the external contours
stabilized at almost -14°C.
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3.2 Results
The aforementioned experimental apparatus allows the continuous recording of temperature
with thermocouples fixed on the heat sinks and on the Peltier cells. The graph allows to
display of the real temperatures, and then the thermal history imposed by the two Peltier on
two sides of the sample. In figure 3.23 an example of temperature profiles was reported. The
blue curve represents the thermal history of face one, called Slow Cooling Side (SCS). The
red curve represents the thermal history of face two, called Fast Cooling Side (FCS).
SCS was taken for 10 minutes at 60°C, to ensure the complete solution homogenization.
After that the temperature was decreased at 1°C/min, from 60°C to 35°C in 25 minutes. Then
the temperature was maintained at 35°C for 20 minutes and suddenly lowered at -20°C, in
order to freeze the formed morphology.
The other side after the maintenance at 60°C, the solution was rapidly brought at 35°C for
45 minutes and thus quenched at -20°C simultaneously to the first side of the sample. It is
possible to separate a general thermal path in 3 regions or zones.
• I zone: The solution is above the cloud point, 41°Cfor the examined solution. The
mixture is usually brought at 60°C to assure the complete homogenization of the
solution.
• II zone: Each side was brought inside the metastable region in independent way. The
time inside the region and the rate can change in order to obtain the desiderated final
morphology. As "rule of thumb" more time and higher temperature mean larger pore
size, less time and lower temperature smaller pore size.
• III zone: The solution is rapidly quenched to freeze the obtained scaffold morphology.
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Fig. 3.23 Example of thermal history. SCS: Slow Cooling Side, FCS: Fast Cooling Side
Next paragraphs show some examples of different asymmetric scaffolds. For each test the
thermal histories applied on two sides of the sample was reported. The foam microstructure
was observed via Scanning Electron Microscopy (SEM), by utilising a Philips SEM Quanta
200 F at 10 kV, fractured in liquid nitrogen and gold sputtered. For each SEM micrograph
three sections of 1mm length were took into account on FCS (right side), center and SCS
(left side). The average pore dimension was determined by counting for at least 50% of
pores of each section. In table 3.2 the experimental pattern of gradient pore scaffolds was
summarized.
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Thermal History
FCS SCS
T1 dT/dt T2 t2 T1 dT/dt T2 t2
35-45/35-20 60°C 25°C/min 35°C 45min 60°C 1°C/min 35°C 20min
32-48/32-20 60°C 25°C/min 32°C 48min 60°C 1°C/min 32°C 20min
30-50/30-20 60°C 25°C/min 30°C 50min 60°C 1°C/min 30°C 20min
30-45/30-20 60°C 25°C/min 30°C 45min 60°C 1.2°C/min 30°C 20min
25-45/25-20 60°C 25°C/min 25°C 45min 60°C 1.4°C/min 25°C 20min
Table 3.2 Experimental pattern of gradient pore scaffolds
3.2.1 35-45/35-20
Figure 3.24 reports the adopted thermal history for this test. After at the homogenization at
60°C, the FCS was suddenly brought at 35°Cwhile the temperature of SCS was gradually
decreased at 1°C/min. The FCS was maintained at 35°C for 45 minutes while the SCS for 20
minutes, then the two sides were rapidly quenched at -20°C.
Figure 3.25 shows the as-obtained scaffold microstructure. The pore dimensions go from
80 µm on SCS, to 130 µm on the center to 260 µm on FCS. 35°C is on the center of the
metastable region for this ternary solution, then higher temperature means higher growth rate
in the pore formation process.
In the TIPS process inside the metastable region, the temperature plays a more important role
than the permanence time, for this reason the scaffold obtained applying the quoted thermal
history reaches the highest pore dimension compared to the other scaffolds.
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Fig. 3.24 Thermal history of the test. FCS: from 60°C rapidly to 35°C for 45 minutes and then frozen;
SCS: from 60°C to 35°C at 1°C/min, 35°C for 20 minutes and then frozen
Fig. 3.25 SEM micrograph of the obtained scaffold. Average pore dimension from 80 µm on SCS, to
130 µm on the center to 260 µm on FCS
3.2.2 32-48/32-20
Compared to the thermal history of the previous test the same decreasing rate of the tempera-
ture was adopted, while the temperature inside the metastable region was set at 32°C. For
this reason in order to freeze both side at the same moment the FCS was kept at 32°Cfor 48
minutes (fig. 3.26).
The scaffold morphology showed a linear increasing of pore dimension from 75 µm on SCS,
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to 110 µm, 230 µm on the FCS (fig. 3.27). In this case like the following test there are
two contrary effects. From one side the increasing of time inside the metastable region (48
minutes) tends to increase the pore dimension, on the other side the diminution of temperature
decreases the kinetic of the phenomenon. However, this process is biased towards the kinetics
then the pore dimensions on SCS and FCS of the scaffold obtained applying this thermal
history are smaller than the pore dimensions with the previous cooling path.
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Fig. 3.26 Thermal history of the test. FCS: from 60°C rapidly to 32°C for 48 minutes and then frozen;
SCS: from 60°C to 32°C at 1°C/min, 32°C for 20 minutes and then frozen
Fig. 3.27 SEM micrograph of the obtained scaffold. Average pore dimension from 75 µm on SCS, to
110 µm on the center, 230 µm on the FCS
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3.2.3 30-50/30-20
Following the same principle of the previous test, the reference temperature was further
decreased up to 30°C. Thus 30°C for 50 minutes on FCS and 20 minutes for SCS (fig. 3.28).
Figure 3.29 reports the SEM micrograph of the obtained scaffold. Starting from the right
side to the left side the average pore dimensions were: 180 µm, 110 µm, 65 µm, respectively.
The same explanation of the previous scaffold can be adopted to describe the so-obtained
microstructure. The temperature prevails over the time and a general decreases of pore
dimension in all three sectors were found.
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Fig. 3.28 Thermal history of the test. FCS: from 60°C rapidly to 30°C for 50 minutes and then frozen;
SCS: from 60°C to 20°C at 1°C/min, 30°C for 20 minutes and then frozen
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Fig. 3.29 SEM micrograph of the obtained scaffold. Average pore dimension from 65 µm on SCS, to
110 µm on the center, 180 µm on the FCS
3.2.4 30-45/30-20
In order to compare the effect of temperature alone keeping constant the permanence time,
several tests changing the rate of cooling on SCS were performed. In this case the FSC was
maintained at 30°C for 45 minutes, while on SCS the temperature decreased from 60°C to
30°C in 25 minutes. At the end -25°C was imposed to freeze the so-obtained morphology.
Figure 3.30 reports the thermal history set at the two face of the sample. As demixing
temperature is the same in the whole sample, pore morphology is homogeneous in all foam
regions, while changing the pore dimension. SEM micrograph (fig. 3.31) reports a pore
dimension of 210 µm on FCS, 115 µm on the center and 60 µm on the SCS.
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Fig. 3.30 Thermal history. FCS: from 60°C rapidly to 30°C for 45 minutes and then frozen; SCS:
from 60°C to 30°C in 25 minutes, 30°C for 20 minutes and then frozen
Fig. 3.31 SEM micrograph of the obtained scaffold. Average pore dimension from 60 µm on SCS, to
115 µm on the center, 210 µm on the FCS
3.2.5 25-45/25-20
The solution was preliminary homogenised at 60°C, then both FCS and SCS were brought
to 25°C, at 25°C/min and 1.4°C/min, respectively (fig. 3.32). Once reached the corner
temperature the FCS was maintained for 45 minutes, while the SCS for 20 minutes, then
both side were quenched at -25°C/min at the maximum rate of the experimental apparatus.
In figure 3.33 the thermal history was shown. The obtained pore size range in this case
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was 45-160 µm (fig. 3.33). At 25°C the pore size gradient appears less evident, indeed the
temperature is almost on the border between the metastable region and the unstable region
where the spinodal decomposition occurs. In the spinodal decomposition mutual diffusion
between the two phases (polymer-rich and polymer-less phase) is the dominant mechanism,
then the difference of residence time between the two sides of the sample less affect the final
morphology.
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Fig. 3.32 Thermal history. FCS: from 60°C rapidly to 25°C for 45 minutes and then frozen; SCS:
from 60°C to 25°C in 25 minutes, 25°C for 20 minutes and then frozen
Fig. 3.33 SEM micrograph of the obtained scaffold. Average pore dimension from 45 µm on SCS, to
90 µm, 160 µm on the FCS
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3.3 Outline
Thermal History Pore dimension
FCS SCS
FCS SCS
T t T t
35-45/35-20 35°C 45min 35°C 20min 260µm 80µm
32-48/32-20 32°C 48min 32°C 20min 230µm 75µm
30-50/30-20 30°C 50min 30°C 20min 180µm 65µm
30-45/30-20 30°C 45min 30°C 20min 210µm 60µm
25-45/25-20 25°C 45min 25°C 20min 160µm 45µm
Table 3.3 Summary of the results of gradient pore scaffolds
Table 3.3 summarizes the applied thermal histories with the relative results. It is evident that
simply manipulating the temperature vs time protocol a wide range of pore dimension was
possible to obtain. In general terms an increase in the demixing temperature or time inside
the metastable region the corresponding pore dimensions globally globally reflects on to an
increase with respect to those obtained at lower temperatures or less time.
Foams were produced via a single step operation without requiring multiple layer or gradient
of porogens. As a matter of principle this procedure can be applied to different biomaterial
and different thickness could be obtained by varying the distance between the Peltier cells.
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Chapter 4
Composite scaffolds: preparation and
characterisation
The use of a ceramic filler in a polymeric network is one of the most adopted techniques
to mimic the native tissue to replace. In this chapter the possibility to fabricate composite
scaffold PLLA/Hydroxyapatite and PLLA/bioglass via thermally induced phase separation
was investigated.
4.1 Materials characterisation
4.1.1 Particle size distribution analysis
To evaluate the particle size distribution a laser diffraction analyser was adopted. Laser
diffraction measures particle size distributions by evaluating the angular variation in intensity
of light scattered as a laser beam passes through a dispersed particulate sample. Large
particles scatter light at small angles while small particles scatter light at large angles. When
particles are irradiated with a laser beam, light is "diffracted/scattered" in various directions
from the particles.
For the intensity of diffracted/scattered light, a fixed spatial pattern is formed in the direction
that the light is emitted. This is referred as the "light intensity distribution pattern".
The light intensity distribution pattern is known to change to various shapes according to the
particles size. The pattern data is then analyzed to calculate the size of the particles, using
the Mie theory of light scattering. The particle size is reported as a volume equivalent sphere
diameter.
The main advantages of this method are: wide range of dimensions, from hundred of
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nanometers to the millimeter; rapid measurements; repeatability; high sample throughput
and standard technique covered by an ISO protocol.
4.1.2 Porosity evaluation
Porosity is defined as the ratio between the void volume, Vv, and the bulk volume, Vb:
f = Vv
Vb
(4.1.1)
Different technique can be adopted to evaluate the porosity of a porous structure (Kara-
georgiou and Kaplan, 2005), in this work two of them were taking into account: liquid
displacement method and boyle’s pycnometer.
About the liquid displacement method, ethanol was used as a wetting agent for its own facility
to penetrate inside the pores. A sample of known massWd (dry weight) and volume Vb (bulk
volume) is placed in a cylinder containing ethanol. Several vacuum steps are adopted to
assure the complete soaking of the sample. Then the sample is removed from the ethanol
and, often, eliminating the excess of fluid, accurately weighted,Ww (wet weight). Knowing
the density of ethanol, re it is possible to calculate the porosity of the scaffold as:
f = (Ww Wd)/re
Vb
(4.1.2)
The gas or boyle’s pycnometer is one or the most relevant instruments to evaluate the
real volume of a porous solid. The general idea is the calculation of the amount of a gas able
to penetrate inside the pores and then, in a indirectly way, the solid volume. The common
gas adopted is Helium for three main reasons: it is a very small compound, ables to penetrate
in nanometric pores; it is a completely inert gas, there is not possibility to wreck the sample;
it follows the ideal gas law: PV = nRT .
The pycnometer consists of two chamber: reference and sample chamber at well know
volume. During the test, the temperature is kept constant.
The volume of the sample, Vx, can be derived from the following formula:
Vx =Vc+Vr
Pe Pr
Pe Pc (4.1.3)
WhereVc andVr are the chamber and reference volume respectively (accurately measured
during the calibration process); Pr is the pressure of the reference chamber, Pc is the pressure
of the empty sample chamber, calculated during the calibration and Pe is the equilibrium
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pressure between the two chamber during the test.
In fig. 4.1 a schematic representation of the pycnometer is reported.
Fig. 4.1 Illustrative representation of the gas pycnometer functioning, from Ho and Hutmacher (2006)
4.1.3 TGA analysis
Thermogravimetric analysis (TGA) consists on detecting the weight variation of a sample
during a temperature ramp. It allows to evaluate the thermal stability, the speed of reaction,
the reaction processes and, in certain cases, the composition of the sample. The sample is
subjected to an imposed thermal cycle while recording its weight as a function of temperature.
This is an useful technique in the reactions of decomposition, where it is possible to appreciate
the variation of the chemical composition in the thermogravimetric graph. The TGA is part
of the group of quantitative and qualitative analysis, and classified among the destructive
test. It is a method of investigation very useful in the study of hydrated compounds, clay
materials, alterations of metallic materials (hot oxidation, etc...).
The thermogravimetric curve is influenced by various factors, the most important are:
• the rate of heating: increasing the rate of heating the decomposition temperatures result
higher, then excessive speeds could lead to distortion of the obtained results;
• the mass and size of the sample: it must be not excessive in order to avoid problems of
heat transport, but must be present in sufficient quantities to be representative of the
sample;
• the flow of the purge gas: must be sufficient to ensure the rapid removal of the
volatile products but, on the other hand, it must not be excessive, in order not to cause
disturbance in the degradation process;
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4.1.4 XRD analysis
An adopted technique to evaluate the material structure was the X-Ray Diffraction analysis
(XRD). XRD is one of the most important characterisation tolls used in solid state chemistry
and materials science. X-ray diffraction is often used for two main reasons, as a fingerprint
of a crystalline materials and for the determination of their structure. Each crystalline solid
has a specific X-ray pattern which may be used as a fingerprint
The dominant effect that occurs when an incident beam of X-rays interacts with a
target material is scattering of those X-rays from atoms within the target material. In a
crystalline materials, the scattered X-rays undergo constructive and destructive interference.
The diffraction of X-rays by crystals is described by Bragg’s Law:
nl = 2dsenq (4.1.4)
Where n is a positive integer, l is the wavelength of incident wave, d is the distance between
two crystalline plane and q is the scattering angle.
The directions of possible diffractions depend on the size and shape of the unit cell of the
material. The intensities of the diffracted waves depend on the kind and arrangement of
atoms in the crystal structure.
4.1.5 FT-IR analysis
FT-IR is the acronym of Fourier Transform InfraRed, the most used method for infrared
spectroscopy. During the spectroscopy some infrared radiation is absorbed by the sample
and some is transmitted (passed through the sample). This spectroscopic technique gives
information on the functional groups present in the molecule. In a IR spectrum two types of
signals are present: related to the particular functional groups and related to "finger-print".
It is not possible that two different molecules have the same infrared spectrum thanks to
finger-print signals. On the other hand, the characteristics peaks of structures fall at the same
frequencies regardless the structure where the molecule is present.
In the IR spectrum the interest zone is from 4000 cm 1 to 400 cm 1. This range can be
ideally divided in two zones: between 4000 cm 1 and 1300 cm 1 and between 900 cm 1
and 400 cm 1. The highest frequency region is the region of the functional groups, while the
lowest frequency region is that of the finger-print.
All things considered, the FT-IR analysis can provide several informations: to identify
unknown materials, to determine the quality or consistency of a sample and to determine the
amount of components in a mixture.
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4.2 PLLA/HA scaffolds
Poly-L-lactic-acid, 1,4 dioxane and distilled water were utilized to prepare the starting
solution. PLLA was used with a 4% wt/wt concentration and a ratio solvent/non solvent
(dioxane/water) 87/13 wt/wt was adopted. Different PLLA/HA ratio were adopted (95/5,
90/10, 70/30, 50/50, 34/66, 25/75). For the first tests hydroxyapatite was kindly given by
Professor Licciulli from University of Lecce, later tests for an in situ production of the HA
were carried out.
4.2.1 Scaffold preparation
The ternary solution was initially kept at 60°C to allow the complete homogenisation. Thus
the powders of HA were added to the solution keeping high temperature to maintain low
viscosity and to allow for a complete dispersion. To avoid the formation of clusters, the
so-obtained quaternary solution was sonicated for 15 minutes at 35 kHz and maintained at
60°C during the process.
After the complete dispersion of HA, the solution was hot poured in a cylindrical High
Density Poly-Ethylene (HDPE) mold (21 mm diameter, 36 mm height) and immersed in a
thermal bath at 30°C for 10 minutes (30°C is a temperature within the metastable region for
this mixture). At the end of the process, the mold is immersed in an ethanol bath at -25°C for
25 minutes to stop the process and freeze the obtained morphology. The foams, then, were
washed in deionised water and dried under vacuum for over than 24h, in order to completely
remove any solvent.
4.2.2 Scaffold characterisation
The granulometric analysis (fig. 4.12) carried out on the particles has revealed the size
distribution . A bimodal distribution with nanometric particles (100 nm) and micrometric
particles (2-100 µm) was analyzed.
The morphology of the composite foams were analysed by SEM-FEI QUANTA 200F,
along the cross section fractured in liquid nitrogen and gold sputtered by Scancoat Six,
Edwars for 120s under argon atmosphere.
In fig. 4.3 composite scaffolds with different HA concentration are showed. As examples
just two concentration are reported, 30/70 w/w, and 50/50 w/w HA/PLLA, respectively. It
is evident that the change of the amount of hydroxyapatite does not influence the global
morphology of the scaffold. This means the HA, in this case, is basically inert for the
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Fig. 4.2 Particle size distribution of HA
separation process. Pore dimensions, in both cases, are around 100 µm, very similar to
the size attained in the absence of HA (i.e. with neat PLLA). There is a basically regular
pore structure with a good pore interconnection. At higher magnification it is possible to
appreciate the integration between polymer matrix and particles. HA looks like completely
covered and surrounded by the PLLA matrix. As expected, comparing the 50/50 and 30/70,
the number of particles in the same section are higher in first case than in the second case
and the borders of the pores appears more indented.
In order to evaluate the variation of the structure as a function of the increase of the HA
content, XRD analysis were carried out. The Panalytical X Pert Powder Diffractometer was
adopted, with 2q angle ranging from 5° to 70°, step angle and step time of 0.15° and 10
seconds, respectively. The samples were cut in cylindrical shape (14mm diameter and 1mm
thickness) and stacked by canada balsam to the sample holder. The balsam has a refractive
index similar to crown glass, then very useful for optical application. The results for the
different composite scaffold were summarised in a unique graph (fig. 4.4), from pure PLLA
(on top) to pure HA (on bottom).
Passing from the neat polymer to the mineral it is possible to recognise a clear trend
of the characteristic peaks. The PLLA pattern presents two peaks located at 16.5 and 19
degrees, (zone "a").
Mineral Hydroxyapatite shows a set of typical peaks around 30° (zone "b") and around 50°
(zone "c"). At higher concentration HA shows its characteristic peaks are more marked and
distinguishable. On the other hand, proceeding from neat PLLA to greater HA content the
two peaks of the polymer reduce in intensity. This analysis remarks in an evident way the
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(a) Composite PLLA/HA 70/30 w/w, [800X] (b) Composite PLLA/HA 70/30 w/w, [3000X]
(c) Composite PLLA/HA 50/50 w/w, [800X] (d) Composite PLLA/HA 50/50 w/w, [3000X]
Fig. 4.3 Different morphologies of composite PLLA/HA scaffolds as a function of the concentration
HA incorporation within the polymeric support.
About the porosity, the evaluation via boyle’s porosimeter and liquid displacement is re-
ported in figure 4.5. It is possible recognize significant agreement among the two techniques.
Increasing HA content, the porosity decreases, since a partial portion of open pore is
occupied by HA particles. This slow porosity reduction reaches the ~85% at HA weight
percentage of 25%. This means that even in the presence of a large amount of HA, the
scaffolds are characterized by a highly porous and interconnected structure, feature necessary
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Fig. 4.4 XRD analysis of composite scaffolds at different concentration in HA
Fig. 4.5 Porosity evaluation via Boyle’s pycnometer and ethanol displacement
to ensure cell proliferation and tissue regeneration.
PLLA and HA have completely different degradation temperatures, 350°C and 1360°C,
respectively. Based on this large difference, it is possibile to carry out measure of TGA, to
evaluate the amount of filler present inside the scaffold.
TGA analysis were carried out by Netzsch STA 449 F1 Jupiter. All samples had an average
initial weight of 30.5 mg. The imposed thermal history was:
• Initial stabilisation at 30°C
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• Increase of temperature from 30°C to 500°C at 10°C/min
• Stabilisation at 500°C for 30 minutes
The non-isothermal TGA measurement of neat polymer, neat filler and their blends are
summarised in figure 4.6. In y-axis the percentage of weight loss, in x-asis the temperature
from 100°C to 450°C .
Fig. 4.6 TGA curves of PLLA/HA foams
TGA curves show that when the temperature increases up to about 400°C, PLLA scaf-
fold nearly loses the whole weight whereas HA maintains the initial mass. The composite
scaffolds rapidly lose their weight starting from 350°C. This indicate that after 350-400°C
nearly all the PLLA in the composite was lost and HA remained. The mineral contents in
the fabricated composite scaffolds could be assessed from the TGA data. The results show
a good according with initial amount of filler inside the solution, the average difference
between the nominal and the final concentration is around 10-15% .
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4.2.3 HA (in situ) synthesis and characterization
In order to better integrate the filler with the overall preparation technique, several tests for
an in situ production of the hydroxyapatite were carried out. The HA can be synthesized
in different ways, e.g. wet chemical process (Pang and Bao, 2003; Tian et al., 2008), the
hydrothermal method [12], sol-gel procedures [13, 14], the solid-state reaction [15, 16], and
emulsion or micro-emulsion routes [17].
In this work the HA was produced via wet chemical process (Wang et al., 2010; Zanotto
et al., 2012), usingCa(NO3)2 ·4H2O and (NH4)2 ·HPO4 purchased from Sigma-Aldrich as
Ca and P precursors, respectively.
0.03 M aqueous solution of (NH4)2 ·HPO4 was added drop wise in a 0.05 M Ca(NO3)2 ·
4H2O aqueous solution under stirring condition.
During the process the pH of the reaction solution was adjusted to 11 by adding sodium
hydroxide (NaOH) and the temperature was maintained at 70±2°C˙
After the preliminary tests, in order to improve the HA production, some preparatives with a
tenfold concentration were adopted, 0.3 M of (NH4)2 ·HPO4 and 0.5 M ofCa(NO3)2 ·4H2O.
The precipitated HA particles were aged for 24 h at room temperature. The resulting product
was centrifuged at the rotation speed of 13000 rpm for 30 min. Then the powder was frozen
at -20°C for 1 h and dried in a freeze dryer system at -40°C for 4 days. The as-obtained
hydroxyapatite was, in one case, directly characterized and in the other cases, calcinated at
600°C for 1h.
The SEM micrographs (fig. 4.7a, 4.7b, 4.7c, 4.7d) show a small variation of morpholo-
gies between the two concentrations, but a large difference in shape between the calcinated
and not calcinated hydroxyapatite. This latter HA appears without a specific shape, it is
hard to define a line of separation amongst the particles. The morphology of the calcinated
hydroxyapatite is quite different. It possesses a regular needle shape, 20nm wide, around
200nm long and the contours of the particles is well defined. The EDX spectrum (fig. 4.8)
confirms the presence of calcium (Ca), phosphorus (P) and oxygen (O). Analyzing the area
under the curve it is possible to calculate the amount of each element and comparing it with
the theoretical atomic percentage of each element of the hydroxyapatite Ca10(PO4)6(OH)2.
The results, reported in table 4.1, show a satisfactory matching among the theoretical and the
experimental values.
XRD analysis of three different HA were carried out and compared. HA produced in prof.
Licciulli’s laboratory via sol-gel technique, as reference, calcinated HA and not calcinated
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Theoretical Experimental
At % At % At
Ca 10 23.8 21±1
P 6 14.3 14 ± 1
O 26 61.9 63 ± 1
Table 4.1 Comparison between theoretical and experimental atomic ratio of HA
HA to individuate the effects of the thermal process.
The firsts two XRD diffraction patterns (fig. 4.9a and 4.9b) are substantially indistin-
guishable. Both show the three characteristic peaks around 30°and the other peaks around
50°. The peaks are very sharp and well defined, which means a high level of crystallinity and
large crystal.
Different is the case of the not calcinated hydroxyapatite (fig. 4.9c). The pattern displays an
increase of the signal at the same angles of the others HA (30°, 50°) but a lower intensity.
The amorphous part is larger than the other two cases and the background noise a low angles
is more accentuated. In any case, the not calcinated HA presents the same molar ratio and
the same configuration of the calcinated HA.
Via laser diffraction analyser the particle size distribution of the so-obtained hydroxyap-
atite was evaluated. In fig. 4.10 the pattern of the calcinated HA with a tenfold concentration
was reported. The other patterns do not present significative variations. The maximum
intensity is around 10 µm and there is a relative small range of particles dimension. The size
of over than 95% of particles is less than 20 µm.
Small particle dimensions is a mandatory feature for scaffold applications, as the particles
must be integrated in the polymer network and they must represent a very small percentage
of the volume of the scaffold pores.
4.2.4 Composite PLLA/(in situ)HA scaffolds
The as-produced hydroxyapatite was incorporated in PLLA solution in order to evaluate
the feasibility of scaffold production. Preliminary results showed a strong influence of hy-
droxyapatite in the TIPS process. It was not possible to obtain the scaffold starting from the
calcinated HA. Following the same protocol adopted in the previous tests, after the freezing
of the scaffold, during the immersion in water the polymeric structure was disgregated. This
phenomenon is probably due to the formation of a solvation shell around the HA particles
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that makes unstable the polymer network.
In figure 4.11 SEM micrographs of composite scaffold with lyophilised HA were reported.
In all cases 10% wt PLLA/filler was adopted. After the preliminary homogenisation at 60°C
the solution was poured in a cylindrical HDPE mold in a thermal bath for 30 minutes at
different temperatures: 25°C, 27°C, 30°C, 33°C. Then the scaffold was immersed in water to
remove the dioxane and dried overnight.
The images report like the temperature has a weak influence on the porous structure, with
an average pore dimension much higher compared to the neat polymer scaffold prepared
at similar condition. This should suggests an influence of the HA during the nucleation
and growth mechanism. Further tests need to be carried out in order to better understand
the interaction between the as-synthesized particles and the TIPS process for the scaffold
production.
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(a) 0.03 M of (NH4)2 ·HPO4 and 0.05 M of
Ca(NO3)2 ·4H2O, not calcinated
(b) 0.03 M of (NH4)2 ·HPO4 and 0.05 M of
Ca(NO3)2 ·4H2O, calcinated
(c) 0.3 M of (NH4)2 ·HPO4 and 0.5 M of
Ca(NO3)2 ·4H2O, not calcinated
(d) 0.3 M of (NH4)2 ·HPO4 and 0.5 M of
Ca(NO3)2 ·4H2O, calcinated
Fig. 4.7 Different morphologies as a function of the thermal process and concentration
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Fig. 4.8 EDX spectrum of HA synthesised via wet chemical method
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(a) HA, via sol-gel method
(b) HA calcinated, via wet chemical method
(c) HA not calcinated, via wer chemical method
Fig. 4.9 XRD patterns of different HA
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Fig. 4.10 Particle size distribution of synthesised HA
Fig. 4.11 SEM micrographs of composite PLLA/(in loco)HA at 10% wt of filler. a) 25°C 30 minutes,
b) 27°C 30 minutes, 30°C 30 minutes, 33°C 30 minutes
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4.3 PLLA/Bioglass scaffolds
Several studies showed the possibility to include bioglass in a polymer matrix via TIPS
starting from a solution of a binary polymer/solvent mixture (Boccaccini and Maquet, 2003;
Maquet et al., 2003, 2004). The scaffold prepared along this route results in a final ladder-like,
anisotropic structure. In this set of experiments a ternary solution polymer/solvent/non-
solvent (PLLA/dioxane/water) was adopted, leading to a wide range of scaffold structures
by varying the thermal history and assuring high interconnectivity, good reproducibility and
homogeneity (Akbarzadeh and Yousefi, 2014; Mannella et al., 2014). The idea is to assess an
experimental protocol to produce composite PLLA/bioglass scaffold via TIPS, starting from
a ternary polymeric solution. PLLA/45S5 and PLLA/1393 scaffold prepared at different
bioglass concentration were compared in order to individuate which type of bioglass best
match this scaffold production technique. Biodegradation study and bioactivity test in prof.
Boccaccini’s laboratory at the University of Erlangen-Nuremberg were carried out.
4.3.1 Scaffold preparation
The scaffolds were fabricated via a TIPS technique, applied to a ternary polymer/solvent/non-
solvent system. The weight concentrations of PLLA was 6% and a ratio solvent/non solvent
(dioxane/water) 87/13 w/w. Starting from this ternary solution the two different types of
bioglass were added at different concentrations: 1%, 2.5%, 5% w bioglass/w polymer for
45S5 (namely PLLA/45S5 BG_1, PLLA/45S5BG_2.5, PLLA/45S5BG_5, respectively), 1%,
2.5%, 5% for 1393 (PLLA/1393BG_1, PLLA/1393BG_2.5, PLLA/1393BG_5, respectively).
Considering the density of PLLA (1270 kg/m3, (Gong et al., 2006)) and density of both
bioglasses (2825 kg/m3, (Blaker et al., 2011)), the corresponding volume concentration were:
0.45%, 1.13% and 2.3%, respectively. Both kinds of bioglass were fabricated via a melt
derived route (Hoppe et al., 2013, 2014). Neat (unfilled) polymeric foams were also prepared
and characterized and used as control. Neat polymer scaffolds were prepared along the same
route and evaluated as control.
The protocol to incorporate the bioglass particles in the polymer solution was very similar
to the PLLA/HA scaffold. Initially, the solution was kept at 60°C to allow the complete
homogenization of the mixture, then the powders of bioglass, at different concentration, were
added. Thus the solution was sonicated for 15 minutes at 35 kHz to avoid the formation
of clusters. During this process, the solution was maintained above 60°C to reduce the
viscosity and facilitate the complete dispersion of the powders. After this step, the mixture
was first hot-poured into an aluminium disc-shaped mould (4 cm diameter, 2 mm height)
and, subsequently, pool immersed in a thermostatic bath at 30°C, for 10 minutes. Finally the
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mould was immersed in an ethanol bath for 20 minutes at -20°C to block any kind of process.
At the end of the preparation, the foams were rinsed in distillate water and dried under
vacuum for at least 24 h, to completely remove the solvents. For the various characterizations,
several parallelepiped samples 6 mm to 8 mm large were cut from the disk. Neat PLLA
scaffold was add as control.
4.3.2 Particle size and SEM analysis
Mastersizer 2000 (Malvern Instruments Ltd) was adopted to evaluate the particle size distri-
bution of the two types of BG powders. 0.1g of BG were dispersed in 0.8l of distilled water
and the average of 10 measures was considered.
To analyze the morphology of the scaffolds, these latters were cut along the cross section by
cutting with a scalpel to avoid compression damages. Thus, the samples were mounted in
an aluminium stab and observed under SEM Phenom Pro-X (Phenom-World, Netherlands).
SEM images were used to evaluate the homogeneity of the microstructure and the average
pore size for each type of scaffold.
4.3.3 Biodegradation study
For the biodegradation study composite and neat scaffold were cut and grouped in separate
vials. The specimens were soaked in phosphate buffered saline (PBS) solution (Amresco
LLC, USA) at 37°C and placed in an orbital shaker (KS 4000i control, IKA-Werke GmbH
KG, Germany) at 90 rpm. The weight of each specimen before aging was recorded. The
medium was changed once a week to maintain constant the pH value. At days 3, 7, 14, 21,
28 three specimens at each time points were removed from the buffer and analysed. Water
uptake and weight loss were evaluated as follows. Water uptake (WA): after pulling out of
the PBS solution, the sample was accurately rinsed in water and, after removing the excess of
water, weighted. Then, the water uptake was calculated according to the following formula:
WA(%) =
Ww Wb
Wb
⇤100 (4.3.1)
whereWw is the weight of the wet scaffold andWb is weight before aging.
Weight loss: After the calculation of the water uptake the scaffolds were dried under vacuum
to remove any presence of liquid and weighted again. The weight loss (WL) was evaluated
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as follow:
WL(%) =
Wb Wd
Wb
⇤100 (4.3.2)
in whichWd represents the weight of the biodegraded dry scaffolds.
4.3.4 Bioactivity test
Bioactivity tests were carried out using the standard in vitro procedure described by Kokubo
and Takadama (2006). According to the protocol, the cut samples were soaked in simulated
body fluid (SBF) in conic flasks and placed in an orbital shaker set at 37°Cand 90 RPM. The
pH of the solution was controlled at 7.25. The SBF was replaced every three days for the
cation concentration decreasing during the course of the experiments (Blaker et al., 2011).
Three samples at 3, 7, 14, 21, 28 days were extracted, abundantly rinsed in distilled water
and then in acetone to prevent any further reaction (Mi et al., 2014). Finally, the scaffolds
were dried for 48h at room temperature.
To evaluate the presence and the morphology of the formed HCA several tests were carried
out:
• SEM analysis at different magnifications by Auriga 0750 Zeiss.
• XRD measurements by Panalytical X-Pert Powder Diffractometer with a Cu Ka radi-
ation source. The spectra were recorded in the range of 2q 10-60 ° with a 0.15 step
size and a step time of 10s. High voltage and tube current were 40kV and 30 mA,
respectively.
• FTIR spectroscopy by Nicolet 6700 (Thermo Scientific, Germany) using attenuated
total reflectance (ATR) technique. Each sample was scanned 32 times at a resolution of
4 cm 1 over the frequency range of 4000-550 cm 1. A window of CsI was employed.
4.3.5 Results
Particle size distribution
In order to compare the two types of BGs a preliminary analysis about the particle size
distribution was carried out. The median of the distributions, D50=8.86m and D50=11.26m
for 1393 and 45S5 BGs, respectively, were calculated. From figure 4.12 it was possible to
observe a very similar particle size distribution. This homology in terms of particle mean
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sizes allows a more reliable comparison between the two types of scaffolds, since BG particle
dimensions could influence the interaction between PLLA and BG.
Fig. 4.12 Particle size distribution of 1393 BG and 45S5 BG
Scaffold morphology
In figure 4.13 the morphology of the obtained scaffolds were reported. A different behaviour
for the two types of BGs was observed. As a matter of fact, for PLLA/1393 BG samples the
presence of the particles does not seem to influence the phase separation and then the final
morphology of the scaffold. Moreover, when increasing the BG concentration to 5%, the
structure of the scaffold results unmodified. The average pore dimension was 80 µm for the
different 1393 BG content.
A different behaviour was detected for the 45S5 BG, low percentages of BG (1-2.5%) do
not seem to alter the process of formation of pores. Conversely, a significant presence of
micropores in the structure was observed when a percentage of 5% 45S5 BG was used. t is
reasonable to infer that the presence of BG altered the nucleation rate during the nucleation
and growth process occurring in this ternary solution at 30°C (Mannella et al., 2014). Fur-
thermore, it has been reported that the 45S5 BG exhibits a higher reactivity than 1393 BG,
i.e. a faster capacity of ions release (Hoppe et al., 2014). Consequently, during the process
of pore formation, the BG particles surrounded by their released ions may act as nucleating
agents and, due to the difference in reactivity, this effect is clearly distinguishable for the
45S5 BG, whereas is not detectable for the 1393 BG. The nucleating effect increases with
BG concentration, then this effect is evident on 5% of BG on the contrary of the 2.5%.
Weight loss and water uptake
Weight loss and water uptake as a function of immersion time in PBS are reported in figure
4.14 and figure 4.15, respectively. The mass of composite scaffold monotonously decreased
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Fig. 4.13 SEM micrographs of composite PLLA/BG scaffold. a) PLLA/45S5 BG_1, b)
PLLA/45S5BG_2.5, c) PLLA/45S5BG_5, d) PLLA/1393BG_1, e) PLLA/1393BG_2.5, f)
PLLA/1393BG_5
with the BG concentration accordingly, on the contrary of neat PLLA that remained almost
constant until the last time point, with a range of 0-2%. Comparing the same BG type, a
significant difference can be confirmed among samples with different concentrations. Partic-
ularly relevant is that just the presence of 1% of BG induces a significant difference with
respect to the unfilled PLLA. As expected, the highest weight loss was for 5% 45S5 BG
sample with 26± 4% versus the 20± 4% for 5% of 1393 BG. BG particles dissolution,
particle loss and erosion of the scaffold (Lim and Park, 2012) induce a more rapid weight loss
on composite scaffolds than the neat PLLA. The presence of the BG particles, even in small
amounts, reduces the integrity of the matrix and then the stability of the foams. In addition,
the difference of reactivity between the two types of BG compositions caused a trend on
weight loss profile, the biodegradation of PLLA/45S5 BG scaffold was always grater than
PLLA/1393 BG keeping constant the concentration.
In figure 4.15 the water uptake results were reported. It is evident there is not large
difference between composite scaffolds at different concentrations. Considering the standard
deviation turing the 28 days, the water uptake can be considered almost constant, in agreement
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Fig. 4.14 Weight loss of composite PLLA/BG scaffolds at different time points
with previous works. The high water uptake value (>600%) just after 3 days denotes the
high porosity and the good interconnectivity of the scaffold. Thus the addition of BG does
not influence in a relevant way the water uptake capacity due to the low amount of filler.
After 28 days, the maximum weight loss was around 25% (in the case of BG at its maximum
concentration, 5%) that implies a change of total porosity from ca. 95% to ca. 96%, with
a negligible influence on the water uptake, in any case below the measurement protocol
sensitivity.
Bioactivity test
Three samples for each time point (3, 7, 14, 21, 28 days) were extracted from SBF, washed
and analysed via SEM, XRD and FTIR. For the sake of brevity only results concerning 5%
at 28 days are here discussed, being representative of all samples. To evaluate the differences
in HA formation of the two BG types, SEM analysis after 28 days of immersion in SBF were
carried out. In figure 4.16 micrographs of composite scaffolds at different magnifications
were reported. In both cases the typical cauliflowers-like shape of HCA was individuated (Mi
et al., 2014). SEM micrographs were taken along the cross section, then the significant con-
128
4.3 PLLA/Bioglass scaffolds
Fig. 4.15 Water uptake of composite PLLA/BG scaffolds at different time points
tent of HCA within the structure denotes the good ability of the SBF to penetrate inside the
pore, in particular composite PLLA/45S5 BG exhibits a homogenous HCA-layer. Interesting
is the presence of the inorganic compound not only around the BG particles, but almost on
the whole surface. Although the presence of HCA-layer inside the PLLA/1393 BG scaffold
appears less evident, also in this case the distribution of HCA appeared homogeneous along
the internal surface of the scaffold. Moreover, in the 1393 BG composite scaffold the original
pore structure remains still evident.
The effect of immersion in SBF after 28 days in terms of chemical structure (fig. 4.17),
was significantly different for neat PLLA and composite scaffolds. The crystallinity of PLLA
was weakly influenced from the presence of BG and there is no presence of peaks of other
molecular structures. In the composite scaffold the peaks corresponding to the polymer
were still present but, at the same time, some of the usual diffraction peaks of HA appeared.
Indeed, the peaks centered at 2q=29°, 32° and 46°, highlighted by the vertical bar, underline
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Fig. 4.16 SEM micrographs of PLLA/BG scaffolds after 28 days of immersion in SBF. a)
PLLA/45S5BG_5, b) PLLA/1393BG_5
the formation of a HCA-like layer, confirming the SEM observation.
Fig. 4.17 XRD pattern of neat and composite scaffolds, as prepared and after 28 days of immersion in
SBF
Figure 4.18 shows the FT-IR spectra of PLLA composites as prepared and at 28 days. As
it is possible to see in figure 4.18a, the three patterns of the specimens before immersion (as
prepared) are basically identical. The peaks of PLLA largely overcome the peaks of BG, for
the low percentage of this latter. Characteristic absorption bands for PLLA ofCH at 2920
cm 1,COO  at 1759 cm 1,CH3 at 1457 and 1383 cm 1, C-O-C at 1183 and 1088 cm 1 are
easily discernible. The spectra of the PLLA and PLLA/BG composite scaffolds after 28 days
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in SBF are presented in figure 4.18b The blue curve shows the already mentioned absorption
bands arising from PLLA; on the other hand, the composite specimens presented numerous
new peaks. Bands at 3635 cm 1 have been assigned to OH anti symmetric stretching and
3550 cm 1 to symmetric OH- stretching (Ryszkowska et al., 2010). The bands of PO3 4 at
564 and 605 cm 1 with the absorption bands ofCO2 3 at 1448 cm
 1 are characteristic of the
FTIR spectrum of HCA layer (Ji et al., 2015). The peaks at 1460 and 1420 cm 1 indicated
that B-type HCA was formed because CO2 3 replaced sectional PO
3 
4 . A displacement of
the carbonyl signal from 1746 cm 1 to 1755 cm 1 was also observed, which is attributed
to the interaction of the hydrogen bond of the carbonyl group of the PLLA and the surface
P-OH groups of HA (Zhou et al., 2007). All these evidences corroborate the hypothesis of
the formation of a HCA-like layer in both types of BGs upon immersion in SBF.
Fig. 4.18 FT-IR spectra of neat and composite scaffolds, as prepared and after 28 days of immersion
in SBF
4.4 Outline
In this chapter composite PLLA/HA and PLLA/BG scaffolds were presented. Neat PLLA
does not possess the appropriate biointegration capability and mechanical proprieties, then to
overcome this limit composite polymer/ceramic filler were produced. About the scaffold with
HA, based on the results, SEM images revealed that the presence of the HA did not influence
the global scaffold morphology. As a matter of fact, a porous and interconnected structure
was observed in the bulk of the scaffolds. By increasing the HA content the porosity reaches
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the ~90%, this means that even with a large amount of HA, scaffolds are characterized by
a high porous structure. Test of XRD and TGA confirmed the presence of HA inside the
polymer network.
In order to individuate which BG composition best matches the scaffold production technique,
two compositions were tested: 1393 and 45S5. SEM micrographs showed that the 45S5
BG interacted with the phase separation mechanism during the formation of the scaffold, on
the contrary of the 1393 which did not affect the morphology of the scaffold. The different
behavior could be due to the higher reactivity of 45S5 respect to 1393. The presence of
BG did not modify the water uptake capability, contrarily on the case of weight loss where,
also at low percentage of filler, a significant difference with the unfilled polymer was found.
Bioactivity tests showed positive results for both composite PLLA/BG scaffolds; SEM
images reveled typical cauliflowers-like shape of HCA after 4 weeks of soaking in SBF and
XRD and FTIR analysis confirmed the formation of HCA layer. These results confirmed the
possibility to successfully include BG and HA particles in PLLA scaffolds via a modified
ternary TIPS and to tune the structure of the scaffold.
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Chapter 5
Static cell cultures
Cell culturing in the scaffold is one of the crucial point to consider a particular biomaterial
suitable for tissue engineering. In the thesis work cell culture experiments were performed
by using mesenchymal stem cells, chondrocytes and osteoblasts in various PLLA-based
scaffold.
In-vitro tests of chondrocytes seeded on PLLA scaffold and PLL/BG scaffold in the prof.
Gundula Schulze-Tanzil’s laboratory at the Paracelsus Medizinische Privatuniversitat were
carried out. Biological evaluation of gradient pore scaffolds with mesenchymal stem cells in
the prof. Rocky Tuan’s laboratory at the University of Pittsburgh were realized.
5.1 Chondrocytes in PLLA scaffolds
Cell functions as well as new tissue regeneration is strictly dependent on the size of the pores.
It is possible to find in literature many works documenting the influence of the pore size in
a porous scaffold for tissue engineering, but with different opinions. Some papers report
that a larger pore size promotes the production of cartilaginous matrix (Zhang et al., 2014),
whereas other papers assert that smaller pore sizes enhance the chondrocyte phonotype and
proliferation (Oh et al., 2010).
The different results are due to a complex combination of factors in the 3D culture, such as
nutrient diffusion, but also exchange and removal of metabolic waste during cell culture. In
any case PLLA scaffolds, were produced via TIPS with two different pore dimensions, 100
µm and 200 µm, respectively to evaluate the influence of the microtopography.
137
Static cell cultures
5.1.1 Scaffold production and analysis techniques
Starting from the same ternary solution, the two types of scaffolds were obtained following
two slightly different thermal histories. Initially the solution was kept above 60°C to ensure
the homogeneity, then poured in a cylindrical high density polyethylene (HDPE) mould and
placed in a thermal bath.
For PLLA with 100 micron sized pores (PLLA-100), the mould was maintained at 25°C for
45 minutes, for PLLA with 200 micron sized pores (PLLA-200), at 32°C for 75 minutes.
Thereafter, the solution was immersed in an ethanol bath at -20°C for more than 20 minutes
to allow the complete freezing of the obtained morphology. Finally, the foams were washed
in distilled water and esiccated under vacuum for 24 hours to ensure the whole removal of
any solvent trace.
Scaffold pore size and topography were analyzed via SEM (Phenom ProX, Phenom-World,
Netherlands) at 5 kV along the cross section. The samples were cut by means of a razor blade
to avoid the collapse of the structure and mounted in an aluminum stub. The porosity was
measured via gas pycnometer and evaluated as the average of three replica (section 4.2.2).
5.1.2 Chondrocyte isolation and cell seeding
Donors of human articular chondrocytes were males (n=2) and females (n=4) with an average
age of 71.6 years (range 64-74) who underwent knee joint or hip joint replacement surgeries.
Donors of human hyaline nasoseptal cartilage (n=11) with an average age of 36.55±14.01
years (range 18-63). This sampling was approved by the Charite-Universitatsmedizin ethical
committee/review board for experiments with human derived tissues. The harvested cartilage
chips were digested by pronase E derived from Streptomyces griseus at 20 mg/mL (6 U/mg,
Serva Electrophoresis GmbH, Heidelberg, Germany) in Ham’s F-12/Dulbecco’s modified
Eagle’s medium (DMEM) (50/50, Merck KGaA, Darmstadt, Germany) for 30 minutes at
37°C. Then, the samples were incubated with collagenase NB5 derived from Clostridium
histolyticum (1 mg/mL, Sigma Aldrich) in chondrocyte growth medium overnight. Isolated
chondrocytes were resuspended in growth medium (96% (v/v) DMEM/Ham’s F-12 (1:1)
with stable L-glutamin, 1% (v/v) amphotericin B, 1% (v/v) MEM-amino acids, 1% (v/v)
penicillin/streptomycin, 1% (v/v) ascorbic acid supplemented with 10% fetal calf serum
(FCS).
Before seeding, the chondrocytes were expanded in T175 flasks.
Scaffolds (cylindrical shape, 4 mm diameter and 3.5 mm) were seeded by using at a cell
density of 25000 chondrocyte/mm3 in 80 µl. The scaffolds were sterilised adopting 70%
ethanol overnight and preconditioned by abundantly rinsing in PBS and finally in FCS for 24
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hours.To guarantee a uniform distribution of cells in the sample, the seeding was mede in
two steps: 40 µL of cell suspension on the top of the scaffold and then after 20 minutes this
latter was turned upside down and seeded with the remaining 40 µL.
Seeded scaffolds were cultured in 6 well plates coated with cell culture suitable agarose (1%,
Sigma-Aldrich) with 5 mL of growth medium for each well. Medium was changed every 3
days. Cells were cultured on the scaffolds for 1 day, 7 days or 14 days.
5.1.3 Live/dead assay
Cell vitality of colonized scaffolds was determined after 7 and 14 days. Live-death staining
was performed using fluorescein diacetate (FDA, Sigma-Aldrich) combined with ethidium
bromide (EtBr, Carl Roth GmbH) or propidium iodide (PI, Sigma-Aldrich) staining. Seeded
scaffolds were incubated in the FDA/EtBr or FDA/PI staining solution and examined under
DMi8 confocal laser scanning microscope (Leica, Wetzlar, Germany).
5.1.4 Histological staining and immunolabeling
In order to carry out histological staining and immunolabeling the scaffolds were fixed
for 1 day with a 4% paraformaldehyde (PFA) and stored at 4°C. They were dehydrated in
ascending alcohol series before embedded in paraffin and cut in section of 5 µ.
For HE staining sections were incubated for 6 minutes in Harry‘s hematoxylin (Sigma-
Aldrich), before rinsed in water and counterstained for 4 minutes in eosin (Carl Roth GmbH,
Karlsruhe, Germany).
To perform AB staining the sections were incubated for 3 minutes in 1% acetic acid and
then incubated for 30 minutes in 1% AB (Carl Roth GmbH). Subsequently, after rinsing in
3% acetic acid and 2 minutes washing in distillate water, cell nuclei were counterstained in
nuclear fast red aluminium sulphate solution (Carl Roth GmbH) for 5 minutes.
Two immunolabeling protocols were carried out. For the first one, the sections or small
segments of the scaffolds (2 mm) were washed with Tris buffered saline (TBS: 0.05 M
Tris, 0.015 M NaCl), overlaid with protease-free donkey serum (5% diluted in TBS) for 20
minutes at room temperature, permeabilized by 0.1% Triton X-100 for 6 minutes, rinsed
and incubated with primary antibodies type I collagen and type II collagen for 1h at room
temperature. Controls without primary or secondary antibody were also included. For the
second immunolabeling donkey-anti-goat-Alexa-488 (Invitrogen, Ca, USA) or donkey-anti-
rabbit-Alexa-cy3 (Invitrogen) coupled secondary antibodies were adopted. Cell nuclei were
counterstained using 4’,6’-diamidino-2-phenylindol (DAPI, Roche, Mannheim, Germany)
and phalloidin-633 (1:100, Santa Cruz Biotechnologies,) to depict cytoskeletal actin architec-
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ture.
In both cases the sections were examined unger DMi8 confocal microscope.
5.1.5 Gene expression analysis
At 7 and 14 days the seeded scaffold were snap frozen and then crushed using mortar and
pistil in liquid nitrogen. The frozen scaffold powder was suspended in 1 ml Qiazol and
homogenized using an ULTRA-Turrax rotor stator. Then, 0.2 mL 1-bromo-3-chloro-propane
was added and samples were centrifuged at 12.000 g for 15 minutes. The upper phase
was combined with a similar volume of 70% ethanol. Samples were further processed as
recommended for the RNeasy Mini Kit (Qiagen) without on-column DNase digestion step.
Quality and quantity of the RNA of all samples were determined with the Nanodrop ND-1000
spectrophotometer.
The cDNA was reverse transcribed using the QuantiTect Reverse Transcription Kit (Qia-
gen) according to the manual. 6 ng cDNA were used for each quantitative real-time PCR
(qRT-PCR) reaction using TaqMan Gene Expression Assays (Life Technologies) with primer
pairs for type II collagen (COL2A1), aggrecan (ACAN) and SOX9. qRT-PCR was per-
formed using the real time PCR detector StepOnePlus (Applied Bioscience [ABI], Foster
city, USA) thermocycler. The primers was supplied by Applied Biosystems with the fol-
lowing NCBI Gene Reference: COL2A1 Hs00264051_m1, ACAN  Hs00202971_m1,
SOX9 Hs00165814_m1. The relative gene expression was normalized to the 18S ex-
pression and calculated for each sample using the DD CT method described by Livak and
Schmittgen (Livak and Schmittgen (2001). A scaffold seeded in the same condition and
evaluated at the first day was adopted as a reference for qRT-PCR.
5.1.6 Results
Scaffold morphology
The dimensions of the round or ovoid pores were evaluated using SEM (fig. 5.10).
PLLA-100 presents average pore sizes of 100 µm, while PLLA-200 average pore sizes of
200 µm. Both topographies showed the presence of micropores, from 10m to 40m, in the
wall of the large pore size. This aspect enhances the interconnection of the scaffold ensuring
nutrients and metabolites exchange.
PLLA-100 was fabricated at 25°C. As reported in a previous work (Mannella et al., 2014)
this temperature is on the boundary between the binodal and the spinodal region, when the
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(a) (b)
Fig. 5.1 SEM micrographs of the adopted PLLA scaffold topography. a)PLLA scaffold average pore
dimension 100µm, b) PLLA scaffold average pore dimension 200 µm
nucleation-growth and spinodal decomposition, respectively, occur. In the mechanism of
nucleation-growth the dimension of pore size is strictly related on time. In the second case,
spinodal region, there is no formation of cluster and then, a mechanism of coalescence, but
the decomposition is determined solely by diffusion. The tuning of these factors allows
the formation of a scaffold with a high degree of interconnection (the major part of large
pores present interconnecting channels of larger than 10 µm) and a good control of pore
size. For the production of PLLA-200 temperature of 32°C and 75 minutes were chosen to
obtain pore dimensions almost double compared to PLLA-100. Under this condition the
solution is within the metastable zone and the higher demixing time allows the widening of
the pores. In both scaffolds, the porosity evaluated via gas pycnometer was 93±0.2%. The
phase separation, indeed, basically does not influence the porosity of the material, this latter
depends on the initial solution concentration.
Cell viability
Live/dead staining was used to prove cell survival within the two different foams. The green
marker, FDA, labels the viable cells, whereas the red markers, EtBr or PI, indicate the dead
cells or the scaffold. Fluorescence micrographs via confocal microscope were taken after 1
and 2 weeks of culture. The vitality assay showed that the majority of the chondrocytes were
still alive within all foams during the two weeks of observation time (figs. 5.2, 5.3). It could
also be noticed that chondrocytes rapidly attached and spread over the surface of the scaffolds.
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At day 7 (fig. 5.2a,b) there was already a large amount of cells on the scaffolds with mostly
live cells (green cytoplasmic fluorescence) and few dead cells (red nuclear fluorescence). The
confocal images highlight the topography of the scaffold, the cells, indeed, spread around the
pore and in most cases it is possible to individuate a flattened or elongated shape of the cells
with many attachment points to the scaffold, which indicates a very good cytocompatibility.
At day 14 (fig. 5.2c,d), an even larger amount of the surface was covered with viable cells
in the two scaffold types. In particular, the surface of the scaffold PLLA-100 is essentially
completely covered by viable cells. On PLLA-200, despite the surface is not so plentifully
bestrew, caused also from the larger pore, the amount of viable cells after 14 days is much
higher compared to 7 days. In this case, the autofluorescence of the scaffold is more evident.
Similar behaviour to that observed with articular chondrocytes is recognisable in the
scaffolds seeded with nasoseptal chondrocytes. After 7 or 14 days the scaffold were cut along
the frontal plane with a razor blade, stained with FDA/PI and cell viability was evaluated on
the cross section. The figure 5.3 shows the cell distribution and viability inside the scaffold
for both types of scaffolds and both time points. After 7 days the cells adhered and spread
inside the scaffolds. Qualitative analysis of numbers of cells attached and spreading on each
scaffold type revealed that after 14 days the number is higher compared to the previous time
point and the PLLA-100 better supports cell proliferation.
Histological and ECM expression
After the chondrocyte/scaffold constructs were cultured for 2 weeks, they were retrieved
and histologically examined via alcian blue (fig. 5.4). The positive staining indicated the
presence of cartilage-specific sulfated glycosaminoglycan in the constructs. On PLLA-100
the chondrocyte spread from the surface of the scaffold towards the inner part, creating a
dense layer. On PLLA-200 the cells penetrated more deeply compared to PLLA-100 but
presented a less evident AB staining.
For both scaffold topographies, typical chondrocyte morphology could be clearly seen
via HE staining, in fig. 5.5 A greater number of round morphological chondrocytes were
observed in the PLLA-100 than in the PLLA-200. As obvious the chondrocytes were attached
to the polymer skeleton of the scaffold and cell-cell interactions were evident.
In order to evaluate the ECM protein expression, two different immunohistochemical
analysis were carried out. The confocal micrographs were taken after the articular chondro-
cytes have been cultured for 1 weeks on the scaffolds. In figure 5.6 type I (green) and type II
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Fig. 5.2 Cell viability of articular chondrocytes on different scaffolds and time points. a) PLLA-100, 7
days cell culture, b) PLLA-200, 7 days cell culture; c) PLLA-100, 14 days cell culture, d) PLLA-200,
14 days cell culture
(red) collagen staining is reported. The nuclei were stained in blue with DAPI. Assessment
of collagen types I and II was qualitative and was based on evaluation of the abundance of
collagen types I and II present around and between the cells within the two foams. The large
amount of type II collagen spread within and on the surface of the scaffold indicates the high
synthetic activity of the chondrocytes. In particular, type II collagen allows the formation
of the fibrils that provide the adequate tensile strength to the tissue. As previous result, the
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Fig. 5.3 Cell viability of nasoseptal chondrocytes on different scaffolds and time points. a) PLLA-100,
7 days cell culture, b) PLLA-200, 7 days cell culture; c) PLLA-100, 14 days cell culture, d) PLLA-200,
14 days cell culture
PLLA-100 scaffold shows a higher cell density probably due to a more compact topography.
The second staining is reported in figure 5.7, SOX9 was labeled in red, in green the
proteoglycan expression was depicted. DAPI counterstained the cell nuclei in blue. The
presence of sulfated glycosaminoglycans is a generally accepted indicator of the differentiated
phenotype of chondrocytes. The presence of the immunolabeled markers could be clearly
shown, DAPI and SOX9 inside the cell and proteoglycans within the ECM. On PLLA-100
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Fig. 5.4 Alcian blue staining at 14 days. In reddish pink nuclei, in blue sGAG. a), c) PLLA-100; b), d)
PLLA-200
the presence of SOX9 is less apparent inside the scaffold owing to the strong blue staining of
DAPI.
Gene expression
To further investigate the chondrocyte differentiation in the foams, real-time PCR analysis
was carried out. Three positive markers for chondrogenic differentiation were adopted: type
II collagen (important marker of cartilage), aggrecan (major proteoglycan in the articular
cartilage) and SOX9 (principal transcription factor for chondrogenic genes). The results of
PCR analysis after 7 days and 14 days were reported in figure 5.8. For each time point, 7 or 14
days, the gene expression of PLLA-100 were higher than the corresponding PLLA-200 and
in particular the results was significant for ACAN and SOX9 at both investigated time points.
Furthermore at 14 days the gene expression was always more expressed of the analogous
at 7 days. This difference was significant for SOX9 for both time points and PLLA-100 for
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Fig. 5.5 HE histological staining at 14 days. a), c) PLLA-100; b), d) PLLA-200
ACAN. Particularly relevant is the increasing of SOX9, passing from 1 week to 2 weeks the
upregulation is almost fivefold. The PCR results showed that the PLLA scaffold allowed
the expression of cartilaginous genes in both variants as time passes. The gene expressions
of type II collagen, aggrecan and SOX9 significantly decreased with the increasing of the
scaffold pore size to 200 µm.
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Fig. 5.6 Immunohistochemical analyses of ECM synthesis after 7 days from the seeding. Red -Type II
collagen, Green- Type I collagen, Blue-Nuclei. a) PLLA-100, b) PLLA-200
Fig. 5.7 Chondrogenic gene expression at 7 days of cell culture: SOX9 (Red), PG (Green), Nuclei
(Blue). a) PLLA-100, b) PLLA-200
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(a) (b)
(c)
Fig. 5.8 Gene expression of type II collagen (a), aggrecan (b) and SOX9 (c) in the two different type
of scaffolds, PLLA-100 and PLLA-200 after 7 and 14 days. Significant difference: *p<0.05;
**p<0.01; ***p<0.001
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5.2 Mesenchimal Stem Cell in gradient pore scaffolds
5.2.1 Mesenchimal Stem Cell (MSCs)
Mesenchymal stem cells were described for the first time, by Friedenstein and Petrakov in
1966, as progenitors derived from the stromal fraction of rat bone marrow (Jackson et al.,
2007). Meanwhile the definitive evidence for the presence in adult bone marrow able to grow
in the form of fibroblasts and to differentiate into various mesenchymal elements arrived by
Friedenstein et al. (1976) in the mid-70. Numerous studies have subsequently confirmed the
multipotentiality of these cells. In the presence of appropriate stimuli, they differentiate into
adipocytes (with cytoplasmic vacuoles containing lipids), osteoblasts (with the deposition of
hydroxyapatite crystals), chondrocytes (with synthesis of the cartilage matrix), and muscle
cells (rich in myotubes) (Jiang et al., 2002). MSCs are relatively rare cells in the bone marrow
(1/105 nucleated cells), preserving the stem properties (Javazon et al., 2004). They are able
to express the genes of embryonic origin, to synthesise cell-cell contact molecules and
components of the extracellular matrix such as collagen and fibronectin, to secrete cytokines
such as interleukin IL-7, IL-8, IL-11, stem cell factor (SCF) and stromal-derived-factor-1
(SDF-1), that regulate the mobilisation of hematopoietic stem cells from the marrow. For this
reason, MSCs play the essential role of homeostatic compartment of bone marrow stromal
cells, constantly renewing the microenvironment required for hematopoiesis. Moreover,
given their derivation from intra-embryonic mesoderm, the MSCs are able to differentiate
in several lineages in addition to those lines of the osteogenic (Arpornmaeklong et al.,
2009; Birmingham et al., 2012), adipogenic (Jackson et al., 2007; Rodríguez et al., 2008),
chondrogenic (Bhardwaj and Kundu, 2012; Huang et al., 2015) and muscle (Meligy et al.,
2012), such as endodermal cells (hepatocytes, pneumocytes) and ectodermal (cells nerve,
glial cells) (Jamnig and Lepperdinger, 2012; Tseng and hui Hsu, 2014; Wang et al., 2016).
This pluripotency, however, is progressively lost as a result of the process of senescence
(Cheng et al., 2011). Tests were carried out in a murine model of osteogenesis imperfecta,
a congenital disease of mesenchymal tissue, characterised by ossification defect. In this
case MSCs from bone marrow were injected in the bone, obtaining functionally bone and
cartilaginous tissue (Kadiyala et al., 1997). Positive results of injection of MSCs were found
also in clinical test: MSCs were infused in children with ostogenesis imperfecta; three
months later the cells rooted without side effect, with an increase of osteoblastic component
and formation of new lamellar bone (Horwitz et al., 1999).
For example in order to develop an osteoblastic phenotype, MSCs are cultured in medium
supplemented with ascorbic acid (AA), b -glycerophosphate (bGP), and dexamethasone
(DEX) (Haynesworth et al., 2016). Three phases can be distinguished in differentiation of
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osteblastic phenotype. During the proliferation phase (first or growth phase) cells tend to
express mRNA for related growth proteins including c-fos, histone, c-myc, transforming
growth factor-b (TGF-b ), procollagen I, and fibronectin (Siggelkow et al., 1999). During the
matrix maturation (second phase) phase cells differentiate into osteoblasts and secrete alkaline
phosphatase (ALP) and produce type I collagen (Togel and Westenfelder, 2011). Finally,
mineralisation is marked by the secretion of collagenous proteins including osteopontin
(OPN), osteocalcin (OC), bone sialoprotein (BSP), and deposition of calcium/phosphate
minerals (Stein and Lian, 1993).
5.2.2 Scaffold preparation
PLLA (MW=114000 kg/mol), 1,4-dioxane (Sigma-Aldrich) and distilled water were used
to produce the PLLA scaffold. The ternary solution employed has a PLLA concentration
of 4 % wt, in 87/13 wt/wt dioxane/water (solvent/non-solvent). Different thermal histories
were imposed on sample sides by an experimental apparatus made in-house using software
controlled Peltier cells (chapter 3). Starting from a solution kept at 60°C for 10 minutes
(well above the cloud point), one side (Slow Cooling Side - SCS) was cooled at 1°C/min
to 30°C and maintained for 20 minutes, whereas the other surface (Fast Cooling Side -
FCS) was suddenly cooled to 30°C, and held for 50 minutes. At the end, the solution was
rapidly quenched to -20°C to freeze the so-obtained microstructure. Thus, to completely
remove the solvents, the foams were washed in deionised water and drying under vacuum. A
schematisation of the thermal history imposed on two side of the sample is depicted in figure
5.9.
5.2.3 Cell seeding
Utilizing a protocol approved by the Thomas Jefferson University Institutional Review Board,
human MSCs extract from bone marrow (hbMSCs) were isolated from healthy donors with
the patients consent (Hu et al., 2009).
An aliquot of bone marrow was harvested from the iliac crest, filtered through a 40 µm
strainer and the flow-through was centrifugated at 300g for 5 min to sediment the red blood
cells. The pellets were suspended using growth medium DMEM containing: 10% FBS
(Invitrogen), 2% antibiotics-antimycotic, 1% Sodium Pyruvate, 4.5 g/L D-Glucose, 4 mM
L-Glutamine and 25 mM HEPES and then plated into 150 cm2 tissue culture flasks at a
density of 106 cells/flask.
The medium was changed every 3 to 4 days. Once 70% to 80% confluence was reached, cells
were passaged. The colony formation and trilineage mesenchymal differentiation capacity
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Fig. 5.9 Thermal history. SCS: Slow Cooling Side, FCS: Fast Cooling Side
of hBMSCs was validated before use. For the preliminary tests different hMSCs were used,
from a female patient 45 years old and two male patients 45 and 59 years old.
8⇤105 mesenchymal stem cells were seeded per PLLA scaffold. The scaffolds were precon-
ditioned by soaking in DMEM cell culture medium overnight, after an overnight in ethanol
70% to allow the sterylization. The cells were seeded in static conditions by injecting them
with a pipette.
5.2.4 Live/dead and MTS assay
Scaffolds were harvested at days 1, 3 and 7 of culture, rinsed in PBS and stained with
ethidium homodimer-1 and calcein to perform a live/dead stain (abcam, ab115347). The
images were taken under a SZX16 Olympus Stereomicroscope. Stereomicroscopy is a fast
and simple method that allows the characterisation of cells in their medium. If performed
quickly, it can be used to illustrate the cells that are dead and alive. It does not offer however,
information on 3D distribution. Live cells are identified on the basis of intracellular esterase
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activity (generating green fluorescence) and exclusion of the red dye. Dead cells are identi-
fied by the lack of esterase activity and non-intact plasma membrane which allows red dye
staining.
Furthermore to evaluate from a quantitative point of view the cell proliferation rate the MTS
assay (abcam, ab197010) was adopted. MTS (3 - (4,5 - dimethylthiazol - 2 - yl) - 5 - (3caro-
cymethoxyphenyl - 2 - 4 - (sulfophenyl) - 2H - tetrazolium) assay is a colorimetric method to
determine the number of viable cells in culture. The yellow MTS tetrazolium compound is
reduced to a brown formazan product that is soluble in culture medium. This conversion is
achieved by NADPH which is produced by dehydrogenase enzymes in metabolically active
cells. After incubating for 3-4 hours at 37°C, three 100 µl samples were pipetted out from
the scaffolds and absorbance was read at 490 nm.
5.2.5 Results
Scaffold morphology
In figure 5.10 the SEM micrograph of the adopted scaffold is reported.
Fig. 5.10 SEM micrograph of the PLLA gradient scaffold adopted. a) FCS - 200 µm; b) 140 µm; c)
SCS - 70 µm
The scaffold presents an average pore dimension of 200 µm on the fast cooling side (left
side) and gradually decrease, 140 µm in center, up to 70 µm on the slow cooling side (right
side). It can be ideally divided in three sections, equally distributed.
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(a) (b) (c)
Fig. 5.11 Schematic representation of
different parts of the scaffolds
analysed via Live/Dead cell viability
assay in PLLA scaffold
Cell viability
Samples via Live/Dead were analysed on side of the scaffold (fig. 6.18a), top/bottom (fig.
6.18b) and cross section (fig. 6.18c).
As an example the live/dead assay after 7 days of cell culture was reported. Fig. 5.12
reports the assay at 7 days on side and the cross section of the scaffold, fig. 5.13 reports the
upper and lower surface.
Comparing the images between side of the scaffold and cross section the difference of cell
viability is evident. On the side there are much more live cells than of the cross section. The
static cell culture do not facilitate the penetration of the medium and than the proliferation
and growth of the cells. As expected, large pore sizes imply a larger presence of live cell but,
in any case, the few amount of dead cells in the small pore size portion of the scaffold is a
good results. Analogous behavior was recognized on the top and the bottom of the scaffold,
the amount of live cells largely overcome dead cells.
MTS assay
To evaluate the cell proliferation following the supplied protocol a preliminary calibration
curve was calculated. 104 5⇤104 105 4⇤105 8⇤105 cells were counted and seeded
in different wells in triplicate. After 24 hours of incubation 20 µL/well MTS reagent into
each well were added and incubated for 4 hours at 37°C. Figure 5.14 shows the calibration
curve with an R2 = 0.99499.
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(a) (b)
Fig. 5.12 Live/Dead Cell Viability Assays of the scaffold in static conditions. a) External surface. b)
Cross section
Adopting the calibration curve as a reference the cell number in the scaffold after 1, 3
and 7 days of culturing was evaluated. Dividing the cell number after 1 day of incubation by
the cell number seeded on the scaffold the cell seeding efficiency was calculate. In this case
considering a cell density of seeding of 800000 cell/scaffold and number of cell after 1 day
of 183000±11100, the cell seeding efficiency is 22.8%±1.3%. As reported in figure 5.15
the cell number in the scaffold after 7 days is more than duplicated compared to the initial one.
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Fig. 5.13 Live/Dead Cell Viability Assays on top and bottom of the scaffold in static conditions
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Fig. 5.14 Calibration curve for MTS assay from 104 to 8⇤105 cells/well
Fig. 5.15 MTS assay on porous PLLA gradient scaffold at 1, 3, 7 days
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5.3 Chondrocytes in composite PLLA/Bioglass scaffolds
To evaluate the influence of bioglass on chondrocyte proliferation, growth and differentiation,
composite PLLA/Bioglass scaffolds at different concentration were produced via TIPS.
Several studies showed that the addition of bioglass in the polymer network increases the
hydrophilicity (Dziadek et al., 2016; Maji et al., 2016; Puppi et al., 2010) of the scaffold
as well as mechanical proprieties (Fabbri et al., 2010) and bioactivity (Miguez-Pacheco
et al., 2015). As previously reported (chap. 2) the bioactivity propriety is the ability to bond
with the living tissue. Bioglass with bioactivity index more than 8 is able to bond with soft
and hard tissue. Hench and Greenspan (2013) showed the HCA crystallites formed on the
bioactive glass surface nucleate and bond to the interfacial metabolites of the cartilage, first
of all type I collagen. Furthermore, the addition of bioglass creates an antimicrobial effect.
In literature the use of composite polymer/bioglass scaffold for cartilage tissue engineering
was reported (Boccaccini et al., 2010; Tellisi and Ashammakhi, 2012; Wu et al., 2013; Zhou
and Yu, 2014), but there are not studies of PLLA/bioglass scaffold. As reported in the section
4.3, 1393 composition better matches with the this production technique, for this reason the
1393 BG was chosen for the cell culture experiment. Two different concentrations (1% and
2.5%) were chosen to evaluate the influence of the amount of bioglass in the cell culture.
5.3.1 Scaffold preparation
Scaffolds were fabricated via ternary TIPS technique, polymer/solvent/non-solvent. The
weight concentrations of PLLA was 6% and a ratio solvent/nonsolvent (Dioxane/water)
87/13. Starting from this ternary solution the bioglass was added at 1% and 2.5% of the
polymer. Initially the solution was kept at 65°C to allow the complete homogenization of the
mixture, then the powders of bioglass, in different concentration, were added. To avoid the
formation of cluster, the as-obtained quaternary solution was sonicated for 15 minutes at 35
kHz. During this process, the solution was maintained above 60°C to reduce the viscosity
and facilitate the complete dispersion of the powders. Thus the solution was poured in a
HDPE mould and immersed in a thermal bath at 30°C for 75 minutes. At the end, the mould
was immersed in an ethanol bath at -20°C for 20 minutes to stop any TIPS process. Finally
washed in distilled water and dried under vacuum for more the 24h to complete remove the
solvents.
For the cell culture experiments the scaffolds were cut in cylindrical shape of 4mm diameter
and 3mm height.
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5.3.2 Chondrocyte isolation and seeding
Donors of human articular chondrocytes were isolated following the same protocol previously
described (section 5.1.2). Briefly, sampling were extracting from male (n=2) and females
(n=4) with an average age of 71.6 years from knee joint or hip joint replacement surgeries.
The cartilage chips where digested by pronase E and incubated with collagenase NB5 in
growth medium. The as-isolated chondrocyte were expanded in T175 flasks before seeding.
The scaffolds were preconditioned adopting 70% ethanol overnight, abundantly rinsed in
PBS to remove any trace of alcohol and finally in FCS overnight. A cell density of 25000
chondrocytes per mm3 of scaffold was used. Seeded scaffolds were cultured in 6 well plates
coated with cell culture suitable agarose (1%, Sigma-Aldrich) with 5 mL of growth medium
for each well. Medium was changed every 3 days. Cells were cultured on the scaffolds for 1
day, 7 days or 14 days.
5.3.3 Live/dead assay and PCR analysis
Cell vitality inside the scaffolds was determined after 7 and 14 days of cell culture. Live/dead
staining was performed using FDA (green label) and PI (red label). Seeded scaffolds were
incubated in the FDA/PI solution and examined under DMi8 confocal microscope.
To evaluate the gene expression of chondrocytes in the scaffold PCR analysis was performed
adopting the same procedure previously reported (section 5.1.6) after 7 and 14 days. The
primers was supplied by Applied Biosystems with the following NCBI Gene Reference:
COL2A1 Hs00264051_m1, ACAN  Hs00202971_m1, SOX9 Hs00165814_m1. The
relative gene expression was normalized to the 18S expression and calculated for each
sample using the DD CT method described by Livak and Schmittgen (2001). Scaffold seeded
in the same condition and evaluated at the first day was adopted as reference for qRT-PCR.
5.3.4 Results
Scaffold morphology
Figure 5.16 shows the scaffold morphologies of the scaffolds adopted for cell seeding. The
first figure reports the scaffold containing 1% of BG, while the second one 2.5%. With
respect to the previous tests, to compare the influence of BG on the chondrocyte growth the
same thermal history for the two compositions was adopted. An average pore dimension
of 150 µm was calculated. In both cases a temperature of 30°C was chosen to allow the
process of nucleation and growth but similarly ensuring a good degree of interconnectivity.
The presence of the BG is evident in both micrographs.
5.3 Chondrocytes in PLLA/BG scaffold
(a) (b)
Fig. 5.16 SEM micrographs of the PLLA/BG scaffold micrography. a)PLLA/BG 1%, b) PLLA/BG
2.5%
Cell viability and gene expression
Cell viability after 7 and 14 days were verified in both scaffold concentration. Staining
FDA/PI were adopted to label in green the viable cells and in red the died cells, respectively.
The images (fig. 5.17) show a good vitality of chondrocytes in both time points and foams.
In particular already from 7 days the largest part of scaffold surface is covered by green cells
with a slight majority in the scaffold with 2.5% of BG. The confocal microscopies highlight
the very few amount of dead cells after 14 days too. Like at 7 days of culture the composite
scaffold with the larger amount of BG appears with a bigger amount of cells than the other
one. The typical elongated shape of chondrocytes, in most case recognisable, denotes the
very good cytocompatibility of the PLLA/BG foam.
As concerns the gene expression, three gene markers were investigated: type II collagen,
aggrecan and SOX9. Figure 5.18 reports the gene expression for all conditions. The
difference was considered statistic significantly if a p-value was less than 0.05 (*) or 0.01
(**). The results show that there is not a homogenous trend between 1% and 2.5% of BG.
The upregulation for collagen is higher in the case of 1% than 2.5%, for ACAN at 7 days
the two foams are almost equal while there is an increase of 2.5% at 14 days, for SOX9 in
both time points the scaffolds 2.5% of BG are more expressed than the relative 1%. In any
case the general trend is an upregulation in every conditions respect to the control with a
significant difference for ACAN at 14 days and collagen at 7 days. Further tests need to be
performed to better understand the different trends recorded as a function of the BG content.
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Fig. 5.17 Cell viability of nasoseptal chondrocytes on composite PLLA/BG scaffolds. a) PLLA/BG
1%, 7 days, b) PLLA/BG 2.5%, 7 days; c) PLLA/BG 1%, 14 days, d) PLLA/BG 2.5%, 14 days
160
5.3 Chondrocytes in PLLA/BG scaffold
(a) (b)
(c)
Fig. 5.18 Gene expression of type II collagen (a), aggrecan (b) and SOX9 (c) in the two different types
of scaffolds, PLLA/BG 1% and PLLA/BG 2.5% after 7 and 14 days. Significant difference: *p<0.05;
**p<0.01
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5.4 Osteoblasts in composite PLLA/HA scaffolds
Many researchers have carried out biological in vitro studies on scaffolds containing HA using
osteoprogenitor cells, like MC3T3-E1, analysing the biocompatibility and osteoinductivity
through proliferation and differentation assays. In particular, alkaline phosphatase activity
(ALP) and the presence of calcium deposits are the investigated markers that evidence the
osteoblastic differentiation.
5.4.1 Scaffold preparation
PLLA (Resomer L 209 S), 1,4 dioxane (Sigma) and distilled water were utilised to prepare
the ternary solution. HA was kindly provided by Professor Licciulli from University of Lecce.
Initially, a homogeneous solution composed by PLLA, dioxane and water was prepared, then
HA particles in a PLLA/HA ratio of 93/7 were added. The solution was initially sonicated at
35kHz for 15 minutes and then kept in a thermal bath at 60°C. Thus the temperature was
suddenly lowered to 30°C for 10 minutes. Later, a quench by direct pool immersion in an
ethanol bath at a temperature of -25°Cwas performed. Finally the foams were washed and
dried under vacuum. Neat PLLA scaffolds, produced following the same protocol, were
added as control.
5.4.2 Cell seeding
Pre-osteoblastic MC3T3-E1 cells (Sigma Aldrich) were cultured in DMEM (Sigma Aldrich)
supplemented with 10% of fetal bovine serum (FBS), 1% of glutamine and 1% of strepto-
mycin/penicillin (growth medium) in 75cm2 cell culture flasks incubating at 37°C with 5%
CO2. Scaffolds were cut in circular-shaped slices: 5mm diameter and 1.5mm of thickness.
The samples were preliminarily sterilised under vacuum in a 70% ethanol solution, then
abundantly rinsed in PBS with calcium and magnesium (Euroclone) for 2 hours and treated
with a 100µg/ml type I collagen solution in 0.02N acetic acid to increase the cell attachment.
Finally, the scaffolds were washed in growth medium to activate the collagen mesh formation
thanks to pH shift. A cell density of 2.5⇤105 cell/scaffold in 25 µl were used. The samples
were placed in a multiwell plate replacing the medium every three days up to 27 days.
5.4.3 Proliferation assay
Cell proliferation in PLLA and PLLA/HA scaffolds was evaluated through viability assays
employing Cell Counting Kit 8 (CCK8, Sigma Aldrich); a sensitive colorimetric kit con-
taining WST-8. This latter is a salt reduced by mitochondrial dehydrogenases to orange
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formazan, evaluated in absorbance at 450 nm. Given that the number of living cells is
directly proportional to the value of absorbance, a standard curve was created to convert the
absorbance value in terms of cell number. Each sample was incubated at 37°C and 5% CO2
for 3 hours with 500 µl of 1:10 diluted reagent in fresh medium. Finally, the medium was
collected and analysed with a spectrophotometer at absorbance of 450 nm. The essays were
carried out at 0, 7, 14, 21 and 27 days of culture in triplicate for each time. Furthermore, not
seeded scaffolds were used as negative controls in each measurement.
5.4.4 ALP assay
The osteoblastic differentiation process was investigated with SensoLyte pNPP Alkaline
Phosphatase Assay kit (Anaspec, AS-72146) measuring the alkaline phosphatase activity, a
marker expressed during the osteoblastic maturation. Incubating the protein extracts with the
enzymatic substrate, p-nitrophenyl phosphate (pNPP), a dephosphorylation process occured
causing the formation of a yellow product, p-nitrophenol. The spectrophotometric measure
through absorbance at 405 nm reveals the ALP activity. According to the protocol kit,
the seeded scaffolds were washed in PBS and incubated with washing buffer. Successively,
samples were grinded and 100µl of 0.2% Triton X-100 lisys buffer was added to each scaffold
and vortex. After the centrifugation at 2500 g at 4°C for 10 minutes, 50 µl of supernatant
was harvested and mixed with 50 µl of substrate for 1 hour into wells of a 96 well plate. The
measurement were performed at 0, 7, 14, 21 and 27 days in triplicate. The data are expressed
in ng/cell using a standard curve to convert absorbance values in ng of alkaline phosphatase.
5.4.5 Results
Cell viability
Cell number variation as a function of days of culture on both kinds of sample in figure 5.19
is reported. From 0 to 21 days, on both substrates, viable cell number has regularly increased
from a starting point of almost 105 to 4.5⇤105 cells, reaching the maximum peak. The small
decrease to 3.5⇤105 cells in the last week can be due to the reach of confluence with a weak
detachment of the cell due the the lack of available surface. Neat and composite scaffolds
show a very similar trend, demonstrating a comparable biocompatibility degree.
ALP activity
The histogram in figure 5.20 shows the ALP activity as nanograms of ALP normalized with
number of cells. From 7 to 14 days, obtained data revealed an increase in ALP activity,
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Fig. 5.19 Cell viability of MC3T3-E1 cells in PLLA and PLLA/HA scaffolds up to 27 days
despite there is not significant difference between neat and composite scaffold. At 21 and
27 days PLLA/HA showed a regular growth, while pure PLLA remained quite constant.
This aspect implies a statistically significant difference at these time points between the two
types of scaffolds. Considering simultaneously the proliferation and ALP assays, it seems
evident that the substrates similarly promote cell growth but the presence of HA increased
the osteoblastic maturation through a significant raise in ALP activity after 21 days when
cell confluence is reached.
Fig. 5.20 ALP activity at 7, 14, 21 and 27 days. Data are normalized using not seeded-scaffold as
negative control and represented by means of average ± SD; *p<0.05
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Chapter 6
Bioreactors in tissue engineering
Bioreactor devices allow to carry out cell cultures in dynamic regimes. In a general per-
spective, a bioreactor allows to control the growth environment replicating as closely as
possible the conditions of the native tissue, considering several aspects: pH , temperature,
pressure, concentration of metabolites and catabolites, but also mechanical and chemical
stimuli. Bioreactors play a key role in the processes of biological tissue engineering and
implementation of dynamic cell culture in three-dimensional environments. More specifically,
these latter relate to cell seeding, optimization of the mass transport in 3D constructs and use
of these devices for in vitro models. The main purpose of the bioreactors can be summarised
in the following points:
1. to allow a homogeneous cell distribution;
2. to maintain vitality of cells seeded on/in porous 3D scaffolds during cultivation;
3. to increase the mass transport (both diffusion and convection mechanism);
4. to achieve specific physical stimulation of the TE construct.
In literature it is possible to find various types of bioreactors depending on the application.
As an example bioreactor for ligament/tendon and for bone are reported.
Bioreactors for ligament and tendon are focused on the replication of the mechanical con-
ditions of the native tissue. Tendons and ligaments transfer the force from muscle to bone
and bone to bone, respectively. They consist of collagens, cells, proteoglycans, elastin,
glycolipids, and water. Water is about 65%-70% of the total weight with a highly organized
structure. Collagen type I is the main structural/functional component and comprises around
70%-80% of the dry weight. Type III collagen is mainly present in the endotenon and
epitenon, but is also in the early phase of tendon repair.
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In fig. 6.1 an example of bioreactor system for ligamen/tendon is reported. The main com-
ponent is the actuating system, which provides the different mechanical regimes. The most
common actuators for this type of bioreactor are: pneumatic actuators (Nirmalanandhan
et al., 2008), linear motors (Doroski et al., 2010) and step motor-ball screws (SMBSs) (Webb
et al., 2006). The pneumatic actuators present the following advantages: cleanliness, low
cost, and high power-to-weight ratio, but it is not possible to use them adopting air as a
medium. Linear motors are electric devices, that implies they are more expensive compared
to pneumatic motors but with a superior accuracy. Moreover, by eliminating the mechanical
transmission, the linear motor can reach higher velocity. The SMBS actuators incorporate
ball screw drives and provide low friction. They offer a combination of high-speed and
high-load capacity, therefore they are ideally suited for applications that require high-speed
precision motion control. Unlike trapezoidal leadscrews, ball screws have rolling surfaces
that wear less than sliding interfaces. The choice between the different types of actuators
depends of the specific test to carry out.
Fig. 6.1 Example of bioreactor system for ligamen/tendon tissue engineering, from Wang et al. (2013)
Bone tissue engineering needs different bioreactor specifications. Supplying the correct
amount of nutrient to allow the cells proliferation is one of the main tasks in the case of bone
tissue. Cells, indeed, product an extracellular matrix that restricts the amount of oxygen and
growth factor concentration. The bioreactor for osteogenesis have to force the medium inside
the pore of the scaffold, promoting the fresh medium exchange. In figure 6.2 a schematic
representation of different available bioreactors is reported.
Rotating wall vessel bioreactors (fig. 6.2a) consist in a cylindrical growth chamber with a
gas exchange membrane. The solid-body rotation is accomplished by a vessel rotating hori-
zontally around its axis, randomising the gravitational forces acting on the cell surface. The
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Fig. 6.2 Example of bioreactor system for bone tissue engineering, adapted from Sladkova and
de Peppo (2014)
culture chamber is completely filled with culture medium (zero headspace) and oxygenated
through a silicone rubber membrane by an air pump that draws incubated air through a filter.
As the vessel rotates, the liquid inside accelerates, until the entire fluid mass is rotating at the
same angular rate as the wall (under no-slip hypothesis). When the velocity of the rotating
fluid reaches the same of sedimentation rate of the cell/scaffold constructs, these latter are
maintained in a "free-fall" state and subjected to dynamic laminar flow (Granet et al., 1998).
Spinner flasks are simple bioreactor systems (fig. 6.2b) composed of a glass or plastic vessel
in which cell/scaffold constructs are suspended inside the medium. The top of the vessel
is usually used for gas exchange and medium oxygenation. A stir bar at the bottom of the
vessel maintains the mixing of the medium. The convective forces generated during stirring
mitigate the nutrient concentration gradients at the surface of the cell/scaffold constructs and
produce turbulences to enhance the mass transport toward the centre of the samples. This
effect is thought to result from the convective transport of nutrients to the surface of the
scaffold in spinner flask culture in contrast to the purely diffusional transport in static culture.
This aspect will increase concentrations of oxygen throughout the scaffold, compared to the
static culture, when a nutrient concentration gradient can form where cells in the centre of
the scaffold receive an insufficient supply of nutrients (Kim et al., 2007; Wang et al., 2009;
Yeatts and Fisher, 2011).
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About the perfusion bioreactor (fig. 6.2c), different systems have been developed, but all
concepts share the similar basic design consisting of a medium reservoir, a pump, a tubing
circuit and a perfusion cartridge. The perfusion cartridge holds the scaffold that is sealed to
avoid the medium flow around it, thus perfusing medium directly through the pores of the
scaffold (Braccini et al., 2005). Many perfusion bioreactor systems have been developed and
tested for bone tissue engineering purposes (Bjerre et al., 2008; Carmona-Moran and Wick,
2015; Hossain et al., 2014; Schmelzer et al., 2015; Yeatts and Fisher, 2011).
The last type is the compression bioreactor (fig. 6.2d). The idea is to mimic the bone physio-
logical environment in vitro, characterized by repeated mechanical stimulation required for
functional bone regeneration. These culture systems consist in a motor, a system providing
linear motion and a compression chamber in which some pistons apply static or dynamic
compressive loads directly to the scaffold constructs. Furthermore, the continuous movement
of piston force the fluid inside the construct, which makes it also similar to the perfusion
bioreactor (Damaraju et al., 2014; Puetzer et al., 2012; Tran et al., 2011; Wartella and Wayne,
2009) for some aspects.
All things considered, all bioreactors try to reproduce in vitro the complex set of stresses to
which the tissues are subjected during the development in vivo.
6.1 Microphysiological Tissue System (MTS) Bioreactor
A microphysiological tissue system (MPS) bioreactor has been developed to replicate in vitro
the in vivo OC physiological conditions (Lozito et al., 2013). The MPS allows a separate
control of the chondral and osseous environment while permitting communication between
chondrocytes and osteoblasts across the OC junction (Alexander et al., 2014), similar to
the conditions of OC tissue in vivo. The structure of the bioreactor, reported in figure 6.3,
was modeled using Solidworks 2014 (Dassault, Systemes). Well, insert, base and lid were
fabricated using via 3D Systems Viper (Rock Hill, South Carolina) using WaterShed XC
11122 resin (DSM Somos, Heerlen, Netherlands). The bioreactor was developed and tested
in the Rocky Tuan’s laboratory at the University of PIttsburgh.
One of the main problem about the reproduction of the osteochondral unit it is the diffi-
culty to supply culture medium conditions in the same complex. The divergent environments
in which cartilage and bone develop are a particularly relevant issue. Features such as growth
factors and supplements, oxygen, pH, and mechanical stimulation are known to be both
important for histogenesis and tissue-specific for bone or cartilage. Should benefit from the
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Fig. 6.3 Schematic representation of the bioreactor. External view and cross section
application of these external conditions, while maintaining an intimate contact between the
two tissues for a well designed bioreactors.
The illustrated bioreactor is composed by four compartments (cells). Each cell is composed
by perforated removable inserts, where the scaffold is allocated. A detachable base facilitates
the removal of the insert at the end of the test. An o-ring, located outside the insert at 5.05
mm from the bottom, ideally divides the chamber in two parts: the lower part for bone tissue
and the upper part for cartilage tissue. Two channels, below and above the o-ring, allow the
necessary nutrient provision. The channels are connected to syringes and bags, the first ones
to supply the medium, the latter to collect the eluted medium. Lids, o-ring provided, seal the
whole bioreactor to prevent from the outside contamination.
The bioreactor can be also used for drug screening. It is a modular device and the number of
cells can be easily modified, from 1 (fig. 6.4a) to 4 (fig. 6.4b) to 96 (fig. 6.4c).
6.1.1 Computational model
A methodology to characterize flow and transport into a MTS bioreactor has been developed.
The rationale is to meet the following questions via fluid dynamics computational model:
• Can the growth medium reach the whole bioreactor?
• Is the concentration of growth factor sufficient for all constructs inside the bioreactor?
• What is the intensity of fluid mixing between the upper and the lower chamber?
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Fig. 6.4 Different configurations of the bioreactor:
a) 1 cell, b) 4 unit cells array, c) 96 unit cells plate
By combining distributed and lumped parameter models it is possible to fulfill all these
requirements. In particular, the degree of perfusion and mixing of nutrients in each region
of the device will be estimated, quantified and compared with data derived from specific
experiments.
Since the bioreactor is a combination of free flow for the inlets and outlets with porous
medium flow for the culture chamber, a fluid-porous interaction model was used. In each
region, the flow was considered incompressible. For momentum balance a general equation
that encompasses the nature of both types of flows was selected. In this way, it is easy to
switch from one to the other by suitably tuning the parameters in each region. This equation
has the structure of Brinkman equation for flow in porous medium, because it combines
viscous terms, such as in Stokes, with friction terms, such as in Darcy. To model free flow, a
convective term (which play a significant role in case of high Reynolds regimes) was added.
In figure 6.5a the computational domain is reported with the relative mesh in ANSYS adopted
(fig. 6.5b).
The momentum balance equation reads as follows:
5 (rgU⇥U) 5(µg(5U+(5U)T )) = g µ
Kperm
U5P
8x 2Wc_up[Wc_down[Wsca f f (6.1.1)
WhereU is the velocity vector field, r and µ are fluid viscosity and density respectively, g is
the porosity of the medium ( g = 1 for the free fluid), Kperm is hydraulic conductivity of the
porous medium (kperm = 0 for the free fluid) and5P the hydrostatic pressure.
The culture medium that perfuses the bioreactor was assumed comparable to water (r =
999.97 kgm3 and µ = 0.001Pa⇤ s) because the dissolved nutrients and other chemical species
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(a) (b)
Fig. 6.5 Bioreactor arrangement in the computational model. a) Bioreactor domain.
G and W denote surface and volume respectively. Gc_up,in: inlet, upper chamber, Gc_down,in: inlet,
lower chamber, Gc_up,out : outlet, upper chamber, Gc_down,out : outlet, lower chamber, Gsca f f old:
scaffold/wall interface, Gc_up: upper chamber, Gc_down: lower chamber, G f luid porous: fluid/porous
interface, Wc_up: upper chamber, Wc_down: lower chamber, Wsca f f old: scaffold. b) Bioreactor mesh.
In grey the free fluid region, in red the porous region
are diluted. The applied boundary conditions were: at the bioreactor inlet (Gc_up,in, Gc_down,in)
a given flow rate; at the surfaces that separate the free fluid and the porous medium from the
bioreactor walls (Gc_up,Gc_down,,Gc_sca f f old) the no-slip condition and at the outlet (Gc_up,out ,
Gc_down,out) the street-free condition (P = 0). An important part of this study consists in
modeling the transport of bio-molecules dissolved in the culture medium that perfuse the
bioreactor. The different nutrients have been modeled as variables passively transported by
the culture medium. Their governing equations have been formulated in terms of volumetric
concentrations.
Under these conditions the equations for the transport of biomolecules are:
5(Dsgs5Cs+rsgsUCs) = 0 8x 2Wsca f f (6.1.2)
5(Df 5Cf +UCf ) = 0 8x 2 Wc_up[Wc_down (6.1.3)
D is the diffusion coefficient for the different biomolecules, C is the solute concentration and
f and s indicate the fluid and scaffold respectively. The specific boundary conditions for the
biomolecules transport were: at the inlet boundaries (Gc_up,in, Gc_down,in) a known concen-
tration has been imposed, using independent values on each inlet section. Homogeneous
Neumann condition has been adopted on the bioreactor wall and outlets (Gc_up,out , Gc_down,out ,
Gc_up, Gc_down). The wall is considered impermeable to nourishments and biomolecules’ flux
in the direction normal to the outlets is assumed equal to zero. Moreover, conservation of
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concentrations and of biomolecules flux have been applied at the interface between fluid and
porous medium (G f luid porous).
The computational model was implemented using ANSYS ICEM CFD v.15.0 (AnsysInc.,
Canonsburg, PA). The geometry of the device was created using ICEM tool and the domain
has been discretized with tetrahedral elements by means of the octree mesh method, which
ensures a refinement of the computational grid where necessary in order to reduce the
computational costs.
6.1.2 PLLA gradient scaffold and GelMA scaffold:
fabrication and modelling
PLLA (MW=114000 kg/mol), 1,4-dioxane (Sigma-Aldrich) and distilled water were used to
produce the PLLA scaffold. The ternary solution employed has a PLLA concentration of 4 %
wt, in 87/13 wt/wt dioxane/water (solvent/non-solvent). The adopted scaffold was the same
as the preliminary tests in static conditions (section 5.2). Briefly the scaffold presents an
average pore dimension of 200 µm on the fast cooling side (left side) that gradually decreases
going to 140 µm in center, up to 70 µm on the slow cooling side (right side). It can be ideally
divided in three sections, equally distributed.
The gelatine metacrylate (GelMA) scaffold was synthesized according to a modified
method of Van Den Bulcke et al. (2000). Powdered, type A gelatin from porcine skin was
obtained from Sigma-Aldrich (St. Louis, MO). One gram of gelatin was added to 33mL of
deionized water and heated at 37°C while stirring for approximately 180 min, or until all
gelatin was dissolved. One milliliter of 94% methacrylic anhydride (Sigma-Aldrich), was
added to the stirring mixture at a constant rate of 150 rpm, and the reaction was allowed to
proceed for 16h at 37°C. The reaction products were dialyzed with 12-14 kDa molecular
weight cutoff dialysis tubing to remove the methacrylic acid and other impurities. Then the
solution was frozen with liquid nitrogen and lyophilized for 1 week. The dry gelMA powder
was resuspended in PBS 1X, mixed with LAP, the final concentration was 10% GelMA and
0.15% LAP. For the final shape, the solution was poured into the insert and cured using an
UV light with wavelength of 390-395 nm.
Concerning the modelling of the two porous medium, in ANSYS environment the porous
component is composed of a fluid phase and a solid phase. The scaffolds constituent the
solid phase were schematized as repetition of one base unit. The pore has a spherical shape
and it is inscribed in a cube with the side equal to a pore diameter. The combination between
sphere and cube represents the base unit (fig. 6.6).
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Fig. 6.6 Base unit of the porous medium. R:
External pore radius,
d : Pore thickness,
L: Cube side,
R d : Internal pore radius
An important parameter to full specify the interaction between the solid and the liquid
phase is the IAD. The interface area density was estimated as a function of the unit base that
describes the porous structure. IAD was calculated as follow:
IAD=
Ses +Sis
Vc
(6.1.4)
Where Ses = 4pR2 is the external surface; Sis = 4p(R  d )2 is the internal surface and Vc
is the total volume of the unit base cell. In table 6.1 the value for different scaffolds and
sections are reported.
IAD [1/m]
Gelma
10 µm
2.9094⇤105
PLLA
70 µm 140 µm 200 µm
3.8924⇤104 1.5675⇤104 1.09156⇤104
Table 6.1 IAD values for GelMA and PLLA scaffold
In table 6.2 and 6.3 the physical and chemical characteristics of fluid and solid phase are
reported, respectively.
The porosity is defined as the ratio between the void volume, Vv, and the total volume, Vt :
f = Vv
Vt
(6.1.5)
177
Bioreactors in TE
Fluid phase (Water)
Molar Mass [ KgKmol ] 18.2
Density [Kgm3 ] 997.0
Specific heat capacity [ JKgK ] 4181.7
Reference temperature [°C ] 37.5
Reference pressure [atm] 1
Reference enthalpy [ JKg ] 0
Reference entropy [ JKgK ] 0
Dynamic viscosity [Kgms ] 8.899*10
 4
Thermal conductivity [ WmK ] 0.6069
Thermal expansion [ 1K ] 2.57*10
 4
Table 6.2 Physical characteristics of fluid phase assumed as water
GelMA scaffold PLLA scaffold
Molar Mass [ KgKmol ] 1.0012 114000
Density [Kgm3 ] 1190 1220
Thermal conductivity [ WmK ] 0 0
Porosity (f ) 0.8 0.93
Permeability (Kperm) [m2] 10 16 3.234*10 9
Table 6.3 Proprieties of solid phase
but also
f = 1  Vs
Vt
(6.1.6)
where Vs is the volume of the solid part.
In this case, solid volume is defined as:
Vs =
Vring
Vcube
=
4pR2d
L3
(6.1.7)
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Usually Kperm in an anisotropic structure, is a tensor quantity. Here, since the scaffolds under
consideration are isotropic, it becomes a scalar parameter. The porosity and the permeability
of the PLLA scaffold have been measured via Boyle’s pycnometer and SEM analysis. Data
for GelMa are scarce in literature. Since it is a surrogate material for cartilage and it remodels
into it after a sufficient incubation time into the bioreactor, we have initialised the model for
the former bioreactor configuration using data that have been previously measured for native
tissue (Taffetani et al., 2014).
6.1.3 Experimental validation
In order to validate the fluid dynamics model, tests about mixing (neat fluid and bovine serum
albumin) and glucose consumption were carried out. The bioreactor is connected to syringes
that allow the fluid perfusion. The pump is a Kyiatec model 200 series, volume, flow rate and
syringes depending on the speed test carried out. The syringes are connected to bioreactor by
assembled tubing in platinum-cured silicone and polypropylene fittings. At the end of the
process a gas exchange medium reservoirs collect the medium passed through the bioreactor.
In fig. 6.7 a schematic representation of the system is shown.
Fig. 6.7 Schematic representation of adopted system
Two different bioreactor configurations were tested, 1 unit cell and 4 unit cells array.
Furthermore, to validate the fluid dynamics model in different conditions, each configuration
was tested with the empty insert, insert with GelMA scaffold and insert with PLLA scaffold
(fig. 6.10) and three different fluid dynamic regimes. In figure 6.9 a sketch of the simulation
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pattern adopted is reported.
(a) (b) (c)
Fig. 6.8 Different insert conditions: a) Empty insert, b) Insert with gelMA scaffold, c) Insert with
PLLA scaffold
6.1.4 Mixing tests
For the flow model, the characteristics Reynolds number of the flow in the bioreactor was
calculated as follow:
Re=
rvD
µ
=
rvpD2
4µ
4
pD
=
rQ˙
µ
4
pD
(6.1.8)
where D = 1mm is the inlet diameter, r = 999.97Kg/m3 and µ = 0.001Pa⇤ s density and
dynamic viscosity of water, Q˙ is the flow rate in each chamber, equal to 1 ml/day, 2 ml/day
and 10 ml/day. Re⌧ 0.01 was found for each condition, thus the hypothesis of laminar flow
can be applied.
In table 6.4 and in table 6.5 the simulation results are reported.
To evaluate the difference of flow rate in the upper channel and in the lower channel after
the passage through the bioreactor, two different colours were adopted (fig. 6.10), green in
the upper part (diluted safrainin o fast green) and red in the lower part (diluted alizarin red).
It is not possible, indeed, to control the amount of flow rate in a direct way, the different flow
rate between the two fluids being too little for an experimental validation. In this way it was
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Fig. 6.9 Simulation pattern: two configurations (1 unit cell and 4 unit cells array), three conditions
(empty insert, insert with GelMA scaffold, insert with PLLA gradient scaffold) and three different fluid
dynamic regimes (LC=Lower Channel; UC=Upper Channel)
possibile to provide, at least, a qualitative trend.
(a) 1 Unit Cell (b) 4 Unit Cells Array
Fig. 6.10 Arrangement of the tests for mixing of the colours
The different fluids were collected after one day of perfusion. The analysis was carried
out via spectrophotometer. A spectrophotometer consists of two instruments, a spectrometer
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1 Unit Cell [ml/day]
Inflow Outflow
UC LC UC LC
Empty Insert
1 1 1.033 0.965
1 2 1.530 1.469
10 10 10.333 9.659
Insert with GelMA scaffold
1 1 1 1
1 2 1 2
10 10 10 10
Insert with PLLA scaffold
1 1 1.032 0.968
1 2 1.427 1.572
10 10 10.032 9.676
Table 6.4 Simulated results of fluid flow rate for 1 Unit Cell
4 Unit Cells Array [ml/day]
Inflow Outflow
UC LC UC LC
Empty Insert
1 1 1.035 0.964
1 2 1.553 1.446
10 10 10.353 9.643
Insert with GelMA scaffold
1 1 1 1
1 2 1 2
10 10 10 10
Insert with PLLA scaffold
1 1 0.898 0.827
1 2 1.495 1.374
10 10 8.985 8.268
Table 6.5 Simulated results of fluid flow rate for 4 Unit Cells Array
for producing light at a specific wavelength, and a photometer for measuring the intensity
of light. A cuvette containing a liquid is placed between the spectrometer beam and the
photometer. The amount of light passing through the tube is measured by the photometer,
which records a voltage signal depending on the amount of light absorbed by the liquid. First
of all the intensity of light (I0) passing through a blank is measured. The intensity is the
number of photons per second. Then, the intensity of light (I) passing through the sample
solution is measured. The transmittance (T) is ratio between the intensity of light passing
through the sample solution and the reference 6.1.9, meanwhile the absorbance (A) is the
decimal logarithm of the reciprocal of the transmittance 6.1.10.
T =
I
I0
(6.1.9)
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A= log10T (6.1.10)
The data were registered in terms of absorbance in a range from 400 nm to 700 nm with
an interval of 10 nm. In y-axis the percentage peak intensity was reported (fig. 6.11, 6.12,
6.13).
(a) 1 unit cell empty insert
(b) 4 unit cell empty insert
Fig. 6.11 Mixing colours tests: empty insert
In all graphs (fig. 6.11, 6.12, 6.13) are the same symbols are used. In solid line the
background, which is the spectrum of colours inside the syringes. Fluid flow rate 1 ml/day in
the upper channel and 1 ml/day in the lower channel in dotted line. In dashed line with 1
ml/day in the upper channel and 2 ml/day in the lower channel. A long dash-dot-dot line for
10 ml/day upper channel and 10 ml/day lower channel.
A qualitative comparison of trends with numerical simulation to verify the outcome of
numerical predictions was possible.
As a matter of facts the experimental trends agree well with the numerical simulations. In
all configurations and flow rates, fluid mixing follows the pressure gradient between lower
and upper chamber. The small difference in inner diameter between the two chambers
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(a) 1 unit cell with GelMA scaffold
(b) 4 unit cell array with GelMA scaffold
Fig. 6.12 Mixing colours tests: GelMA scaffold
implies that the upper outlet has a higher flow rate, and a red-in-green color mixing with
the associated change of green absorption spectrum. In the case of empty insert in 1 unit
cell, the model predict an inlet-outlet difference of 3.3% for the same flow rate configuration,
1-1 and 10-10, (1.033 ml/day or 10.333 ml/day upper outflow for 1 and 10 ml/day in inflow,
respectively) and a 53% upper inflow-outflow difference for the different upper and lower
flow rate configuration (1.530 ml/day outflow compared to 1 ml/day inflow). This prediction
is reflected onto the respective color spectra (fig. 6.11a). At equal flow rates the color spectra
perfectly overlap, at different flow rates the green color presented an increase in the peak
in correspondence of the maximum of the red peak. The combination of color is more
accentuated in the case of 4 unit cells case, figure 6.11b, as also confirmed by numerical
data. 3.5% for equal flow rate, 1-1 and 10-10, 55% for different flow rate 1-2. As expected
the most relevant mixing occurs for the unequal flow rate configuration, with a complete
change in outflow maximum peak intensity (green dashed line). By visual inspection, this
corresponds to a violet tint and the main peak at 510 nm (coincident with the red color inflow
peak) and a minor peak at 620 nm (coincident with the green color inflow peak). Focusing
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(a) 1 unit cell with PLLA scaffold
(b) 4 unit cell array with PLLA scaffold
Fig. 6.13 Mixing colours tests: PLLA scaffold
on a 1 unit cell with the GelMA scaffold in the insert figure 6.12a, the simulation predicts
no fluid mixing, and effectively the experimental inflow and outflow spectra superimpose
perfectly. Different is the case of the 4 unit cells array (6.12b). The numerical modelling
suggests no mixing, essentially the same outcome as for the 1 unit cell. However, in the
experimental flow results there is an additional peak in the upper chamber outflow spectrum
at 510 nm. This suggests that the GelMA scaffold, indeed, allows some degree of diffusion,
and that the cumulative effect of 4 chambers in series makes this more apparent.
Finally, for the PLLA scaffold, both for the 1 cell and the 4 cells bioreactor (fig. 6.13),
the spectra show a more pronounced commingling between the two chambers than would
be expected from the numerical modeling. This is hardly unexpected since the porous
PLLA scaffold is far from being as regular as modeled in the numerical simulations, and the
mechanism governing transport is a combination of diffusion and perfusion inside the pores.
As in the other cases, the most significant commixing occurs for the different fluid flow rates
in upper and lower chambers.
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6.1.5 BSA transport
Tests to experimental validate the fluid dynamics model about the diffusion of a specific
molecule were performed.
In this study, Alexa Fluor 555-conjugated albumin from bovine serum (BSA) (BSA555,
65kDa, Molecular Probes) was adopted.
The BSA is a serum albumin protein isolated from cows. Bovine serum albumin (often from
a fetal bovine source) is also used as a nutrient in cell and microbial culture. In molecular
biology, BSA is used to stabilize some restriction enzymes during digestion of DNA and
to prevent adhesion of the enzyme to reaction tubes, pipet tips, and other vessels. BSA is
considered to be a universal blocking reagent in many applications. This is because BSA
does not affect the functions of other proteins (enzymes) that do not need it for stabilization.
BSA is also commonly used to determine the quantity of other proteins, by comparing an
unknown quantity of protein to known amounts of BSA in, for instance, the Bradford Protein
Assay. BSA is used because of its stability to increase signal in assays, its lack of effect
in many biochemical reactions, and its low cost, since large quantities of it can be readily
purified from bovine blood, a byproduct of the cattle industry.
From literature (Lin et al., 2014) a BSA concentration of 10 µg/ml was used. In all different
flow rate regimes the BSA was perfused in the lower channel. To full specify the BSA
transport in ANSYS model two parameters are necessary: Ds,s the diffusion coefficient inside
the porous media; t the mass transfer coefficient between solid and liquid phase.
The diffusion coefficient is zero considering the PLLA impermeable to the solute, while
4.5x10 10[m2/s] for GelMA. Evaluating a diffusion regime inside the pores, the Sherwood
number is around the unit, then t becomes the ratio between the diffusion coefficient and the
pore diameter.
Sh=
td
Ds,s
= 1) t = Ds,s
d
(6.1.11)
In table 6.6 the transport coefficients for BSA and glucose are summarized. Concerning the
experimental test, after 1 day the medium was collected and analysed by Biotek synergy
HT spectrofluorometer in fluorescence detection method, 530/25 filter excitation and 590/35
filter emission.
First of all a standard curve was realised (fig. 6.14). To construct the standard curve 6
different concentrations were adopted: 1, 2.5, 5, 10, 20, 30 µg/ml, for each concentration a
different intensity signal, expressed in Relative Fluorescence Units (RFU), was registered.
The RFU is used in analysis employing fluorescence detection. Fluorescence is identified
using a charged coupled device (CCD), when the labeled fragments, are energized by laser
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BSA Glucose
GelMA PLLA GelMA PLLA
Df = Ds, f [m2/s] 7.1⇤10 10 7.1⇤10 10 6.7⇤10 10 6.7⇤10 10
Ds,s[m2/s] 3.918⇤10 18 0 3.958⇤10 10 0
t[m/s] 2.025⇤10 5 0 1.56⇤10 9 0
Table 6.6 Transport coefficients for BSA and glucose in PLLA and GelMA environment. The values
were acquired from (Anandan et al., 2007)
light and travel across the detection window. A software measures the results, determining the
quantity or size of the fragments, at each data point, from the level of fluorescence intensity.
Via standard curve, slope of the interpolating straight line, it was possible to calculate the
concentration of BSA on the different samples.
Fig. 6.14 Standard curve of BSA concentration from 0 µg/ml to 30 µg/ml
In figure 6.15 the comparison between experimental and simulated data is reported.
The graph shows the in y-axis the BSA concentration in µg/ml and x-axis the three conditions
(without, gelMA and PLLA scaffold) in different regimes. In bar graph the experimental
results each one with a specific error bar, in star symbol the modeled data.
Except for the case of different flow rates between lower and upper channel empty insert
and with PLLA scaffold, the BSA concentration basically remains unchanged after crossing
of bioreactor. The main deviation compared to the initial concentration is in 4 unit cells. The
final concentration in the lower channel is almost 5g/ml, whereas 4g/ml in upper channel.
In each case a good accord amongst the simulated and the experimental check can be noticed.
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(a) 1 Unit Cell
(b) 4 Unit Cells Array
Fig. 6.15 BSA concentration in µg/ml in different conditions and regimes. In bar graph the
experimental results each one with a specific error bar, in star symbol the simulated data
6.1.6 Glucose consumption
Animal cells, heterotrophs, derive their energy from coupled oxidation-reduction reactions.
Glucose (C6H12O6;MW : 180.16g/mol) is a primary fuel for heterotrophs. Energy derived
from glucose is stored in the form of high-energy phosphate bonds in ATP, or other nucleotide
triphosphates, and as energy-rich hydrogen atoms associated with the co-enzymes NADP
and NAD.
Efficient energy metabolism and maintenance of a reduced cellular environment depend upon
the fine balance of the pathways in response to environmental factors.
Glucose is unable to diffuse across the cell membrane without the assistance of transporter
proteins. Some hexose transporters allow glucose to flow passively from high to low concen-
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tration without requiring the expenditure of cell energy. Those that move glucose against its
concentration gradient consume energy, generally in the form of ATP. In vitro, the external
glucose concentration exceeds the intracellular concentration. Once inside the cell, glucose
is phosphorylated to glucose-6-phosphate (G6P) primarily by hexokinase. G6P can be con-
verted to glucose-1-phosphate (G1P), or enter the glycolytic or pentose phosphate pathway.
Glucose provides the reducing power needed to neutralize oxidative species (oxidative stress)
that form in vivo and in vitro.
When glucose levels are sufficient, its metabolites move through the PPP and glycolytic path-
ways to form glyceraldehyde-3-phosphate (G3P). Energy from glycolysis that is ultimately
stored as ATP is derived from reactions that occur at the level of glyceraldehyde-3-phosphate
and below. Pyruvate and the vitamin NAD have distinct roles in the transfer of reducing
equivalents into the mitochondrial systems. NAD delivers reducing equivalents to the elec-
tron transport system by shuttles that bypass the TCA cycle and pyruvate delivers reducing
equivalents through the TCA cycle.
Cell lactic acid dehydrogenase (LDH) can re-oxidize cytoplasmic NADH by converting pyru-
vate to lactic acid. This is a wasteful process that leads to a metabolic dead-end. NADH that
has not been oxidized by the aspartate:malate or gylcerol:phosphate shuttle is metabolized by
LDH. A buildup of lactic acid in cell culture systems is evidence that the shuttles are unable
to re-oxidize all of the NAD required to support G3P catabolism. At high levels, lactic acid
becomes toxic to cells.
The glucose consumption was modelled by Michaelis-Menten term. In this way the relation-
ship between nutritious consumption and nutritious concentration is not linear and it can be
described as:
v=
VmaxC
Km+C
esC (6.1.12)
where v is the reaction rate , Vmax is the maximum consumption rate depending on the species
and cell type, C is the concentration of the species, Km is the Michaelis-Menten constant,
equal to concentration of species when the reaction rate is half of Vmax and es is the solid
fraction of the porous medium.
The aforementioned values were imposed to Vmax = 9.925 ⇤ 10 17mol/cells and Km =
0.5026464kg/m3 (Pattappa et al., 2011). In this way, the non-linear model of Michaelis-
Menten allows to consider the variation of consumption rate as a response to the concentration
of the metabolite. This one involves a better approximation of the metabolic behaviour of the
cells.
GelMA and PLLA gradient scaffold with a MSCs suspension respectively of 106 cells/ml and
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2.5⇤105 cells/scaffold (taking into account the cell seeding efficiency) in a 4 unit cell array
were adopted. After 1 day the medium was collected and analysed by Biotek synergy HT
spectrofluorometer, in this case via colorimetric detection. The Glucose Assay Kit (abcam
ab65333) adopted in this study, specifically oxidizes glucose to generate a product which
reacts with a dye to generate color with a peak intensity of l = 570nm.
To measure the glucose concentration a calibration curve was built. Following the protocol
provided from the kit, standard curve dilution were prepared, 0, 2, 4, 6, 8, 10 nnmol/well (fig.
6.16).
A time point of 1 day was chosen as representative time to compare the two result sources.
Fig. 6.16 Standard curve of Glucose Assay Kit
Indeed one day is a enough to emphasize eventual relevant differences from the initial con-
centration of glucose, but, in the same time, the cell density is basically the same as the
beginning.
Table 6.7 and figure 6.17 report a comparison between the obtained data from the model and
the empirical results.
As shown, there is a very good matching in both cases. About GelMA scaffold the difference
between the average and the simulated value is less then 7% in the upper channel case and
less then 4% in the lower channel case. On the other hand, for PLLA scaffold, considering
the standard deviation, the data matching are substantially the same between the two different
conditions.
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Initial
Condition
GelMA scaffold
% Consumption
PLLA Scaffold
% Consumption
Simulated Experimental Simulated Experimental
UC 1.0053 4.90 5.23±1.11 6.54 5.38±1.2
LC 1.0053 8.14 7.95±1.08 10.81 8.65±2.05
Table 6.7 Glucose consumption in GelMA and PLLA scaffold after 1 day of proliferation inside the
bioreactor, all values are expressed in mg/ml
Fig. 6.17 Graphic representation of glucose consumption in GelMA and PLLA scaffold. In bar graph
the experimental results, in star symbol the simulated data
6.2 Cell culture inside the bioreactor system
Preliminary tests to examine the cell viability inside the bioreactor were carried out. Gradient
pore scaffold in PLLA and GelMA scaffold were adopted.
The cell seeding protocol reported in chapter 5 was adopted. Brefly 800,000 mesenchymal
stem cells were seeded per PLLA scaffold. The scaffolds were preconditioned by soaking
in DMEM cell culture medium overnight, after an overnight in ethanol 70% to ensure the
sterylization. The cells were seeded in static conditions by injecting them through a pipette.
In the GelMA scaffold a suspension of 10⇤106 cells/ml was injected.
Scaffolds were harvested at days 3 and 7 of culture and evaluated via live/dead stain and
MTS assay.
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Fig. 6.18 Schematic representation of
different parts of the scaffolds
analysed via Live/Dead cell viability
assay in PLLA scaffold (a) (b) (c)
Fig. 6.19 Schematic representation of
different parts of the scaffolds
analysed via Live/Dead cell viability
assay in GelMA scaffold (a) (b) (c)
6.2.1 Live/Dead
Samples via Live/Dead were analyzed on the side of the scaffold (see fig. 6.18a and fig.
6.19a), top/bottom (fig. 6.18b and fig. 6.19b) and cross sections (fig. 6.18c and fig. 6.19c).
For each configuration, the cell colonization corresponding to different pore dimension
was analysed.
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Fig. 6.20 Live/Dead Cell Viability Assays on the side of scaffold in different pore dimensions regions
Fig. 6.21 Live/Dead Cell Viability Assays on top and bottom of the scaffold
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Fig. 6.22 Live/Dead Cell Viability Assays on the cross section of scaffold in different pore dimensions
regions
Figure 6.20 report the live and dead at 3 days and 7 days on the side of the scaffold,
figure 6.21 upper surface and lower surface, figure 6.22 on the cross section, in different pore
dimensions regions.
After 3 days it is possibile to see as there is a good cellular adhesion in all sides of scaffold
but also on the upper part and in the lower part. Notwithstanding there is not a direct channel
inside the bioreactor to feed the cell to the center, the presence of a good amount of live cells
shows that the perfusion regime allows a complete diffusion of nutrient.
The cross sections underline a good penetration though non perfectly homogeneous. As
expected large pore sizes show a better penetration but the few amount of dead cells also in a
small pore size portion of the scaffold is a good results.
After 7 days, the total amount of cells is higher compared to 3 days, especially on the side of
the scaffold and everywhere one observe a good cell vitality.
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Fig. 6.23 Live/Dead Cell Viability Assays on GelMA scaffold
As concerning the gelatine methacrylate (fig. 6.23) both in the side and in center the
number of live cells far exceed the dead cells. This demonstrates the good quality of the
gelatine for cell vitality and proliferation.
6.2.2 MTS
The ability of the fabricated scaffolds and GelMA to allow adhesion and proliferation of
hMSCs was evaluated by MTS assay after three and seven days. The cell seeding efficiency
inside the PLLA scaffold was preliminary evaluated around 25%. One can notice (fig. 6.24a)
after seven days of proliferation a neat increase of mesenchymal cells, 4.5⇤105 compared
to 2.7 ⇤ 105 after three days. This result proofs the ability of the materials to support and
promote cell proliferation.
The same test was carried out for gelMA scaffold (fig. 6.24b). This technique allows to see
the amount of viable cells by chemical conversion of MTS, this process involves two steps:
diffusion of MTS from medium to cell and diffusion of formazan from cell to medium. Both
steps are slow processes, then probably three-four hours are not a sufficient time to estimate
the correct amount of cells. In any case from a relative point of view, the number of cells is
almost duplicated. This aspect coupled with the Live/Dead vitality test show the good quality
of the gelatine for cell culture.
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(a) MTS assay in PLLA scaffold (b) MTS assay in GelMA scaffold
Fig. 6.24 MTS assay at 3 and 7 days in PLLA and GelMA scaffold inside the bioreactor
6.3 Osteochondral regeneration
6.3.1 Chondro-Osteo differentiation
PLLA gradient scaffolds and GelMA scaffolds were seeded to induce the differentiation in
osseous-like tissue and cartilage-like tissue of human Mesenchymal Stem Cells. In order to
obtain a very strong experimental evidence of the capacity of the system to allow the cells
differentiation, hBMSCs from different patients were used.
The three replica of the experiments were performed pooling hBMSCs at passage 3 (P3)
from diverse patients: 1st replica (1 female patient 44 years old and 2 male patients 45 and
59 years old), 2nd (1 female patient 70 years old and 2 male patients 60 and 66 years old),
3rd (1 female patient 62 years old and 2 male patients 39 and 55 years old). Cylindrical
PLLA scaffolds (same dimension of the insert) and GelMA scaffold were uniformly seeded
with 800,000 bone marrow hBMSCs derived from total joint arthroplasty patients.
The scaffolds were preconditioned by soaking in DMEM cell culture medium, after an
overnight immersion in ethanol 70% to allow the sterylization. Then the scaffolds were
placed in the bioreactor or in multi-well plate. The gradient scaffolds in the bioreactor were
placed with the small pore side (~70 µm) in the upper chamber (UC) and the large pore
side (~200 µm) in the lower chamber (LC). In the bioreactor for 7 days a growth medium
(DMEM, 10% fetal bovine serum (FBS), penicillin/streptomycin/fungizone) was perfused at
2 ml/day, meanwhile in the multi-well plate the same growth medium was changed every 2-3
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days. After 7 days different media were adopted. Three sets of experiments were carried out.
• 1st Set. Influence of culture media. To obtain a distinct differentiation between the two
parts of the scaffold, different media were adopted. Chondrogenic medium (DMEM,
10 ng/ml TGF-b3 (PeproTech), 1% insulin-transferrin-selenium, 50 µM L-ascorbic
acid 2-phosphate (AsA2-P), 40 µg/ml L-proline) was supplied to the UC, and os-
teogenic medium (DMEM, 10% FBS 0.1 µM dexamethasone, 50 µg/ml AsA2-P, 10
mM b -glycerophosphate) to the LC, both at a flow rate of 2 ml/day. In this case PLLA
scaffold and GelMA were adopted.
• 2nd Set. Influence of pore size. To identify the influence of pore dimension in the
differentiation of hMSCs, the same medium in upper chamber and in the lower chamber
was adopted. In one case only osteogenic medium in the other case only chondrogenic
medium, with the same aforementioned compositions and at the same flow rate 2
ml/day. For both test the PLLA gradient scaffold was used.
• 3rd Set. Influence of bioreactor. As a control two gradient scaffolds and two homo-
geneous scaffolds were seeded and placed in 6-well plate. About the homogeneous
scaffolds two different pore size were adopted, ~70 µm and ~200 µm, Gradient scaf-
folds and 200 µm scaffolds in osteogenic medium were cultured on the one side,
whereas gradient scaffolds and the 70 µm scaffolds in chondrogenic medium on the
other side.
In fig. 6.25 a schematic representation of the experimental pattern is reported.
After 30 days of differentiation the scaffolds in bioreactor and in plate were analyzed.
One scaffold for each type was fixed for histology staining. The other three scaffolds were
cut in two parts on the traverse plane for real-time PCR analysis.
6.3.2 Histology staining
The scaffolds removed from bioreactor and multi-well plate were fixed in 4% paraformalde-
hyde overnight and then followed the deparaffinization process. After a double immersion
in xylene, the samples were dipped in paraffin and maintained at 4°C. At the end of the
process the scaffolds were cut in 10 µm section and stained with alcian blue and alizarin
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Fig. 6.25 Graphic representation of the adopted experimental pattern. a) GelMA scaffold, b) PLLA
gradient scaffold, c) 200 µm, d) 70 µm scaffold,. In yellow colour the growth medium, in blue colour
the chondrogenic medium and in red colour the osteogenic medium
red. Alcian blue is one of the most widely used cationic (it has many positive charges on the
molecule) dyes for the highlights of glycosaminoglycans. It is thought to work by forming
reversible electrostatic bonds between the cationic dye and the negative (anionic) sites on the
polysaccharide. These electrostatic bonds can be readily broken, revealing what appears to be
a variation in bonding among different types of glycosominoglycans. When the concentration
of electrolyte required to break the bond is increased progressively, then neutral, sulphated
198
6.3 Osteochondral regeneration
and phosphated mucopolysaccharides may be identified in tissue sections. Alizarin Red S,
an anthraquinone derivative, may be used to identify calcium in tissue sections. The reaction
is not strictly specific for calcium, since magnesium, manganese, barium, strontium, and iron
may interfere, but these elements usually do not occur in sufficient concentration to interfere
with the staining. Calcium forms an Alizarin Red S-calcium complex in a chelation process,
and the end product is birefringent.
• 1st Set. Influence of culture media. At 4 weeks of differentiation, cell morphology and
extracellular matrices (ECMs) were examined by histological analysis. In both cases,
PLLA the constructs exhibited strong alcian blue staining on the side residing in the
upper chamber perfused with chondrogenic medium and alizarin red staining in the
part residing in the lower chamber (exposed to osteogenic medium) (6.31).
Less evident but equally visible is the case of GelMA. In this case the cell spots clearly
different from gel matrix were possible to distinguish (fig. 6.33).
(a) Alizarin red staining in PLLA scaffold (b) Alcian Blue staining in PLLA scaffold
Fig. 6.26 Histology staining. a) Small pore size in the upper chamber exposed to chondrogenic media;
b) Large pore size in the lower chamber exposed to osteogenic media
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(a) Alcian Blue staining in GelMA scaffold (b) Alizarin red staining in GelMA scaffold
Fig. 6.27 Histology staining. a) Upper chamber exposed to chondrogenic media; b) Lower chamber
exposed to osteogenic media
• 2nd Set. Influence of pore size. In figures 6.28a and 6.28b the whole scaffold section is
reported. In both cases it is evident a gradient of differentiation along the pore dimen-
sion gradient. In the first case, fig. 6.28a, the hMSC differentiation affects the entire
scaffold but there is a higher production of GAGs in the upper part, corresponding to
small pore size. This is probably due to the fact that the small pore dimension can
recreate the hypoxic environment to promote the cartilage formation (see section 5.1).
In the second case (fig. 6.28b) a higher alizarin red staining is evident in the large pore
dimension, the bottom of the scaffold. The possible causes can be the larger dimension
of osteoblasts compared to chondrocyte and an easier nutrient perfusion.
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(a) Alcian blue staining. Gradient
scaffold in bioreactor
(b) Alizarin red staining. Gradient
scaffold in bioreactor
Fig. 6.28 Histology staining of gradient pore PLLA scaffold exposed to the same medium in upper
and lower chamber. a) Gradient scaffold cultured in the bioreactor, exposed to osteogenic medium, b)
Gradient scaffold cultured in the bioreactor, exposed to chondrogenic medium
• 3rd Set. Influence of bioreactor. To evaluate the influence of the bioreactor different
tests in multi-well plate were carried out. For the first group, gradient and 200 µm
scaffold in osteogenic medium (fig. 6.29), it is possible to individuate in both cases
the production of calcium from osteoblasts, though less than in the bioreactor. The
perfusion of the nutrient inside the construct in this case is less accentuate.
Dissimilar the behaviour is for the second group, gradient and 70 µm scaffold. The
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homogenous scaffold has an uniform and elevate production of GAGs in the entire
scaffold that means a good cartilage-like tissue. The gradient scaffold presents an
comparable expression of the bioreactor.
(a) Alizarin red staining (b) Alizarin red staining
Fig. 6.29 PLLA scaffold with gradient and homogenous pore size, cultured in multi well plate,
exposed to osteogenic medium. a) Gradient scaffold; b) 200 µm scaffold
(a) Alcian blue staining (b) Alcian blue staining
Fig. 6.30 PLLA scaffold with gradient and homogenous pore size, cultured in multi well plate,
exposed to chondrogenic medium. a) Gradient scaffold; b) 70 µm scaffold
6.3.3 Real-Time quantitative PCR
Simultaneous to the histological analysis, Real-Time quantitative PCR was carried out. The
scaffolds were collected separately. Each construct was cut and analysed the top and the
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bottom of the scaffold. RNA was extracted using Trizol (Invitrogen) following the standard
protocol after the smashing of the sample in liquid nitrogen environment. SuperScript III kit
(Invitrogen) was utilised with random hexamer primers to complete the reverse transcription.
Real-time RT-PCR was performed using the StepOnePlus thermocycler (Applied Biosystems,
Foster City, CA) and SYBR Green Reaction Mix (Applied Biosystems). The expression
levels of 18S were used as endogenous controls and the various gene expression levels
were calculated using the comparative Ct method. SOX 9, Aggrecan (ACAN), collagen
type II (COL2) were used as indicative genes for cartilage, Runt-related transcription factor
2 (RUNX2), Bone sialoprotein 2 (BSP II) and osteopontin (OPN) for bone. The gene
expressions were analysed.
• 1st Set. Influence of culture media. In both cases, chondrogenic and osteogenic media,
the regulation of tissue specific genes is very well defined. hBMSCs cultured in 3D
scaffold were used as control, all values were reported as relative gene expression
related to hBMSCs not differentiated. The scaffolds were cut in parts corresponding to
upper chamber and lower chamber, and each part was analyzed via Real-Time PCR. In
figures 6.31, 6.32, 6.33, 6.34 the different gene expressions were reported. Focusing
on chondrogenic genes (COL 2, ACAN and SOX 9) their upregulation is up to several
hundred thousands times (COL 2) more expressed in the case of UC compared to
LC. In the case of bone-like tissue the difference of gene expression between the
two parts is less marked than the chondro-like tissue but in any case a clear trend is
distinguishable.
(a) (b) (c)
Fig. 6.31 Relative gene expression of cartilage markers in PLLA gradient scaffold cultured in the
bioreactor with diverse differentiation media in upper and lower chamber
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(a) (b) (c)
Fig. 6.32 Relative gene expression of bone markers in PLLA gradient scaffold cultured in the
bioreactor with diverse differentiation media in upper and lower chamber
(a) (b) (c)
Fig. 6.33 Relative gene expression of cartilage markers in GelMA scaffold cultured in the bioreactor
with diverse differentiation media in upper and lower chamber
(a) (b) (c)
Fig. 6.34 Relative gene expression of bone markers in GelMA scaffold cultured in the bioreactor with
diverse differentiation media in upper and lower chamber
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• 2nd Set. Influence of pore size. For the second set of experiments after one week of
cells proliferation the same differentiation media for upper chamber and lower chamber
were adopted. In one case chondrogenic medium, in the other case osteogenic medium.
This set of experiment was carried out to verify if the only difference in morphology,
without other factors, could influence the gene expression. Adopting the same protocol
of previous test, the scaffold was cut in parts to enlighten the diverse contribution. Both
in chondrogenic and in osteogenic media the trend is well defined. For cartilage-like
tissue the small pore size higher enhances the chondro-differentiation (fig. 6.35), while
the bone-like is enhanced from the large pore size (fig. 6.36).
In the case of cartilage tissue this behavior can be due to more intense contact between
cells. The larger pores required more cells to fill the entire free space, while the smaller
pores can be more easily filled with cells. Filling the pores can increase the cell-
cell interactions and provide a good three-dimensional microenvironment to promote
chondrogenic differentiation and cartilage tissue formation.
(a) (b) (c)
Fig. 6.35 Relative gene expression of cartilage markers in PLLA gradient scaffold cultured in the
bioreactor with the same differentiation media in upper and lower chamber
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(a) (b) (c)
Fig. 6.36 Relative gene expression of bone markers in PLLA gradient scaffold cultured in the
bioreactor with the same differentiation media in upper and lower chamber
• 3rd Set. Influence of bioreactor. The third set of experiment was realised in multi-well
plate to show the influence of the bioreactor in the cell culture. Furthermore, tests
in homogeneous scaffold in term of pore dimension were effectuated as endogenous
control. Taking into account the chondrogenic tests (fig. 6.37) it is possible to see a
trend in the case of gradient scaffold, the small pore size are always more expressed
that the large pore size. In the case of 70 µm scaffold (fig. 6.38) the main upregulation
of the gene it is not persistent on the same part of the scaffold (COL2 and ACAN
bottom, SOX9 top). The PCR results show very high values in absolute terms for all
chondro genes, this aspect proves the good capacity of the scaffold to allow the cell
proliferation and differentiation also in the simplest cell culture conditions.
Similar results were found in the osteogenic test reported in figure 6.39. In both cases
the span of the values between large and small pore is less remarkable than in the
chondro differentiation, in any case, while in the gradient scaffold this tendency is
constant, the 200 µm (fig. 6.40) does not exhibit a constant higher upregulation of the
gene in a specific section of the scaffold.
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(a) (b) (c)
Fig. 6.37 Relative gene expression of cartilage markers in PLLA gradient scaffold cultured in multi
well plate
(a) (b) (c)
Fig. 6.38 Relative gene expression of cartilage markers in PLLA 70µm scaffold cultured in multi well
plate
(a) (b) (c)
Fig. 6.39 Relative gene expression of cartilage markers in PLLA gradient scaffold cultured in multi
well plate
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(a) (b) (c)
Fig. 6.40 Relative gene expression of bone markers in PLLA 70µm scaffold cultured in multi well plate
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Chapter 7
Conclusions
Different strategies to produce PLLA-based scaffolds for osteochondral regeneration purposes
were investigated in this thesis. PLLA has been widely used as material for three-dimensional
polymer scaffolds suitable for cell transplantation, owing to its biodegradability and biocom-
patibility. The scaffolds were produced via TIPS technique starting from a ternary solution,
which presents the main advantage to control pore size simply by varying the T vs. time
protocol.
By taking advantage of this aspect, an experimental apparatus able to produce porous foams
with a monotonous uni-dimensional pore size gradient via TIPS was developed and pre-
sented. Generally, one of the most adopted techniques to produce foams with a gradient pore
dimension consists in the bonding together of several layers with different controlled pore
distribution. Although these techniques are versatile, the main disadvantage is represented
by the number of steps necessary to obtain the overall morphology and the resulting disconti-
nuity between layers. According to the technique proposed in this thesis work, the foams
were produced via a single step operation, without requiring the junction of multiple layers
or the use of graded porogens.
A monotonous unidimensional variation of pore dimensions along the foam thickness was
obtained by imposing different thermal histories on the two surfaces of sample (via pro-
grammed Peltier cells). Manipulating the temperature and/or the time during the nucleation
and growth process, a relatively large pore size range can be obtained. By increasing demix-
ing temperature pore size globally increases (i.e. 80-260 µm at 35°C); on the other hand,
when decreasing the temperature, pore size globally decrease (i.e. 40-160 µm at 25°C).
In principle, this procedure can be adopted to produce foams with various overall thicknesses
or different materials, by varying the distance between the Peltier elements or the ternary
solution.
To mimic as closely as possible the tissue to regenerate, a neat polymer is often not adequate.
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PLLA, indeed, does not posses the appropriate bioactivity and, in the case of bone tissue,
osteoconductivity. To overcome these limits, composite PLLA/HA scaffolds were produced.
Some papers described the possibility to include HA in a polymer network via TIPS, starting
from a binary mixture polymer-solvent. However, in those cases, the so-obtained scaffolds
show an irregular and anisotropic structure with very few parameters to tune as a function of
the specific tissue applications. The exploitation of the liquid-liquid separation can overcome
these limits.
Based on the results of the thesis work, it is possible to state that the presence of the HA did
not influence the phase separation process in terms of demixing temperature. As a matter of
fact, a porous and interconnected structure was observed in the bulk of the scaffolds. SEM
analysis revealed the presence of HA particles, confirmed by XRD analysis. As for porosity,
when increasing HA content, the overall porosity decreases since a partial portion of open
pore is occupied by HA particles. In spite of this slow reduction, porosity reaches about
~90% at HA weight percentage of 66%. This result confirms that even in the presence of
a large amounts of HA, the scaffolds are characterized by a highly porous structure. TGA
analysis showed a good agreement with the amount of filler within the initial solution, with
an average discrepancy of 10-15%.
Besides hydroxyapatite different varieties of another very interesting filler was tested: the
bioglass. In particular, two different BGs compositions (1393 and 45S5) were compared in
terms of topography, biodegradation and bioactivity. About the scaffold morphology, SEM
micrographs showed that the addition of 1393 BG did not affect the final morphology of the
scaffolds; on the contrary, the presence of 45S5 BG, at higher percentages, interacted with
the phase separation process, probably due to the higher reactivity of the 45S5 compared
to the 1393. The composite scaffolds showed a significant increase in weight loss when
compared to the pure PLLA. The bioactivity tests showed positive results for both composite
PLLA/BG scaffolds; via SEM images the typical cauliflowers-like shape of HA morphology
was observed after 4 weeks of soaking in SBF; XRD and FTIR analysis confirmed the
formation of HCA layer. These results strengthen the possibility to successfully include
BG or HA particles in PLLA scaffolds via a modified ternary TIPS in a reliable ’one-shot’
protocol for the synthesis of foamed composites where the compositional variable (filler
content) can be tuned up separately. This fact allows one to compare the effectiveness of
different types of fillers and contemporary accurately tune the structure of the scaffold.
In addition to the material characterization, several biological tests for cell culturing of
different cell lineages on different substrates were also carried out.
TIPS technique was adopted to produce pure PLLA scaffold with two different average
pore dimensions ~100 µm and ~200 µm. The results showed that the scaffolds maintained
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the differentiated phenotype of articular and nasoseptal chondrocytes and supported the
proliferation of MSCs. The important influence of the pore size in a porous scaffold for
cartilage tissue engineering was previously reported with divergent results as a function of the
scaffold material and cell type. This is the first work investigating the influence of pore sizes
of PLLA scaffolds on human chondrocyte differentiated phenotype. The study reveals that a
relative small difference in scaffold pore size determined recognizable effects on cartilage
markers, in particular small pore dimensions (100 µm) best promote chondrogenesis in PLLA
scaffolds.
Live/dead and MTS assay in PLLA gradient scaffolds seeded with MSCs showed the re-
markable ability of the scaffold to support the proliferation, specifically via MTS assay a
cell number more than duplicated compared to the initial one after 7 days of culture was
observed.
Preliminary viability tests of articular chondrocytes in composite PLLA/BG showed a very
satisfactory cytocompatibility of the scaffold to support the cell culture.
Biological studies on PLLA/HA demonstrated that filler did not influence the cell viability
on scaffold during in vitro cell cultures with mouse preosteoblastic MC3T3-E1 cells. Further-
more, the osteoblastic phenotype was supported by the presence of HA particles evidencing
the ability of the filler to increase the ALP activity respect to pure PLLA.
The last part of the thesis was dedicated to the study of a bioreactor capable to reproduce
the physiological conditions of the osteochondral junction. The bioreactor was preliminary
characterized and modeled, then tested with the gradient pore scaffold. The microphysio-
logical tissue system (MTS) bioreactor has been developed to replicate in vitro the in vivo
the osteochondral physiological conditions, allowing a separate control of the condral and
osseous environments. At the end of the period of culturing (7 days of cell expansion and
28 days of differentiation) a spatially defined biphasic differentiation of hMSCs within the
scaffold was observed. The different cells type (chondrocytes and osteoblasts) were obtained
from a unique cell variety. Furthermore, the effect of the culture media, pore size and biore-
actor were separately investigated. Finally, single unit biodegradable scaffold produced with
local gradient pore structure was tailored for chondro- and osteoinduction and successfully
used in-vitro for studying and improving osteochondral tissue repair, providing mechanical
stability and local cues for cell differentiation.
In conclusion, different approaches were adopted in order to fathom which strategies best
work on chondral and osteochondral regeneration based on PLLA scaffold produced via
TIPS technique.
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Chapter 8
Future work
The results showed in this thesis seem to open new perspective for future developments.
First of all, a better comprehension of the phase separation mechanism could increase the
possibility to obtain wider pore dimension range. Phase separation is a complex combination
of thermodynamics and kinetic mechanisms that depends on the specific adopted system. A
deeper knowledge of the system, by simulating a complete phase diagram of the solution,
should allow a better control of the final morphology of the scaffold.
As for the gradient pore scaffold, we focused on the gradient of pore size generated by
the different time periods spent by each sample layer inside the metastable region at a
given temperature. Further tests can be carried out by setting different temperatures at
each side of the scaffold, to investigate the effect of two mechanisms (nucleation-and-
growth and spinodal decomposition) inside the same construct. The methodology to produce
the gradient pore scaffold here developed is potentially easily scalable and applicable to
multiple systems. Moreover, different polymer solutions and thickness of the foam can be
tested. The composite scaffolds, preliminary investigated, need further investigations. A
combination of the gradient pore dimension with HA particles should perfect mimic the
difference of morphology between the compact bone and the spongy bone. At the same
time, by taking advantage of the TIPS technique, a gradient of filler along the axis of the
foam or a combination of compositional and pore dimension gradient can be designed and
attained. In principle, local average pore dimension and spatial dispersion of filler can be
easily manipulated by a single-step production process.
Furthermore, concerning bioglass particles, once assessed that the 1393 better matched with
the scaffold production technique, different ions can be added to the standard composition,
such as Cu, Li, etc. in order to increase the interaction scaffold-living tissue.
Preliminary in-vitro tests with different cell lineage showed the good biomimetic capacity
of the scaffold but to really verify if the scaffold can be used for clinical applications, in-
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vivo tests should be designed and carried out. Tests in animal models can provide crucial
informations to optimize the scaffold’s design and performance.
Finally, the seeded scaffold inside the bioreactor system can be used for in-vitro screening of
new drugs for chondral and bone repair as a model for analysing the response of cell response
due to an inflammatory signal (e.g. IL-b1) in a customizable 3D system.
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